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ABSTRACT 
 
The increase in multidrug resistance (MDR) among bacterial pathogens is an 
ongoing threat to public health, with the CDC estimating more than 2.8 million MDR 
infections in the United States each year, and greater than 35,000 deaths annually. Gram-
negative bacteria possess intrinsic mechanisms to resist available therapeutics and are 
frequently responsible for difficult-to-treat nosocomial, blood stream, and soft tissue 
infections. In addition to biophysical and genetic MDR mechanisms, Gram negatives are 
metabolically versatile, enabling them to utilize host-derived nutrients to promote 
proliferation and colonization within the host. The metabolic versatility of Gram-negative 
bacteria is due, in part, to the transcription of a diverse array of compound-specific 
transcriptional regulators, which facilitate the integration of extracellular signals into 
transcriptional changes. This ability to adjust to a changing extracellular environment 
contributes to the success of a bacterium as an opportunistic pathogen. Many 
opportunistic pathogens are found in environmental reservoirs and evolve or acquire 
mechanisms within these competitive niches that are also effective during host-infection. 
Some of these multipurpose systems pertain to the utilization of host-derived compounds. 
While the title ‘host-derived’ suggests that these compounds are exclusively encountered 
as integral parts of the host, bacteria also encounter host-derived compounds in other 
contexts, such as within soils or aquatic ecosystems. The compounds focused on in this 
dissertation can be derived from within the host, but are also found within environmental 
niches. Here we investigate, through genetic, transcriptomic, and biochemical 
approaches, how three Gram-negative bacteria of varying degrees of virulence, 
Pseudomonas putida, Stenotrophomonas maltophilia, and Pseudomonas aeruginosa, 
interact with several host-derived compounds, including creatine, sphingosine, and 
mucin. It is important to gain a deeper understanding of how bacteria utilize these host-
derived compounds, and how this utilization effects the transition to and exploitation of 
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CHAPTER 1: Introduction  
 
 
1.1 Bacterial metabolic versatility  
Bacteria are instrumental in the recycling of earth’s essential elements. Through 
processes such as respiration, nitrification/denitrification, and carbon and nitrogen 
fixation, bacteria incorporate elements from organic or inorganic sources, such as dead 
biotic material or the atmosphere, into themselves or into compounds that can be utilized 
by other living organisms. Bacteria participate in nutrient recycling in various niches, 
including soils and water systems, with each environment possessing a distinctive 
assortment of available nutrients. In soils, bacteria are important players in the carbon 
and nitrogen cycles, fixing atmospheric CO2 or N2 for assimilation into other 
organisms[1]. Conversely, bacteria return carbon and nitrogen to the environment through 
decomposition of organic matter, respiration, and mineralization[1]. In aquatic niches, 
bacteria participate in the oxidation of organic matter, mineralizing elements such as 
sulfur, iron, and phosphorous [2], [3], [4]. Pseudomonas and Stenotrophomonas species, 
which will be the focus of this dissertation, participate in many important biogeochemical 
cycling processes in environmental niches but are also able to transition successfully 
from water and soil to the human infection niche, which is abundant in organic nutrients 
[5], [6], [7], [8]. The growth and survival of bacteria in a variety of niches whether nutrient 





1.2 Metabolic strategies for bacterial nutrient acquisition  
Several elements are required for all life, especially the macronutrients carbon, 
hydrogen, nitrogen, phosphate, sulfur, and oxygen. In order to satisfy elemental 
requirements bacteria employ a variety of strategies focused on nutrient acquisition. Here 
we will focus on strategies used by Pseudomonas and Stenotrophomonas species to 
acquire essential carbon and nitrogen from the environment. These Gram-negative 
bacteria are characterized as chemoheterotrophic, gaining carbon and nitrogen from other 
organisms (decaying organic matter, host-derived compounds) and the environment 
(fixation of CO2) and copiotrophic, responding quickly to and successfully exploiting 
nutrients that are abundant in the environment [9], [10], [11], [12].  
Nutrient availability is the limiting factor for bacterial growth in any given 
environment [13]. In a diverse microbial niche competitive interactions are complex, with 
species of bacteria out-competing each other for limiting nutrients in non-transitive 
fashions (Figure 1.1) [13], [14]. Depending on the environment, bacterial growth strategies 
can be divided into two categories, exploitative competition and competition by 
interference [13], [15], [16], [17]. 
 
1.2.1 Exploitative Competition 
Exploitative competition is a passive process where a certain bacterial species 
dominates a niche by efficiently utilizing the available nutrients, resulting in depletion of 
resources and growth inhibition of competing organisms [13], [17]. Success in the 
exploitative field of competition is aided by constant and/or fast growth kinetics [18]. In a 
nutrient rich but competitive environment, fast growth, or a copiotrophic growth strategy, 
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ensures niche domination, while in nutrient limited environments slower but constant 
growth and an oligotrophic or generalist metabolic strategy is favorable [19], [20], [21], [22]. 
The impact of bacterial diversity and increased competition in a given environment on 
bacterial growth rate is demonstrated by the evolution of a bacterial species after it 
changes its niche. The transition of P. aeruginosa from environmental reservoirs into the 
human lung demonstrates how adaptation to a specific niche can impact bacterial growth 
strategy. During the beginning stages of infection, P. aeruginosa enters the lung as a 
generalist with high metabolic versatility and is able, through the use of its diverse 
compound-specific metabolic systems, to rapidly exploit host-derived compounds to 
promote fast growth and colonization [23]. As P. aeruginosa transitions into a chronic 
lung infection, it begins to adapt to the lung environment, acquiring mutations resulting 
in loss of motility, a decrease in transcription of virulence associated genes, development 
of auxotrophy, and slower growth [24], [25], [26]. Reciprocal to the correlation between 
development of auxotrophy and decreased growth rate in P. aeruginosa, a positive 
correlation between growth rate and metabolic versatility has been observed in 
Escherichia coli and many other Gram-negative bacteria [27], [28], [29], [30].  
 Given that constant efficient growth is always a safe bet for niche domination, 
having a genome large enough to house various metabolic pathways, as well as a large 
proportion of regulatory genes for precise control, provides a significant competitive 
advantage when there is a fluctuating and diverse array of nutrients available [31]. 
Increased metabolic flexibility allows a bacterium to efficiently adjust its metabolic 
strategy in order to dominate a given niche, while tight control of genes by transcriptional 
regulators maintains a favorable balance between energy expenditure and yield [32]. This 
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is especially important when there is extensive metabolic overlap between competing 
species, a situation where a small decreases in growth efficiency can have a large impact 
on competition and therefore survival [13], [33], [34], [35], [36], [37], [8], [38].  
Pseudomonas species are generalist Gram-negative bacteria with large, 
metabolically versatile genomes and a high ‘environmental scope index’ or ESI, which 
means that they are capable of growing in a diverse array of environments [31], [39]. This 
high ESI as well as their competitiveness in diverse microbial environments is due in part 
to their metabolic versatility. When Pseudomonas flourescenes is grown in competition 
with other soil-dwelling bacteria, ~45% of the characterized induced genes are involved 
in transport and metabolism of specific compounds [40]. Pseudomonas aeruginosa, a 
bacterium characterized as an opportunistic pathogen – a pathogen that can cause 
infection under certain circumstances such as when the immune system of the host is 
compromised – also alters transcriptional levels of metabolic genes in response to the 
selective pressures of its niche. When P. aeruginosa transitions from a diverse reservoir, 
such as the soil or water, into a chronic lung infection of an individual with cystic 
fibrosis, persistence becomes more important than fast growth for niche domination, and 
slow growing, auto-aggregative, exopolysacchride-producing small colony variants 
(SCVs) arise , [29], [30], [41]. These SCVs are clones of P. aeruginosa that have reversibly 
inverted large areas of their genome, resulting in transcriptional repression of a majority 
of metabolic genes [28]. Transcription of siderophores – transport molecules that have a 
high affinity for certain compounds – is another way that bacteria compete for essential 
nutrients that are under heavy demand. Pyoverdines are the iron scavenging siderophores 
secreted by P. aeruginosa to sequester iron from co-infecting cystic fibrosis (CF) 
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pathogen Staphylococcus aureus [42], [43]. Sequestration of free iron in the lung inhibits the 
activity of S. aureus’s electron transport chain, forcing a shift to fermentative metabolism 
and reducing S. aureus’s fitness in the CF lung [44].    
 
1.2.2 Competition by interference  
 When extensive metabolic overlap between species in a given niche causes  
growth rate to be insufficient for niche domination, bacteria must resort to more active 
forms of competition, including competition by interference. Antagonistic behavior 
towards competing bacteria manifests in the secretion of secondary metabolites such as 
anti-bacterial compounds, contact-dependent inhibition involving the injection of 
competing neighbors with toxins, and secretion of enzymes to inhibit intra-species 
communication [13], [17]. Competing bacteria can ablate communication between members 
of a different species, called ‘quorum-signaling’, by using quorum-sensing inhibitors to 
physically block communicatory molecules called ‘auto-inducers’, or by degradation of 
auto-inducers via secreted lytic enzymes [45]. While secreted enzymes aimed at 
degradation of auto-inducers are generally harmful to targeted bacterial populations, 
other secreted secondary metabolites help to liberate nutrients for the community at large, 
an example of cooperative ecological strategy. 
 
1.2.3 Cooperation  
 Cooperation via synergistic metabolic networks or intra/inter-species cross-
feeding is an effective metabolic strategy when co-existing microbes don’t have much 
metabolic overlap or when the majority of nutrients in a niche are sequestered within 
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highly complex substrates [19], [20], [21], [46], [47], [48]. Cooperation between species has been 
studied in various environments ranging from the gut and soil to the cystic fibrosis lung 
during infection, where pathogens in the lung coexist by stratifying into different regions 
depending on oxygen and nutrient requirements [49], [50], [51], [52]. 
Co-existing microbes tend towards synergistic, or syntrophic, metabolism when 
the primary available nutrient source is too complex for any one member of the niche to 
rapidly or efficiently metabolize alone. The co-evolution of Pseudomonas putida sp. 
KT2440 and Acinetobacter sp. C6 grown on benzyl alcohol as the sole source of carbon 
is an example of this. The growth rate of both bacteria is much higher when they are able 
to synergistically metabolize benzyl alcohol, with Acinetobacter participating in the first 
step of metabolism to supply benzoate as a carbon source for P. putida [53], [54]. 
Lignocellulose is another substrate that requires bacterial cooperation for metabolism, 
due to its highly complex and recalcitrant structure. When supplied as the sole source of 
carbon, bacterial communities form consortia to synergistically degrade lignocellulose, 
but when a more accessible nutrient is added to the mix, the once cooperative groups fall 
back into competition [46]. Many bacterial synergistic processes that take place in the soil 
also aid in the growth of more complex organisms such as plants. An example of this is 
the process of nitrification, which relies on the interplay between ammonia-oxidizing and 
nitrite-oxidizing species of bacteria [55].  
Cooperative metabolic strategies are also useful during bacterial pathogenesis. In 
silico modeling has been used to predict the capacity for cross-feeding between 
opportunistic pathogens that commonly co-infect the lungs of individuals with cystic 
fibrosis. Some of the predictions made via in silico modeling have been supported 
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experimentally, such as the ability of mucin degradation by Streptococcus species to 
supplement growth of Burkholderia species by supplying acetate for consumption [49], [50], 
[51].  
The metabolic strategies outlined above are focused on interspecies cooperation, 
but intraspecies cooperation is also a common bacterial metabolic strategy when the 
primary nutrient source is homogeneous or when nutrients are limited [33], [48], [56], [57], [58], 
[59]. When a single nutrient source is supplied in continuous culture, subpopulations with 
substrate preferences for metabolic intermediates of the primary substrate arise within a 
monoculture bacterial population. This phenomenon has been observed in populations of 
Escherichia coli, where after ~800 generations of growth on glucose, polymorphic 
populations with preferences for secondary metabolic intermediates, acetate and glycerol, 
were isolated from culture [33], [48], [58], [59]. This cooperative intraspecies cross-feeding 
strategy, made possible by genetic and physiological diversification over time within a 
single population, can transform a previously homogeneous nutrient landscape into a 
dynamic one, supporting the growth of multiple polymorphic populations at different 
rates [33], [48], [58], [59].  
Other cooperative strategies that can function in either an intra- or inter-species 
capacity are the formation of protective multicellular architectures called biofilms, and 
the production of siderophores, which can be used for acquisition and dissemination of 
public goods to members of a given population [57], [60], [61], [62], [63], [64], [65], [66].    
While the afore-mentioned cooperative strategies are useful in certain situations, 
in niches where more metabolic overlap occurs between species, such as in fresh, 
brackish, and tap water environments, competition for nutrients increases, driving 
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bacterial away from altruism [38], [67]. It is the evolutionary pressures exerted by these 
highly competitive environments that create bacteria with the metabolic flexibility and 
competitive strategies essential to becoming effective opportunistic pathogens, and it is 
from these environments that most opportunistic pathogens emerge [8], [38], [68], [69], [70], [71]. 
 
1.3 Gram-negative bacteria with varying degrees of virulence interact with host-
derived compounds  
The metabolic strategy of a given bacteria plays a large role in determining its 
ability to establish an infection within a host. Specifically, the ability to access and utilize 
host-derived compounds is an absolute requirement for opportunistic pathogens during 
infection, an idea that is not new[72]. Many host-derived compounds, or compounds 
similar to those found in the host, are also found in environmental niches [73], [74]. 
Therefore, systems for utilization of host-derived nutrients are not limited to professional 
and opportunistic pathogens but are also found in many non-pathogenic bacterial species. 
Three Gram-negative bacteria of varying virulence are the focus of this dissertation: the 
primarily non-pathogenic Pseudomonas putida, the emerging opportunistic pathogen 
Stenotrophomonas maltophilia, and the common opportunistic pathogen Pseudomonas 
aeruginosa. The characteristics of these bacteria, and their degree of interaction with the 




1.3.1 Pseudomonas putida   
Pseudomonas putida is a Gram-negative bacterium found primarily in soils and 
water systems [74], [75]. Extensive research has been conducted using P. putida strain 
KT2440 focusing on its capabilities for biotechnology and bioremediation, as well as its 
natural activities within the rhizobiome, specifically highlighting how characteristics such 
as stress-tolerance and versatile metabolic and physiological strategies contribute to its 
success [74], [75].   
 
1.3.1.1 Roles in biotechnology and the rhizobiome 
 P. putida’s physiological flexibility and stress-tolerance mechanisms, combined 
with its metabolic versatility, contribute to its ability to degrade biosurfactants and soil 
contaminants such as the aromatic compound toluene [74], [76], [77], [78], [79]. P. putida is able 
to successfully degrade toluene even at high concentrations ranging from 50%-90% (v/v) 
in the culture, demonstrating its high resistance to solvents [76], [77]. This solvent resistance 
can be attributed to the involvement of over 100 solvent-tolerance related genes, 
including those specifically involved in membrane-stress tolerance, which are controlled 
by the ColR/ColS two-component regulatory system [74], [80], [81], [82]. The many metabolic 
pathways under the control of transcriptional regulatory systems like ColR/ColS 
endogenously transcribed by P. putida make its genome a valuable source of metabolic 
modules that can be pieced together and transferred to other species of bacteria, enabling 




P. putida is also very tolerant of orthologous metabolic pathways, defined as 
pathways derived from other species of bacteria, and trans-metabolic systems, defined as 
artificially designed metabolic systems, together making P. putida a valuable organism 
for the building of and execution of biotechnical projects like the production of 
biosurfactants [75], [78], [83], [84], [85], [86], [87]. P. putida has already been utilized as an agent of 
bioremediation which involves the introduction of high-stress tolerant and metabolically 
versatile organisms into a polluted environment to degrade toxic substances like oil [88]. 
In addition to its vast biotechnical applications, P. putida is a valuable member of the 
rhizosphere, promoting crop growth through plant protection from disease via 
antagonism towards plant pathogens [89], [90], [91].  It is within soils that P. putida may 
encounter mammalian host-derived compounds, which are frequently deposited during 
waste excretion and tissue decay, providing the opportunity for interaction between host-
derived compounds and the generally non-pathogenic bacterium. Plants and other 
protozoan and invertebrate members of the soil community also produce compounds that 
are generally thought of in a mammalian context [92], [93], [94]. Some of the methods P. 
putida uses for plant protection and growth promotion could be manipulated for host 
infection, including the production of biofilms and secondary metabolites like 
antimicrobials and siderophores [89], [95], [96], [97], [98].  
 
1.3.1.2 Incidence of infection  
Although the incidence of P. putida infection in humans is low, there are several 
reported cases [99], [100], [101], [102], [103], [104], [105], [106], [107]. Due to the bacterium’s low 
pathogenicity, the majority of P. putida infections occur in immune-compromised 
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individuals, manifesting as skin and soft tissue infections, systemic infections 
(bacteremia), and nosocomial infections [107]. One of the main concerns when considering 
the presence of P. putida in the hospital setting is the potential to transfer multi-drug 
resistance (MDR) genes to pathogenic bacteria [108]. Like other soil-dwelling bacteria, P. 
putida is constantly acquiring and evolving mechanisms to resistance antibacterial 
compounds produced by competing microbes in the environmental niche. Analysis of P. 
putida KT2440’s genome reveals the presence of many resistance-associated genes 
(Figure 1.2)[109]. These resistance-associated genes run the risk of being transferred to 
pathogens and making therapeutic strategies less effective [108]. It is also possible for P. 
putida strains to pick up genes that increase their ability to infect a host, such as genes 
needed for successful tissue colonization and nutrient acquisition from host tissues [110]. 
Chapter 2 of this dissertation characterizes a specific set of genes in P. putida strain 
KT2440 associated with the detection and degradation of creatine, a host-derived 
compound that is present in many host tissues [111]. Creatine degrading genes homologous 
to those found in P. putida strain KT2440 are present in several strains of P. putida 
including two pathogenic strains, HB4184 and H8234, potentially indicating that creatine 
degradation may be linked to pathogenicity of the generally non-pathogenic bacterium 
[110].  
 
1.3.2 Stenotrophomonas maltophilia  
The Gram-negative bacterium Stenotrophomonas maltophilia is a predominantly 
soil and water-dwelling microbe with potential to be a successful opportunistic pathogen 
due in part to its ubiquity and intrinsic multidrug resistance. S. maltophilia is commonly 
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associated with the rhizobiome, where it participates in nitrogen and sulfur cycles and has 
been observed to improve plant growth [112], [113], [6], [114]. The success of S. maltophilia in 
its environmental niches is due to many factors including its metabolic versatility, 
secondary metabolite production, and intrinsic stress tolerance, qualities which also make 
S. maltophilia a functional opportunistic pathogen.    
 
1.3.2.1 Emerging opportunistic pathogen 
The majority of Stenotrophomonas maltophilia is isolated from soils and water 
systems and it is within these niches where robust responses to antimicrobials and other 
abiotic stressors were most likely evolved or acquired, transforming S. maltophilia into a 
MDR and highly stress tolerant microbe [37], [115], [116]. The distribution of S. maltophilia 
within the environment is wide spread, and it has been recovered from plant roots, soils, 
animals and invertebrates, and environmental and potable water sources [37].  Due to the 
presence of S. maltophilia in water systems, it is not surprising that the microbe is also 
found on the surfaces of medical and dental supplies, surfaces that can be in frequent 
contact with humans [117], [118], [119], [120], [121].  
While Stenotrophomonas maltophilia is not highly virulent, it has many qualities 
that enable survival of opportunistic pathogens. S. maltophilia is intrinsically resistant to 
several antimicrobial classes including β-lactams and aminoglycosides [122]. S. 
maltophilia’s resistance to these antibiotics is due to a high number of multidrug efflux 
pumps, transcription of lytic enzymes, and a relatively low membrane permeability [122].  
In addition to antibiotic resistance, S. maltophilia forms robust biofilms on a variety of 
surfaces, including the materials used to make equipment such as intravenous cannulae, 
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prothestics and nebulizers[37], [117], [118], [119], [120], [121], [123]. Adherence to surfaces is one 
potential way that S. maltophilia gains access to the human body. Once inside the host, 
the weakly pathogenic bacterium is able to utilize its repertoire of extracellular and cell-
associated virulence factors to establish an infection [122].   
Among S. maltophilia’s extracellular virulence factors are serine proteases, such 
as the Xps Type II secretion system (T2SS) protease StmPr1 involved in degradation of 
connective tissue and host immune system components, and clinical isolate-associated 
lipases, phospholipases, and haemolysins [122]. Cell-associated factors include 
lipopolysaccharide (LPS), which affords protection against host complement, and pili and 
fimbrial structures that aid in adherence to host epithelial cells and biofilm formation. 
Clinical isolates of S. maltophilia use flagella for initiation of infection and adhesion to 
epithelial cells with aid from Stenotrophomonas maltophilia specific fimbriae called 
SMF-1 fimbriae [122], [124]. SMF-1 fimbriae have been implicated in haemagglutination, 
biofilm formation, and adherence to mammalian cells [124]. The participation of flagella in 
adhesion has been observed in the cystic fibrosis (CF) lung, where loss of flagella during 
chronic infection leads to lower adherence of S. maltophilia to host cells. Other types of 
pili are also likely involved in biofilm formation and maintenance including Type IV 
pilus machinery and TadE-like machinery [125], [126], [127], [128]. There are several other 
genes observed to be required for biofilm formation in high-stress environments like the 
CF lung, including rmlA (glucose-1-phosphate thymidylyltransferase), which is involved 
in the LPS/EPS biosynthetic pathways [129]. Phylogenetic studies of multiple strains of S. 
maltophilia, both clinical and environmental, show marked distinctions between those 
strains primarily isolated from environmental niches versus those recovered from host 
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infection. One study analyzing 171 publically available S. maltophilia genomes identified 
that the strains separated into 23 monophyletic lineages, 2 of which were comprised 
strictly of environmental isolates while the other 21 were a mix of environment and 
human-derived strains, demonstrating the slow adaption of environmental S. maltophilia 
strains to the human niche [130]. The human-derived strains in this study were most similar 
to strains isolated from hospitals, suggesting transmission in the hospital setting [130].  
  
1.3.2.2 Incidence of infection  
 Over the past decade Stenotrophomonas maltophilia has become more prevalent 
in infection niches typically dominated by opportunistic pathogens such as Pseudomonas 
aeruginosa, driven by more effective antibiotic treatment of the other pathogens and the 
relative antibiotic resistance of S. maltophilia. Infections involving S. maltophilia are 
generally associated with poor outcomes, especially in cases of CF lung infections. These 
lung infections frequently involve multiple opportunistic pathogens. P. aeruginosa is one 
of the most prevalent Gram-negative bacteria to infect the CF lung and co-infection with 
S. maltophilia is a common occurrence leading to patient decline. The synergy between 
P. aeruginosa and S. maltophilia during infection can result in higher incidence of 
morbidity and higher mortality rates among patients, with one study measuring a co-
infection mortality rate of 64%, which is a higher rate than that observed in cases of 
singular infection with either pathogen [131]. While P. aeruginosa is commonly the 
dominant pathogen in the CF lung, there are also cases in which S. maltophilia is the 
primary opportunistic pathogen present. In a survey of 104 individuals with CF, S. 
maltophilia was cultured out of 7.7% of patients, and in several of these patients S. 
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maltophilia dominated the niche [132]. This survey identified S. maltophilia infection as an 
independent risk factor in severe pulmonary exacerbations [132]. Although the scientific 
community has yet to definitively determine whether S. maltophilia infection is the 
causative agent of lung decline, or whether advanced lung decline allows for S. 
maltophilia infection, it holds true that CF patients infected with S. maltophilia have a 
three-fold higher risk of death or lung transplant [133].  
 S. maltophilia infects not only individuals with cystic fibrosis, but also occurs in 
oral, tracheal, and blood infections in immune compromised individuals [134], [135], [136], 
[137]. While the health of the patient and strain of S. maltophilia affect the outcomes of 
these infections, they can be severe; for example, bacteremia caused by S. maltophilia 
carries a mortality rate of 65-69% [135], [136]. The high mortality rates associated with S. 
maltophilia infections are concerning as cases have been increasing over the past decade 
[138]. A ten-year retrospective study identified S. maltophilia in 47.3% of children’s 
tracheal secretions after undergoing tracheotomy, making it one of the 6 most common 
opportunistic pathogens present in these post-operative airway infections [137]. 
Vancomycin resistant S. maltophilia has also been associated with mucosal injury 
infection in chemotherapy patients [139]. The increased prevalence of S. maltophilia 
infections is especially concerning given its intrinsic antibiotic resistance and stress 
tolerance. S. maltophilia’s ability to utilize complex nutrient sources found in the host is 
another characteristic that promotes bacterial growth during infection.  Chapter 4 of this 
dissertation characterizes S. maltophilia’s response to and utilization of mucin, a rich 
host-derived nutrient source that is not readily metabolized by the majority of 
opportunistic pathogens.  
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1.3.3 Pseudomonas aeruginosa  
There are several Pseudomonad species capable of causing infections in plants, 
invertebrates, and animals, but the majority of Pseudomonas species including P. putida, 
P. flourescenes, P. stutzeri, and P. chlororaphis act primarily as saprophytic members of 
soil and water communities. Pseudomonas aeruginosa is the most-well studied 
Pseudomonad due to its ability to cause severe infection in humans. The vast metabolic 
versatility encoded by P. aeruginosa’s 5-7 Mb genome contributes to its ability to survive 
in various environments and to effectively transition into a human host [140], [141], [142]. 
Analysis of P. aeruginosa’s genome reveals a large percentage of genes encoding 
biological sensors and transcriptional regulators involved in complex transcriptional 
responses to the ever-changing extracellular environment [140], [143]. Although P. 
aeruginosa is the most well studied of the Pseudomonads, there are many genes present 
in its large genome that have yet to be characterized and share little to no similarity with 
previously characterized genes [140], [143]. Due to the severity and/or chronic nature of P. 
aeruginosa infections in immune-compromised humans and the high incidence of P. 
aeruginosa infection, further investigation into the identities and potential functions of P. 
aeruginosa’s uncharacterized genes remains a high priority.  
 
1.3.3.1 Transition from environment to the lung  
 The majority of the species belonging to the genus Pseudomonas are non-
pathogenic soil and water dwelling bacteria, but several are pathogenic to plants, animals, 
and invertebrates [144], [140], [145], [146], [147]. Several of the pathogenic species of 
Pseudomonas, including P. putida and P. stutzeri, are occasionally implicated in human 
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disease, but P. aeruginosa is by far the most pathogenic towards humans [105], [141], [148], 
[149]. Although P. aeruginosa is able to cause severe infections in humans, it is commonly 
isolated from environmental niches like the other members of its genus. There is evidence 
to suggest that evolutionary pressures exerted by environmental factors such as phage 
interactions, osmotic and pH stress, and inter-microbial competition, can lead to the 
emergence of P. aeruginosa epidemic strains by triggering frequent recombination and 
gene acquisition through horizontal gene transfer (HGT) within P. aeruginosa’s genome 
[150], [151]. For example, one of the clones of P. aeruginosa most frequently isolated from 
individuals with cystic fibrosis is also frequently isolated from aquatic sources [152]. A 
separate study found that isolates collected from soils polluted with gasoline were 
extremely similar to clones isolated from clinical settings [153]. Although it is plausible to 
believe that the similarities between environmental and epidemic P. aeruginosa isolates 
is the result of environment to host transition, an extensive sampling study observed that 
P. aeruginosa was only abundant in environmental niches impacted by humans and was 
rarely found in pristine environmental niches [154]. The uneven environmental distribution 
of P. aeruginosa, biased towards man-impacted environments, suggests that P. 
aeruginosa’s primary niche may be the host and that it is deposited into soils and water 
systems via host-environment interactions.  
There is evidence that the host environment selects for P. aeruginosa strains 
possessing virulence gene-encoding pathogenicity islands, as they are present in the 
majority of characterized clinical isolates [155]. P. aeruginosa isolates that have adapted to 
chronic infection in the lung invert large regions of their genome, resulting in a lack of 
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flagella and excessive EPS production. These SCVs are generally less immunogenic 
allowing P. aeruginosa to persist within the niche [28], [156], [157].  
 Although the most common infections caused by P. aeruginosa are folliculitis and 
otitis, P. aeruginosa lung infections have much more severe impacts on patient health. P. 
aeruginosa lung infections occur in individuals who are immunocompromised or 
incapacitated to some degree, such as individuals on assisted ventilation, those with 
chronic obstructive pulmonary disorder (COPD), or those with cystic fibrosis (CF). In 
these cases, it is easier for P. aeruginosa to bypass initial host immune mechanisms 
including muco-cillary clearance responses, which are severely impaired in CF lungs. 
Once past these barriers, P. aeruginosa can implement several virulence strategies to 
establish infection. Metabolic flexibility is an important factor when establishing 
infection, as nutrients must be derived from the host environment. P. aeruginosa’s 
metabolic diversity allows it to grow well within the host lung and utilize the many 
proteinaceous and lipid components available. The liberation of nutrients from cells 
through cytotoxic methods is also a virulence strategy of P. aeruginosa involving 
virulence factors encoded in pathogenicity islands. Several pathogenicity island-
associated virulence factors secreted by P. aeruginosa’s type III secretion system 
machinery (T3SS) are involved in host cell toxicity and host tissue invasion, and are 
strongly correlated with worse clinical outcomes [155], [158], [159]. These T3SS effectors, 
including ExoU, ExoT, ExoS, and ExoY, are instrumental in host cell lysis and tissue 
invasion, although a single P. aeruginosa isolate generally does not possess all of these 
effectors. The tradeoff between effectors usually occurs between ExoU and ExoS. These 
two effectors do not coexist in the P. aeruginosa genome, but are indicative of whether a 
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certain strain of Pseudomonas will be cytotoxic or invasive. ExoU is associated with a 
cytotoxic phenotype while ExoS along with ExoT are associated with host tissue 
invasion, via disruption of tight junctions between epithelial cells and dampening of 
phagocytic activity and lysosome signaling in macrophages [160], [161], [162], [159], [163]. Other 
secreted factors such as pyocyanin and Exotoxin A also participate in the acute phase of 
infection, facilitating oxidative damage to host tissues and inhibiting host protein 
biosynthesis, respectively [155]. Another strategy that P. aeruginosa uses to establish itself 
in the host niche is colonization via flagellar attachment to host cells. While adherence to 
host cells via pili and flagella is important to prevent clearance of the pathogen, flagellar 
structures are very immunogenic and are selected against as the infection transitions from 
acute to chronic [164], [165], [166].  
 Isolates of P. aeruginosa collected from chronic CF lung infections are 
phenotypically unique to environmental or acute phase isolates.  In order to maintain a 
chronic infection, Pseudomonas must dampen its immunogenicity to protect itself from 
host immune responses. Strategies to evade immune detection include down-regulation of 
flagella and up-regulation of alginate and EPS production to create protective biofilm 
structures [159], [166], [167]. P. aeruginosa strains that have adapted to the host lung almost 
never express ExoU because of its ability to induce inflammation [163]. Host-adapted 
strains are also commonly deficient in proteases, non-motile, display a loss of the LPS O-
side chains that are usually present in environmental isolates, and have different LPA 
acylation patterns [155], [168], [169], [170], [171]. All of these factors render P. aeruginosa more 
resistant to therapeutics, less immunogenic, and more likely to persist in the lung [159]. 
Chapter 3 of this dissertation investigates one facet of P. aeruginosa’s ability to resist 
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innate immune mechanisms; specifically how P. aeruginosa detects and metabolizes the 
host-derived antimicrobial sphingosine.  
 
1.3.3.2 Incidence of infection  
 Pseudomonas aeruginosa infection carries a high healthcare cost burden, 
estimated by the CDC in 2017 to be approximately $767 million. These costs were 
accrued over the span of 32,600 cases, 2,700 of these resulting in death as reported by the 
CDC. A majority of these infections are complicated by high frequencies of MDR and 
involve individuals who are critically ill and immunocompromised. Of a survey of 740 
patient isolates, 226 were MDR and strongly correlated with higher mortality in the 
hospital setting [172]. In a similar study that identified bacteria present in infected burn 
wounds, 58.6% of recovered P. aeruginosa samples were found to be MDR [173]. Severe 
P. aeruginosa infections manifest in patients in a variety of ways, including bacteremia, 
urinary tract infections (UTI), ventilator associated pneumonia (VAP), hospital and 
community acquired pneumonia (HAP/CAP), and skin and soft tissue infections [173], [174], 
[175], [176], [177], [178], [179], [180], [181], [182], [183], [184]. In many of these types of infections, P. 
aeruginosa is one of the most prevalent Gram negatives observed [174], [176], [177], [181], [182], 




1.4 Systems for detection of and transcriptional response to specific compounds: 
AraC/XylS transcriptional regulators  
The ability to detect and respond to the extracellular environment is essential to 
bacterial survival in any niche. A large genome may afford the high metabolic flexibility 
needed to survive in a diverse array of environments, but in order to efficiently utilize 
available resources, transcription of certain pathways must be prioritized over others. 
Transcriptional regulators (TRs) participate in this prioritization process, activating or 
repressing transcription of certain genes in response to specific compounds or 
environmental conditions [185], [186]. Gram-negative bacteria utilize many different families 
of transcriptional regulators, but in this dissertation we will focus on a diverse family of 
regulators, the AraC/XylS family [187], [188]. This family of TRs is characterized most 
broadly by the presence of two DNA binding helix-turn-helix (HTH) motifs in the C-
terminal domain, which are responsible for binding to specific DNA sequences within the 
promoter region of the target gene termed ‘half sites’. The HTH domain is highly 
conserved throughout members of the family [186], [188]. The N-terminal domain of 
AraC/XylS family proteins is not well conserved and is usually involved in ligand 
binding and/or dimerization. Due to the weak conservation and low sequence similarity 
of the N-terminal domains between members of the family, it is very difficult to predict 
the cognate ligands for specific regulators [186], [188]. Due to the unreliability of 
bioinformatic predictions there are many AraC/XylS TR family members whose ligands 
remain unidentified.    
The canonical members of the AraC/XylS family are the arabinose-specific TR 
AraC from Escherichia coli, and the toluene-specific TR from P. putida, XylS. While 
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these two transcriptional regulators share ligand-specific activitation and dimerization 
ability, there are several differences in how they function. AraC exists as a dimer bound 
to DNA at two half-sites denoted I1 and I2, changing conformation from looped to linear 
after it binds its ligand arabinose, allowing the transcription of arabinose metabolic 
machinery to occur (Figure 1.3A) [189]. XylS is constitutively expressed at low levels but 
is also under the control of a xylene-responsive promoter [190], [191], [192]. XylS exists in an 
unbound monomeric state until the concentration of monomers increases to the saturation 
point where dimers begin to form [190]. XylS monomers increase in concentration when 
there is higher basal transcription of xylS due to plasmid-borne expression, or when 
inducing compounds such as 3-methylbenzoate (3-mBz) are present [190], [191], [192]. Once 
sufficient dimers are formed, they bind to their respective half-sites in the distal and 
proximal regions to the Pm promoter, which is responsible for the transcription of an 
operon involved in the lower (meta) pathway of degradation of aromatic compounds 
(Figure 1.3B). While the specific inducing compounds, half-site sequences, and 
responsive genes vary between TRs that belong to the AraC/XylS TR family, most 
members align with either the AraC or XylS mechanism of transcriptional activation.  
 
1.4.1 GATRs: A subset of AraCs that detect amine-containing compounds  
 Although the N-terminal domains of AraC/XylS TR family members are not well 
conserved, there are several subfamilies characterized by the presence of specific N-
terminal motifs. One of these subfamilies is comprised of AraC-type TRs that contain a 
glutamine amindotransferase-1 (GATase-1) type domain in the N-terminus. These 
GATase-1-containing AraC-like TRs, or GATRs, are involved in recognizing amine-
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containing compounds, particularly N-methylated amines, but do not show the amide-
group transferase activity characteristic of the GATase-family of enzymes. Several 
members of this subfamily and their cognate ligands have been characterized in P. 
aeruginosa and Burkholderia thailandensis. Among these are arginine-responsive ArgR, 
choline-responsive CdhR, glycine-betaine responsive GbdR, and sarcosine-responsive 
SouR. [193], [194], [195], [196], [197], [198]. 
 
1.5 Biomedical importance  
 The steady increase in multi-drug resistance observed in Gram-negative 
opportunistic pathogens is an on-going healthcare concern worldwide. Current reports 
from the CDC attribute greater than 2.8 million infections and greater than 35,000 deaths 
to MDR microbes. MDR Pseudomonas aeruginosa is among the microbes deemed a 
‘serious threat’ by the CDC. Treatment and management of MDR Gram negatives is 
especially difficult due to how easily drug resistance cassettes are transferred between 
bacteria in the hospital setting. Evidence of independent acquisition of drug resistance 
genes after exposure to antibiotics has been seen in Gram-negative bacteria including, but 
not limited to, Klebsiella pneumonia, Escherichia coli, and Salmonella typhimurium [199], 
[200], [201]. In all of these cases, plasmid borne antibiotic resistance cassettes can be easily 
transferred between bacteria within the host or within the hospital setting, making it 
difficult for therapeutic treatments to keep up with the dynamic resistance profiles of 
bacterial pathogens. Apart from class-specific antibiotic resistance genes, such as 
carbapenemases that are frequently transferred between bacteria and make certain classes 
of antibiotics less effective, the acquisition of broad-spectrum efflux pumps is also 
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concerning [202], [203], [204], [205]. Efflux-pump machinery allows bacteria to pump out 
antibiotics at an alarming rate, conferring resistance to a wide range of antibiotics. 
Because of the constant evolutionary pressure exerted on bacterial pathogens by 
antibiotic therapies, we are seeing a rise in antibiotic resistance and a decline in the 
effectiveness of available therapeutics [206]. The growing threat of multidrug resistance 
worldwide highlights the urgent need to identify alternative targets for therapeutic 
intervention. Investigation into the processes involved in the host-pathogen interaction, 
including how microbes detect and utilize host-derived nutrients, is an integral step in 
developing new strategies for prevention and control of opportunistic bacterial infections.  
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1.6 Chapter 1 Figures  
 
Figure 1.1 A simplified example of non-transitive competition for resources shows 
the three different outcomes of three species competition for nutrients. The general 
scheme is that the Species A (solid red) outcompetes Species B (solid white) for 
nutrients, but Species B is able to outcompete Species C (stripped). By impeding the 
growth of Species B, Species A allows for growth of Species C, but Species C depletes 
nutrients required by Species A, meaning that by inhibiting Species B, Species A inhibits 
its own growth. Scenarios 1, 2, and 3 depict how the absence of any one species impacts 
the balance of species within the niche. This non-transitive competition occurs within the 
environment and during poly-microbial host infections. 
Figure 1.2 The environmental bacterium Pseudomonas putida transcribes many 
resistance-associated genes within its genome. This circular map of P. putida 
KT2440’s genome highlights the presence of putative resistance-associated genes via the 
presence of a pink dot. Resistance genes appear to exist in clusters throughout the 
genome. The internal jagged grey line is a representation of differences in sequence 
composition, including GC content and codon bias, as compared to the genome as a 
whole. Genomic regions where the grey line dips below the blue inner circle have a 
higher probability of having originated from a different bacterial species and may have 
been acquired through horizontal gene transfer.   
Figure 1.3 The majority of members of the AraC/XylS family of transcriptional 
regulators (TRs) operate in one of two canonical fashions (A) The arabinose-
responsive TR of Escherichia coli operates in the light-switch fashion where the AraC 
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dimer exists bound to operator (O2) and initiator (I2) regions upstream of the araBAD 
promoter region. Regulator unbound to its ligand arabinose fixes the DNA in a curved 
confirmation making the promoter region of araBAD inaccessible to RNA polymerase. 
Upon binding ligand (arabinose), AraC dimers switch confirmation and bind to the two 
initiator regions (I1 and I2) upstream of the promoter and switch the DNA confirmation to 
linear allowing transcription by RNA polymerase. (B) The canonical XylS TR of 
Pseudomonas putida is constitutively expressed at low basal levels as unbound 
monomers. Once the concentration of monomers reaches a saturation point, or the 
presence of an inducing ligand like 3-mBz induces a conformational change in XylS 
monomers, dimers form and bind to distal and proximal regions to the Pm promoter, 
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Figure 1.3 The majority of members of the AraC/XylS family of transcriptional 
regulators (TRs) operate in one of two canonical fashions.  
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CHAPTER 2: Pseudomonas putida KT2440’s utilization of creatine as a sole 
nitrogen source is transcriptionally regulated by PP_3665  
 
2.1 Abstract  
 Pseudomonas putida is a soil-dwelling Gram-negative bacterium that rarely 
causes infection in humans. The majority of P. putida research focuses on its use in 
biotechnology and bioremediation due to its high stress tolerance and metabolic 
versatility. Although not as virulent towards humans as other Pseudomonads like 
Pseudomonas aeruginosa, P. putida occasionally infects severely immunocompromised 
individuals, causing blood stream and soft tissue infections. Here we characterize P. 
putida’s interaction with the host-derived polyamine compound creatine, which is found 
in eukaryotic tissues and acts as a buffer for the charging of high-energy compounds like 
adenosine tri- and di-phosphate (ATP/ADP). Through genetic and biochemical 
approaches, we identify a glutamine amidotransferase-1 domain-containing AraC-family 
transcriptional regulator (GATR), PP_3665, which is necessary for the transcription of a 
creatine amidohydrolase-encoding gene (PP_3667) in the presence of creatine, and 
evaluate the role of PP_3665 in P. putida’s ability to utilize creatine as a sole source of 
nitrogen. This study identifies a previously uncharacterized GATR and contributes 
important information to the fields of bacterial transcriptional regulation and polyamine 
metabolism. 
2.2 Introduction 
 Like many primarily soil dwelling microbes, the Gram-negative bacterium 
Pseudomonas putida has evolved a vast and diverse array of transport and metabolic 
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machinery to fuel its organoheterotrophic lifestyle [1]. Within the rhizosphere, fast and 
efficient adjustment to the surrounding environment ensures successful acquisition of 
essential nutrients and activation of stress responses that are crucial to P. putida’s 
survival [2]. Effective response to the extracellular environment is partly afforded by the 
large number of transcription regulatory proteins encoded by the Pseudomonas genome. 
About 2% of the predicted genes in the 6.15 Mbp P. putida KT2440 genome contain a 
conserved AraC-type DNA-binding Helix-Turn-Helix motif, characteristic of many 
catabolism-related transcription regulators [3]. These AraC-like transcription regulators 
control a large number of metabolic processes within P. putida, although for many, the 
cognate inducing ligands and target regulons have not been identified.    
 P. putida PP_3665 encodes an AraC-type transcription regulator upstream of a 
creatinase gene (PP_3667). Among characterized Pseudomonas genomes, only P. putida 
and P. resinovorans maintain close predicted orthologs of both the creatinase gene and 
the associated AraC-family transcription regulator in this syntenic arrangement [3]. Both 
of these species of Pseudomonas are present primarily in soils and are active participants 
in the rhizobiome, i.e. bacteria within the rhizosphere. It is within the rhizosphere that P. 
putida most likely encounters creatine, as creatine and its anhydrous form, creatinine, are 
present in soils, deposited via animal urine or feces as well as through animal tissue 
degradation [4], [5], [6], [7]. 
Creatine is a polyamine compound found in many eukaryotic tissues where it 
serves to buffer charging of high-energy carriers like adenosine triphosphate (ATP) and 
adenosine diphosphate (ADP). It is particularly abundant in tissues that require large 
pools of ATP and ADP for periods of intense energy expenditure, such as fast twitch 
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muscles [8]. Metabolism of creatine in eukaryotes occurs via partial metabolism and 
modification by gut-residing bacteria creating 1-methylhydantoin, a metabolite that is not 
easily metabolized by the body and can lead to tissue inflammation. Given this toxic 
metabolite, the major avenue of creatine homeostasis in eukaryotes is the excretion of 
creatine and creatinine in the urine. Pseudomonas species have been observed to 
metabolize creatine and creatinine, as well as the breakdown product, 1-methylhydantoin 
[8], [9], [10], [11], [12], [13], [14], [15], [16]. The final products of creatine and creatinine metabolism 
by Pseudomonas can vary depending on the specific degradation pathway. For creatinine, 
the process begins with breakdown of creatinine to creatine by a creatininase (creatinine 
amidohydrolase). Creatine is then further degraded to sarcosine and urea by creatinase 
(creatine amidinohydrolase), and sarcosine is then converted to glycine and formaldehyde 
by the tetrameric sarcosine oxidase (SoxBDAG), or to methylamine by sarcosine 
reductase and/or glycine reductase (Fig. 1A) [8], [9], [17], [18].  
Production of creatinase is inducible in P. putida when the bacterium is supplied 
with creatine as the sole carbon or nitrogen source, but the induction mechanism is 
currently unknown [12]. In this study we identify the regulator required for transcriptional 
induction of creatinase in P. putida and demonstrate its role for P. putida growth on 
creatine as a sole nitrogen source.  
 
2.3 Materials and Methods  
2.3.1 Strains and Growth Conditions  
Pseudomonas putida strain KT2440 and mutants made from this parent strain 
were grown at 30°C shaking (170 rpm) in morpholinopropanesulfonic acid (MOPS) 
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media supplemented with 25 mM pyruvate, 5 mM arginine, and 20 µg/ml gentamicin 
when needed for plasmid maintenance [19]. Escherichia coli strains DH5α and S17λpir, 
used for cloning and mating with P. putida, and E. coli strain T7 used for recombinant 
protein expression, were maintained in lysogeny broth (LB), Lennox formulation, 
supplemented with 7 µg/ml gentamicin or 150 µg/ml carbenicillin as appropriate. E. coli 
strains were grown at 37°C with shaking (170 rpm). Strains and plasmids used in this 
study can be found in Table 2.1.  
 
2.3.2 Construction of P. putida PP_3665 deletion strain and complementation 
construct  
A 980 base pair (bp) upstream of the coding reading of PP_3665 were amplified 
with primers engineered to include a HindIII restriction digest site and an overlap region 
for splicing by overlap extension (SOE) (primers can be found in the PP_3665 deletion 
construct section of Table 2). A 1 kb fragment downstream of the coding region of 
PP_3665 was amplified with primers engineered with EcoRI restriction site and overlap 
region. The two fragments flanking the PP_3665 coding region were spliced together via 
SOE PCR using the outside restriction-site containing primers, digested with HindIII and 
EcoRI, and ligated into similarly cut plasmid pMQ30 containing a gentamicin resistance 
cassette for initial selection and the sacB gene for counter selection. pMQ30 containing 
the flanking regions of PP_3665 (pMQ30:PP_3665KO) participated in homologous 
recombination with P. putida. A clean deletion of gene PP_3665 in P. putida strain 
KT2440 was achieved via homologous recombination as previously described, described 
in detail below [20], [21].  
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Plasmid pMQ30:PP_3665KO was cloned and propagated in E. coli strain DH5α, 
then transferred into conjugative strain E. coli S17λpir. The S17λpir strain carrying 
plasmid pMQ30:PP_3665KO was then mixed in 1:1 and 1:10 ratios with Pseudomonas 
putida strain KT2440, spot-plated on LB agar plates, and incubated at 30°C for 18 hours 
to allow for conjugation to take place. Half of each spot was then scraped and plated on 
LB agar plates amended with 50 µg/ml gentamicin to select for colonies that underwent 
the first crossover event. Several single crossover clones were then grown for 5 hours in 
LB broth at 30°C with shaking to allow for the second crossover event to occur. After 
this incubation, 100 µl of culture was plated onto LB agar with no salt and amended with 
10% sucrose to screen for those colonies that underwent the second crossover event. The 
resulting colonies were screened for a clean deletion of the PP_3665 gene or a reversion 
to the wild type chromosome with primers #1601 and #1602 (Figure 2.1B). The clone 
LAH111 with genotype ∆PP_3665 was stocked for use in future experiments.   
PP_3665 complementation in the ∆PP_3665 strain was achieved by expression of 
PP_3665 from a plasmid.  Briefly, the coding region of PP_3665 and divergently 
transcribed gene pssA (to ensure the full coding region of PP_3665 was included) were 
amplified using primers engineered with HindIII and BamHI cut sites (#1158 and #2350). 
The ~2.5 kb fragment was digested with the aforementioned enzymes and ligated into the 
similarly cut pMQ80 plasmid. The resulting pMQ80:pssA/PP_3665 complement plasmid 
was then electroporated into P. putida KT2440 ∆PP_3665 as previously described with 
the voltage set at 2.2 kV [20]. Sequences of primers used to construct plasmids can be 
found in Table 2.2.  
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2.3.3 Nitrogen source growth assays 
P. putida KT2440 wild type and ∆PP_3665 strains carrying the pMQ80 empty 
vector, and P .putida KT2440 ∆PP_3665 complemented with pMQ80:pssA/PP_3665 
were grown overnight at 30°C shaking in 1x MOPS buffer amended with 25 mM 
pyruvate, 5 mM arginine, and 20 µg/ml gentamicin. Cells from overnight culture were 
collected by centrifugation, washed with 1x MOPS media lacking nitrogen, and adjusted 
in 1x MOPS no nitrogen to an optical density at 600 nm (OD600) of 0.5. These normalized 
cell suspensions were added to pre-warmed 1x MOPS no nitrogen media amended with 
20 mM pyruvate, 20 µg/ml gentamicin, and 2 mM of one of the following nitrogen 
sources: choline, creatine, creatinine, sarcosine, or arginine. A control for growth in 
media lacking nitrogen was also included. Cells were added to each condition to a final 
optical density at 600 nm (OD600) of 0.05 in a 48-well plate. Cultures were incubated at 
30°C shaking at 170 rpm for 18 hours. The optical densities of cultures were measured at 
times 0 hours and 18 hours using a Synergy H1 plate reader (BioTek, Winooksi, VT). 
Growth was reported as the fold growth of each strain amended with a nitrogen source 
over the growth in the 0 mM nitrogen condition.   
Fold Growth = (OD6002mM N-source/OD6000mM nitrogen) 
 
2.3.4 PP_3665-dependent transcriptional induction assays and PP_3667 promoter 
mapping 
A transcriptional reporter fusion of the PP_3667 promoter to the coding region of 
green fluorescent protein (PP_3667-gfp) was constructed for use in compound-specific 
transcriptional induction assays. The promoter region of PP_3667 was amplified with 
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primers that contain 3’ extensions that anneal to the pMQ80 vector backbone upstream of 
the region encoding the GFP protein. The full PP_3667 promoter (-228 bp from the 
translational start) as well as a -193 bp promoter truncation was spliced into the pMQ80 
vector by splice overlap extension (SOE) PCR upstream of the coding region of GFP 
following the previously described protocol [22]. Further truncations of the PP_3667 
promoter, -104 bp and -80 bp from the translational start, were spliced to gfp by splice 
overlap extension PCR (SOE) and the PP_3667-gfp fusion fragment was then digested 
with restriction enzymes EcoRI and HindIII and ligated into the similarly cut pMQ80 
backbone.  
 Each plasmid encoding the PP_3667 promoter-gfp fusion, full or truncated, was 
electroporated into P. putida KT2440 wild type or ∆PP_3665 for transcriptional 
induction assays. To test metabolite-specific induction using the full PP_3667 promoter 
gfp reporter construct, P. putida KT2440 wild type and ∆PP_3665 carrying the 
pMQ80:PP_3667-228gfp plasmid were grown overnight in 1x MOPS media amended with 
25 mM pyruvate, 5 mM arginine, and 20 µg/ml gentamicin. Overnight cultures were 
adjusted to a uniform OD600 and added to 1xMOPS media amended with 20 mM 
pyruvate, 20 µg/ml gentamicin, and +/- 2 mM of each experimental small molecule to a 
final OD600 of 0.5 in a 48-well plate. The compounds creatine, creatinine, sarcosine, and 
glycine betaine were tested for their PP_3665-dependent induction via the PP_3667 
promoter. Plates were incubated at 30°C with periodic shaking for 18 hours with readings 




 To determine the region of the PP_3667 promoter essential for creatine-
responsive PP_3665-dependent induction, induction assays using PP_3667-gfp 
transcriptional reporters engineered with truncated regions of the PP_3667 promoter 
upstream of gfp were conducted. The assays were conducted as described above with the 
following adjustments; P. putida KT2440 wild type strains carrying the 
pMQ80:PP_3667-228-gfp, pMQ80:PP_3667-193-gfp, pMQ80:PP_3667-104-gfp, or 
pMQ80:PP_3667-80-gfp plasmids were induced in 1xMOPS media amended with 20 mM 
pyruvate, 20 µg/ml gentamicin, and +/- 2 mM creatine. The full (-228) and -193 PP_3667 
promoters were tested for PP_3665-dependence by measuring the transcriptional 
induction of gfp carried on the respective reporter plasmid in the P. putida KT2440 
∆PP_3665 background. Fold induction was reported using the equation: Fold Induction = 
(Fluorescence Units2mM N-source/Fluorescence Units0mM nitrogen)  
 
2.3.5 MBP-PP_3665 fusion construct and protein purification  
 A maltose binding protein-PP_3665 (MBP-PP_3665) fusion was engineered in 
the pMALc2x vector as previously described [17], [23], [24]. Briefly, the coding region of 
PP_3665 was amplified with primers engineered to include EcoRI and HindIII restriction 
sites (#2596 and #2597). The ~1 kb fragment was then digested with restriction enzymes 
EcoRI and HindIII (New England Biolabs, Ipswitch MA), purified using Fisher’s 
GeneJET Gel Extraction and DNA Clean Up Kit (ThermoFisher Scientific, Waltham, 
MA), and ligated into the similarly cut pMALc2x vector downstream of the MBP coding 
region present in the vector. Cloning and propagation of the pMALc2x:MBP-PP_3665 
vector was carried out in E. coli DH5α cells grown in LB broth supplemented with 150 
	
	 51	
µg/ml carbenicillin for plasmid maintenance. The pMALc2x:MBP-PP_3665 vector was 
then transformed into E. coli T7 cells which are engineered to support protein expression.  
 Expression of purification of MBP-PP_3665 was conducted as previously 
described [17], [23], [24]. Briefly, E. coli T7 cells carrying the pMALc2x:MBP-PP_3665 
plasmid were grown in a 50 ml volume of LB broth supplemented with 150 µg/ml 
carbenicillin, shaking at 170 rpm at 37°C for 3 hours. Protein expression was induced by 
addition of isopropyl-β-D- thiogalactopyranose (IPTG) to 1 mM followed by an 
additional 2.5 hours of growth. Cells were then collected by centrifugation, frozen at -
20°C overnight, thawed, and brought up in 4 ml lysis buffer per 1 gram cells (lysis 
buffer: 20mM Tris HCl, pH=7.4, 1 mM EDTA, 200 mM NaCl, 1x Halt protease 
inhibitor, 3 mg/ml lysozyme). After a 20-minute incubation to allow for lysis to occur, an 
additional 5 volumes of lysis buffer was added to further dilute the lysate. Cell lysates 
were then clarified by a 20-minute centrifugation (21,000 x g at 4°C) and run through an 
amylose resin column. After running the lysate through the column, the column was 
washed with 10x the resin bed volume (wash buffer:  20 mM Tris-HCl, 150 mM NaCl, 1 
mM EDTA pH 7.4) and the protein was eluted using one resin bed volume of elution 
buffer containing 10 mM maltose (elution buffer: 20 mM Tris-HCl, 150 mM NaCl, 1 mM 
EDTA, 10 mM maltose, pH 7.4). Expression and purification of MBP-PP_3665 fusion 
protein was visualized via Coomassie staining and concentration was measured via 
nanodrop. Aliquots of protein were stored at -80°C in 20% glycerol for future use in 




2.3.6 Electrophoretic Mobility Shift Assays (EMSA) 
 Electrophoretic mobility shift assays (EMSAs) using MBP-PP_3665 protein and a 
biotinylated PP_3667 promoter probe were conducted as previously described [23]. 
Briefly, the promoter region of the PP_3665-dependent gene PP_3667 was amplified 
using primers #1160 and #2615 to create the 5’-biotinylated probe and primers #1159 and 
#1160 for amplification of the cold probe. The promoter region of the dhcA gene was 
used as a competitive target to test the specificity of PP_3665 promoter binding. All 
probes were gel purified using Fisher’s GeneJET Gel Extraction and DNA Clean Up Kit 
(ThermoFisher Scientific, Waltham, MA). EMSA binding reactions were conducted with 
the changes previously described and the replacement of poly(dI-dC) with salmon sperm 
DNA to a final concentration of 500 µg/ml [23]. Binding reactions were incubated for 40 
minutes at 37°C then run through a 5% acrylamide gel for 1 hour at 100V. After transfer 
to Biodyne B Pre-Cut Modified Nylon Membrane (ThermoFisher), biotinylated probe 
was visualized as per manufacturers instructions with changes as previously described 
with the Pierce Lightshift Chemiluminescent EMSA kit (ThermoFisher Scientific) [23]. 
Primers used for amplification of probes can be found in Table 2.2.  
 
2.3.7 Growth conditions and RNA preparation for semi-quantitative RT-PCR 
 P. putida KT2440 wild type and ∆PP_3665 overnight cultures were grown in 
1xMOPS amended with 25 mM pyruvate and 5 mM arginine at 30°C with shaking at 170 
rpm. Overnight cultures were washed in 1xMOPS and adjusted to OD600 = 1.0 in 
1xMOPS with 20 mM pyruvate, and 600 µl of adjusted culture was added to 600 µl pre-
warmed 1xMOPS with 20 mM pyruvate +/- 2 mM creatine in a 24-well plate. Each P. 
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putida strain was grown in the +/- creatine condition in technical duplicate and biological 
triplicate. Cultures were incubated at 30°C with shaking with sample collection at 1 hour 
via centrifugation and preservation of RNA in 600 µl of hot RNAzol RT® (Sigma-
Aldrich). Analysis of creatinase gene (PP_3667) expression at 1 hour was conducted by 
semi-quantitative RT-PCR.  
 
2.3.8 RNA Extraction, Purification, and Semi-Quantitative RT-PCR 
 RNA was extracted and purified from samples frozen at -80°C in RNAzol buffer 
(SigmaAldrich) using the RNeasy Mini Extraction Kit (Qiagen) as per the manufacturers 
instructions with the following adjustments. After the initial RNA extraction, the RNA 
samples underwent a DNaseI treatment and a subsequent RNeasy purification. cDNAs 
were then created from the purified RNA samples via reverse transcription using 
Superscript RT II (Thermofisher) and random hexamer primers. cDNA samples were 
treated with RNaseH after reverse transcription to eliminate remaining RNA. Semi-
quantitative RT-PCR was conducted by adding equal amounts of cDNA substrate to PCR 
reactions containing primers specific to the experimental gene-of-interest, encoding a 
creatinase enzyme PP_3667, or the control gene, encoding a peptidylprolyl-isomerase D 
enzyme ppiD/PP_2304. Gene-specific DNA abundance in each reaction, as visualized by 
running PCR samples on 1% agarose gels, was used as an indicator of the relative 
abundance of gene transcripts for each gene at the 1 hour time point in the presence or 




2.3.9 Phylogenetic Tree Building  
The protein FASTA sequences of homologs of the PP_3667 gene that possess an 
associated AraC (PP_3665 homologs) were compiled via the STRING protein database 
and downloaded from the National Centers for Biotechnology Information database [25], 
[26], [27], [28], [29], [30], [31], [32], [33], [34], [35, 36]. Sequences were entered into a phylogenetic tree-
building pipeline available on Phylogeny.fr [37], [38]. This pipeline strings together 
alignment of multiple protein sequences via MUSCL, determination of phylogeny using 
maximum likelihood via PhyML, and tree rendering by TreeDyn. The sequence of a 
creatine amidinohydrolase from Candidatus thioglobus sp. NP1 that has no associated 
AraC transcriptional regulator was used as the out-group for tree rooting. A list of the 
accession numbers for protein sequences used in tree building is included in Table 2.3.  
 
2.4 Results 
2.4.1 PP_3665 is essential for P. putida KT2440 growth on creatine, and its 
precursor creatinine, as sole nitrogen sources 
To test whether the transcriptional regulator PP_3665 is necessary for creatine 
metabolism in P. putida, we evaluated wild type and deletion strain ∆PP_3665’s ability 
to grow on various nitrogen sources related to creatine metabolism. After 18 hours of 
incubation both the P. putida wild type and P. putida ∆PP_3665 complement strains 
grew most efficiently on choline and arginine as sole nitrogen sources (Figure 2.2A). 
When P. putida WT was supplied with creatine as the sole nitrogen source, its growth 
was comparable to growth on choline (Figure 2.2B). Growth of P. putida ∆PP_3665 on 
creatine was significantly lower when compared to WT and complemented strains 
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(****p-value<0.0001) (Figure 2.2A). When supplied with the anhydrous form of 
creatine, creatinine, as the sole source of nitrogen, P. putida WT growth was significantly 
lower when compared to both choline and creatine growth (***p-value=0.0001, *p-
value=0.0111, respectively) (Figure 2.2B), but growth of P. putida ∆PP_3665 strain did 
not display a further growth deficiency on creatinine as compared to growth on creatine 
(Figure 2.2A).  
 
2.4.2 PP_3665 binds the promoter region of PP_3667 and induces transcription of 
PP_3667 in the presence of creatine 
Compounds related to the creatine metabolic pathway were tested for their ability 
to induce transcription of the PP_3667 promoter in a PP_3665-dependent manner 
(Figure 2.3A). Significant transcriptional induction was observed in the presence of 
creatine, averaging 13.2 fold over the no-inducing-compound condition (p-
value<0.0001). The induction of the PP_3667 promoter in the presence of creatine was 
also significantly higher in wild type as compared to the ∆PP_3665 deletion strain (p-
value<0.0001), indicating that PP_3667 promoter induction in the presence of creatine is 
a PP_3665-dependent process. We also demonstrated that the transcriptional regulator 
PP_3665, tagged with a maltose-binding protein (MBP) tag for purification (MBP-
PP_3665), binds to the promoter region of PP_3667, causing altered shift of the PP_3667 
promoter probe in the presence of MBP-PP_3665 due to PP_3665-probe binding (Figure 
2.3B). Altered PP_3667 promoter migration in the presence of MBP-PP_3665 is 
demonstrated in Lanes 2, 3, and 4 of the gel in Figure 2.3B. PP_3667 probe migration in 
the absence of MBP-PP_3665 is shown is Lane 6. The PP_3667 promoter-specific 
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binding of PP_3665 is supported by the lack of altered probe migration when a creatine-
unrelated probe, dhcA, was mixed with purified MBP-PP_3665, which is shown in Lane 
1 (Figure 2.3B).  
 
2.4.3 Identification of the PP_3665 binding site in the PP_3667 promoter 
PP_3665-dependent transcriptional induction of the PP_3667 promoter is highest 
when the full promoter region (-228 bp from the translational start site) is present. When 
the promoter is truncated to include only 193 bps upstream of the translational start site, 
transcriptional induction drops to approximately half of the induction observed when 228 
bp upstream are included (Figure 2.4A). Truncations of the PP_3667 promoter beyond 
104 bp upstream of the translational start eliminate all creatine-dependent transcriptional 
induction of the reporter gene. The creatine-dependent induction of the -228 bp and -193 
bp reporters is also PP_3665-dependent, with a significant difference in fold induction 
observed between the reporters in the P. putida wild type and P. putida ∆PP_3665 strains 
(-228bp p-value<0.0001, -193bp p-value=0.001) (Figure 2.4B).  
 
2.4.4 PP_3665 transcriptionally regulates the creatine-amidohydrolase gene 
PP_3667 in the presence of creatine 
Relative transcript abundance of the creatine-amidohydrolase gene PP_3667 is greatly 
increased in wild type P. putida KT2440 in the presence of creatine. P. putida ∆PP_3665 
shows no change in PP_3667 transcripts in the presence of creatine. There are also no 
marked changes in transcript abundance of the control gene ppiD/PP_2304 +/- creatine in 
either the wild type or ∆PP_3665 strains of P. putida. Transcript abundance in wild type 
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P. putida quickly increases in the presence creatine, with noticeable changes in as little as 
1-hour post-creatine exposure (Figure 2.5).  
 
2.4.5 Orthologs of PP_3667 with an associated glutamine amidotransferase-1 
containing transcriptional regulator are maintained in nonpathogenic and 
pathogenic bacteria  
Orthologs of the PP_3667 creatinase cluster into two clades; Clade 2 includes exclusively 
environmental species while Clade 1 includes a majority of pathogenic bacteria (Figure 
2.6). The pathogenic Acinetobacter species within Clade 1 maintain a genomic region 
that is orthologous to P. putida’s PP_3665-PP_3668 region on a plasmid-borne 
transposon (Figure 2.7). The presence of creatine-metabolic genes on a transposon 
maintained in pathogenic bacteria supports the hypothesis that creatine metabolism is 
beneficial during pathogenesis. PP_3665-PP_3668 orthologs are also present on a 
plasmid in the non-pathogenic bacterium Shinella, demonstrating a potential 
environmental source of mobile creatine-metabolic genes.  
 
2.5 Discussion  
Creatine is a polyamine compound present in many of the ecological niches 
occupied by Pseudomonas species. A large creatine pool is found within vertebrates, 
where it participates in the cycling of phosphate between high-energy ATP and ADP 
molecules. The body is constantly recycling its creatine stores leaving spent creatine to be 
excreted into the surrounding environment through urine and feces [4], [5], [6], [7]. Most of 
the creatine in the body is non-enzymatically converted into creatinine before excretion, 
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making this cyclic form of creatine abundantly present in the colon, where gut-resident 
microbes degrade it, and the rhizosphere where it can be utilized by soil-dwelling 
microorganisms [7], [39], [40], [41]. Because of the conversion of creatine to creatinine within 
veterbrates before excretion, many bacterial pathways for creatine metabolism begin with 
lysis of creatinine via creatinine amidohydrolase enzymes [41]. [42], [43], [[44] . The ability to 
metabolize the naturally occurring forms of creatine (cyclic and/or noncyclic) allows 
bacteria to access a rich nitrogen source and in some cases a sufficient source of carbon 
[14], [45]. This manuscript identifies a creatine-responsive transcription regulator, PP_3665, 
in P. putida that is critical for utilization of creatine as the sole nitrogen source.  
 
2.5.1 Functional PP_3665 is essential for activation of P. putida’s predominant 
pathway for utilization of creatine as a sole nitrogen source.  
 The AraC/XylS-family of transcriptional regulators is a diverse family generally 
characterized by a helix-turn-helix (HTH) DNA binding C-terminal domain and a N-
terminal domain dedicated to dimerization and/or ligand binding [46]. The creatine-
responsive transcriptional regulator of P. putida, PP_3665, belongs to a subset of 
AraC/XylS-family regulators that contain a glutamine amidotransferase-1 (GATase) 
domain in the N-terminal region with structural similarity to the DJ-1/ThiJ/PfpI 
superfamily of proteins. Members of this superfamily include the human DJ-1 protein, 
which while its functions in humans is unknown, has high similarity to bacterial ThiJ 
proteins that are involved in bacterial thiamine biosynthesis. Bacterial AraC-family 
transcriptional regulators in the GATase subfamily have a likely non-catalytic ThiJ-like 
domain in the N-terminus, which includes a conserved cysteine residue that is present in 
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the catalytic domain of active bacterial GATase proteins such as Klebsiella pneumoniae’s 
ThiJ [47], [48], [49].  Members of the GATase 1-containing AraC transcriptional regulator 
(GATR) family have been identified in multiple Gram-negative and Gram-positive 
bacteria, including Pseudomonas species, although their functions remain predominately 
unknown. Several of the characterized GATRs in P. aeruginosa participate in pathways 
involving metabolism of amine-containing compounds like arginine, glycine betaine, 
sarcosine, and carnitine [17], [23], [50], [51]. The P. putida GATR identified in this manuscript, 
PP_3665, controls the metabolism of the amine-containing compound creatine via 
transcriptional induction of creatinase PP_3667. 
The participation and necessity of PP_3665 in creatine metabolism is 
demonstrated in Figure 2.2, where a loss of PP_3665 results in the inability of P. putida 
to grow on creatine as the sole nitrogen source. As shown in Figure 2.3, PP_3665 binds 
with specificity to the promoter region of PP_3667, subsequently inducing transcription 
of PP_3667, which encodes a functional creatinase with the ability to efficiently lyse 
creatine into sarcosine and urea [9], [10], [11], [12], [13], [52], [53], [54]. Transcription of the 
creatinase-encoding gene PP_3667 occurs relatively quickly in wild type P. putida, 
within 1 hour after exposure to creatine. This suggests that lysis of creatine by creatinase 
PP_3667 is the preferential pathway of P. putida creatine metabolism and that quick 
metabolism of creatine when it is available in the environment is likely a beneficial 
metabolic strategy for P. putida.  It is interesting to note that while there is significantly 
less P. putida WT growth on creatine, creatinine, and sarcosine as sole nitrogen sources 
as compared to choline, P. putida WT utilizes creatine and sarcosine significantly more 
efficiently then creatinine (Figure 2.2B). Creatinine is generally a precursor to creatine in 
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the context of bacterial metabolism (Figure 2.1A) but creatinine metabolism via N-
methylhydantoin and N-carbamoylsarcosine has also been observed in P. putida strains 
[42]. Depending on which pathway of creatinine metabolism is favored by the particular P. 
putida strain, creatine may or may not be an intermediate of metabolism. The lack of P. 
putida KT2440 growth on creatinine as a sole nitrogen source, independent of whether 
creatinase PP_3667 is being produced, may be due to inefficient lysis of creatinine 
resulting in an intermediate that is not creatine [42], [55]. The hypothesis that creatinine is 
lysed by P. putida KT2440 into an intermediate that is not creatine, such as N-
methylhydantion, is supported by the negligible induction of creatinase PP_3667 in the 
presence of creatinine.  
The genome of P. putida KT2440 does not appear to transcribe a putative 
creatinine amidohydrolase protein, while several other strains of P. putida, including 
strain S16, W619, and RS56, possess one transcribed divergently or in the vicinity of 
creatinase PP_3667 homologs. The evidence for creatininase function was demonstrated 
using the cloned and purified enzyme from P. putida strain RS56, GenBank Accession: 
AF164677 [56]. In all cases, these creatininase genes are either transcribed divergently 
(strains S16 and RS65) or located in close proximity (strain W619) to a creatinase gene 
orthologous to P. putida’s PP_3667 creatinase encoding gene (60% coverage and 83% 
identity with P. putida RS65 creatinase). P. putida strain KT2440 possesses the 
creatinase (PP_3667) but not the cognate creatininase present in other creatinase-
containing strains. The absence of the creatininase could explain the lack of PP_3665-
dependent induction of PP_3667 when creatinine is the starting substrate. Other 
enzymes, such as one of the multiple creatinase domain-containing paralogs of PP_3667 
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present in the P. putida KT2440 genome, may be capable of creatinine lysis but at an 
inefficient rate, resulting in a slower rate of creatine or N-methylhydantoin production 
and lower PP_3665-dependent PP_3667 induction.  
If you eliminate the primary inducer, creatine, from the analysis of the PP_3665-
dependent transcriptional induction assays, a small yet significant difference in PP_3665-
dependent PP_3667 induction is observed in the presence of creatinine between the WT 
and ∆PP_3665 strains (**p-value=0.0021)(Figure S2.1). This modest PP_3665-
dependent increase in PP_3667 transcriptional induction of the creatinase in the presence 
of creatinine may be indicative of weak recognition of an alternative intermediate like N-
methylhydantoin by transcriptional reporter PP_3665, or that creatinine is spontaneously 
converted into creatine slowly over time. It is also interesting to note that glycine betaine 
significantly inhibits basal transcription of creatinase PP_3667 independently of 
PP_3665. This may be indiciative of an inhibitory feedback mechanism perpetuated by 
downstream products of creatine metabolism or the direct or tangential involvement of 
other compound-specific regalutors in creatine metabolism.   
 
2.5.2 Conservation of creatinase PP_3667 and amidotransferase 1-containing AraC 
family transcriptional regulator PP_3665 illustrate the utility of the inducible 
system in creatine rich environments 
Pathways for creatinine and creatine metabolism are conserved among many 
bacterial species. When looking at sequence similarity and genomic organization between 
bacteria, the presence of a creatine-responsive inducible metabolic system appears to be 
conserved among several species. The evidence of this rests in the presence of homologs 
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of P. putida’s creatinase, PP_3667, along with a cognate amidotransferase 1-containing 
AraC family transcriptional regulator, PP_3665, transcribed in the same general 
organization as P. putida, in multiple bacteria (genomic organization in P. putida 
KT244o shown in Figure 2.1B). The phylogenetic tree in Figure 2.6A shows which, 
likely inducible, creatinase enzymes are most closely related to each other and to 
PP_3667 of P. putida. The creatinase enzymes appear to cluster into a predominantly 
pathogenic clade (Clade 1) and an exclusively nonpathogenic clade (Clade 2), indicating 
potential divergent evolution of creatinase genes in bacterial populations interacting 
within the rhizosphere versus the hospital/human host. It is interesting to note that for 
each sub-clade within Clade 1 there appears to be a nonpathogenic bacterial species to 
represent the origin of the creatinase enzyme in the rhizosphere. For example, soil 
resident Paraburkholderia is a closely related species to Burkholderia cenocepaciea, an 
opportunistic pathogen involved in cystic fibrosis infections and Burkholderia 
pseudomalli, the causative agent of the musculoskeletal infection meliodosis [57], [58], [59].  
All of the bacterial species noted in Figure 2.6A are primarily soil or water 
dwelling species while some can cause opportunistic infections. The retention of the 
bacterial creatinase enzyme in opportunistic pathogens such as Burkholderia sp. supports 
the hypothesis that creatine metabolism can be a beneficial metabolic strategy during 
infection. The benefit of the creatine-inducible system during opportunistic infection is 
further supported by the retention of creatinase and AraC transcriptional regulator in 
Acinetobacter strains. In each of the three pathogenic Acinetobacter strains (A. 
baumannii, A. nosocomialis, and A. pitti), homologs of the creatinase and associated 
regulator are present in transposons present on plasmids, potentially derived from soil 
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resident microbe Moraxella osloensis, which possesses the most closely related enzyme 
(Figure 2.7).  
P. putida’s PP_3667 and PP_3665 proteins cluster with the soil-dwelling 
nonpathogenic bacterial strains in Clade 2, most of which are notable for their ability to 
fix nitrogen or participate in denitrification in soils, but orthologs are also found in 
pathogenic P. aeruginosa strains isolated from Shanghai fever patients [60]. The 
distribution of creatinase and creatinase-inducing transcription regulators among soil-
dwelling bacteria, as well as the maintenance of these proteins in opportunistic 
pathogens, illustrates the importance of being able to transition efficiently to creatine 





2.6 Chapter 2 Figures  
 
Figure 2.1 Pathway of bacterial creatine metabolism. (A) Pseudomonas putida 
KT2440 does not transcribe a putative creatinine amidohydrolase, but other enzymes of 
similar function may act on creatinine to form creatine. Creatine is then lysed by creatine 
amidinohydrolase (CreA) to sarcosine and urea. Oxidation of sarcosine by SoxBDAG, as 
characterized in Pseudomonas aeruginosa, creates glycine and formaldehyde as end 
products of creatine metabolism. (B) Organization of the creatine-responsive 
transcriptional regulator and creatinase genes in P. putida strain KT2440. A clean 
deletion of transcriptional regulator PP_3665 was made in P. putida to determine the role 
of PP_3665 in transcription of creatinase CreA (PP_3667). 
 
Figure 2.2 PP_3665 contributes to P. putida KT2440’s growth on creatine and 
creatinine when supplied as the sole nitrogen source. After 18 hours of growth (A) 
with choline, creatine, creatinine, sarcosine, or arginine supplied as the sole nitrogen 
source to P. putida wild type, ∆PP_3665 and complemented strains, the OD600 of cultures 
was measured. Growth of each strain on 2mM nitrogen source was reported as the fold 
growth over the 0mM nitrogen (no nitrogen) condition; Fold Growth = (OD6002mM N-
source/OD6000mM nitrogen). Statistical significance was determined via 2-way ANOVA with 
Tukey’s multiple comparison’s test. P. putida wild type and complement strains grew to 
a significantly higher density as compared to ∆PP_3665 in the presence of creatine 
(****p-value<0.0001). (B) Growth of P. putida WT on creatinine as a sole nitrogen 
source was significantly lower as compared to growth on choline (***p-value= 0.0001). 
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Growth of P. putida WT on creatinine is statistically lower then growth on creatine (*p-
value= 0.0111). Statistical significance was determined via One-way ANOVA with 
Tukey’s multiple comparison’s test. The data shown are averages of three independent 
experiments; error bars represent standard deviation from the mean.  
 
Figure 2.3 PP_3665 induces expression of PP_3667 in the presence of creatine and 
binds preferentially to the PP_3667 promoter region. A transcriptional reporter fusion 
of the promoter region of PP_3667 to the coding region of gfp was used to measure 
PP_3667 gene expression in the presence of several nitrogen sources. (A) After a 5-hour 
incubation with 2 mM creatine significant fold induction of the PP_3667-gfp reporter 
was observed in P. putida wild type (****p-value<0.0001) as compared to the negligible 
induction detected in ∆PP_3665. All other nitrogen sources, including creatinine, 
sarcosine, and glycine betaine, demonstrated negligible inducing power in P. putida wild 
type as compared to ∆PP_3665. Fold Induction was calculated by the equation Fold 
Induction = (Fluorescence Units2mM N-source/Fluorescence Units0mM N-source) Statistical 
significance was calculated using 2way ANOVA with Sidak’s multiple comparisons test. 
The data shown are averages of three independent experiments; error bars represent the 
standard deviation from the mean. (B) MBP-PP_3665 preferentially binds the promoter 
region of PP_3667 causing probe shift (Lanes 2-4). The promoter region of the dhcA 
gene was not bound by MBP-PP_3665, demonstrating the specificity of PP_3665 for the 





Figure 2.4 The region between positions -228 and -104 from the translational start 
site of PP_3667 is essential for PP_3665-dependent gene induction. Promoter 
truncations were measured as base pairs upstream from the translational start of 
PP_3667. (A) Maximum induction of the PP_3667-gfp reporter was achieved when 228 
bps upstream of the PP_3667 translational start site (-228) were provided, while the -193 
truncated promoter reduced transcriptional induction by half. Removal of base pairs 
beyond -104 completely ablated transcriptional induction of the PP_3667-gfp reporter. 
Statistical significance was calculated by Ordinary one-way ANOVA using Tukey’s 
multiple comparisons test. ****p-value<0.0001, **p-value=0.0023. (B) Transcriptional 
induction of the -228 and -193 PP_3667-gfp reporters remained PP_3665-dependent. The 
data shown are averages of three independent experiments; error bars represent the 
standard deviation from the mean. Statistical significance of differences between 
promoter truncation inductions was calculated via 2way ANOVA using Sidak’s test for 
multiple comparisons. ****p-value<0.0001, **p-value=0.0010. 
Fold Induction = (Fluorescence Units2mM N-source/Fluorescence Units0mM N-source) 
 
Figure 2.5 PP_3665 controls the transcription of the creatine-amidohydrolase 
encoding gene PP_3667 in the presence of creatine Transcription of creatinase gene 
PP_3667 at 1 hour post-creatine exposure, as measured by semi-quantitative qRT PCR, is 
increased in response to creatine in wild type P. putida but not in ∆PP_3665. There is no 
change between transcriptional levels of a control gene PP_2304, encoding a 
peptidylptolyl isomerase D, in the presence or absence of creatine in either wild type or 




Figure 2.6 Homologs of creatinase PP_3667 and the associated AraC transcriptional 
regulator PP_3665 are found in both pathogenic and nonpathogenic bacterial 
strains. The PP_3667 and PP_3665 genes of P. putida KT2440 are closely 
phylogenetically related to homologs found in other soil-resident bacteria. Homologs are 
also found both on the chromosome and plasmid-borne in bacteria that cause infection in 
humans (highlighted in red), demonstrating the potential utility of the creatine-responsive 
metabolic system in bacterial pathogenesis.   
 
Figure 2.7 Putative creatine-responsive creatine metabolic genes are maintained on 
a transposon in several Acinetobacter sp. Orthologs of P. putida’s creatine-responsive 
transcriptional regulator, creatinase gene, and MFS transporter are present on a plasmid-
borne transposon, as outlined above, in pathogenic Acinetobacter species.  
 
Figure S2.1 PP_3665-dependent induction of PP_3667 in the presence of creatinine. 
Transcription of PP_3667 is significantly lower in the ∆PP_3665 mutant in the presence 
of creatinine, the usual precursor to creatine in bacterial metabolism (**p-value=0.0096). 
Glycine betaine significantly suppresses the transcription of PP_3667 independent of the 
presence of PP_3665 to approximately half of the 0mM nitrogen transcriptional 
induction (****p-value<0.0001). Fold induction was calculated using the following 
equation: 
Fold Induction = (Fluorescence Units2mM N-source/Fluorescence Units0mM N-source) 






2.7 Chapter 2 Tables  
Table 2.1 Strains and plasmids used in this study.  
Table 2.2 Sequences of primers used in this study.  






















































Figure 2.2 PP_3665 contributes to P. putida KT2440’s growth on creatine and creatinine 

















Figure 2.3 PP_3665 induces expression of PP_3667 in the presence of creatine and binds 









































Figure 2.4 The region between positions -228 and -104 from the translational start site of 



















Figure 2.5 PP_3665 controls the transcription of the creatine-amidohydrolase encoding 
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Figure 2.7 Putative creatine-responsive creatine metabolic genes are maintained on a 
















































Table 2.1 Strains and plasmids used in this study. 
Designation Genotype	or	Description Plasmid Primers	Used	in	Condition
LAH237 P.	putida 	KT2440	WT	 pMQ80	 none
LAH258 P.	putida 	KT2440	∆PP_3665	 pMQ80 none
LAH295 P.	putida 	KT2440	∆PP_3665	 pMQ80:pssA/PP_3665 2613-2614
LAH249 P.	putida 	KT2440	WT	 pMQ80:PP_3667Prom-228gfp 2590-2591
LAH284 P.	putida 	KT2440	WT	 pMQ80:PP_3667Prom-193gfp 2592-2591
LAH297 P.	putida 	KT2440	WT	 pMQ80:PP_3667Prom-104gfp 2602-2591
LAH298 P.	putida 	KT2440	WT	 pMQ80:PP_3667Prom-80gfp 2605,	2604,	2603,	2591
LAH254 P.	putida 	KT2440	∆PP_3665	 pMQ80:PP_3667Prom-216gfp 2590-2591
LAH265 P.	putida 	KT2440	∆PP_3665	 pMQ80:PP_3667Prom-193gfp 2592-2591
LAH293 E.	coli	T7 pMALc2x:MBP-PP_3665 2596-2597
LAH256 P.	putida 	KT2440	WT	 none none
LAH111 P.	putida 	KT2440	∆PP_3665	 none none
Strains	and	Plasmids
 
























2615 CreatinaseProm_F_biotin 5'/Biosg/TGT GGA TCC GTT TGT CCG AGA CTT TGT GGC
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CHAPTER 3: The role of metabolic operon sphBCD in Pseudomonas aeruginosa’s 
response to the host-derived antimicrobial sphingosine  
 
3.1 Abstract  
 Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes 
difficult to treat nosocomial infections in individuals with chronic obstructive pulmonary 
disorder (COPD) or cystic fibrosis (CF). Multidrug resistant P. aeruginosa is a serious 
threat to public health and novel approaches to treatment and control of these infections 
are needed. P. aeruginosa is not only resistant to exogenous antibacterial compounds, but 
it is also highly resistant to many innate-immune mechanisms. Here we characterize, 
through genetic and biochemical approaches, the interaction between the host-derived 
antimicrobial sphingosine and P. aeruginosa. We identify a putative metabolic operon, 
sphBCD, which encodes a putative cytochrome c (SphB), oxidoreductase enzyme 
(SphC), and aldolase enzyme (SphD), that act on sphingosine and evaluate the role of 
sphBCD in P. aeruginosa’s ability to resistant high levels of sphingosine. This study 
expands on our knowledge of how P. aeruginosa evades a component of host innate-
immunity and provides a foundation for further work in identifying ways to disrupt this 
sphingosine-resistance machinery, with the goal of rendering P. aeruginosa more 
susceptible to host innate-immune defenses.  
3.2 Introduction 
 Sphingolipids are key players in the human innate immune system’s defense 
against bacterial pathogens, with high activity against both Gram positives and Gram 
negatives [1], [2], [3], [4], [5], [6]. A variety of sphingolipids are found at sites throughout the 
body that are prone to bacterial infection, including mucosal barriers, the lungs, the skin, 
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and concentrated in hair follicles [4],  [7], [8], [9], [10]. Imbalances or deficiencies in certain 
skin and mucosal barrier-associated sphingolipids have been shown to increase chances 
of bacterial infection, illustrating the importance of these antimicrobial lipids in defense 
against pathogens [11].  
Sphingolipids’ mechanism of action against bacterial pathogens is predicted to be 
similar to that of cationic peptides, beginning with bacterial membrane disruption that 
can be caused by charged functional groups such as the primary amine present in the 
majority of sphingolipid structures. Increased permeability of the inner and outer 
membranes allows for increased diffusion of sphingolipids into the cytosol of bacterial 
cells where the formation of large inclusion bodies can cause further structural damage. 
The negative effects of sphingolipids on different species of bacteria are illustrated in a 
study by Fischer et al that depicts, through scanning electron micrographs, how 
accumulation of sphingoid bases sphingosine, phytosphingosine, and dihydrosphingosine 
cause ultra-structural damage and ultimately lead to cell death in both Gram negatives 
Escherichia coli and Porphyromonas gingivalis and Gram positive Staphylococcus 
aureus [4], [5]. The most substantial structural cell damage that occurs in gram-negative 
bacteria when treated with sphingolipids is the separation of the outer and cytoplasmic 
membranes, which is similar to the type of damage caused by cationic peptides like 
cathelicidins [4]. The concentrations of sphingoid bases needed to cause this severe and 
cytotoxic membrane disruption in E. coli and P. gingivalis are relatively low compared to 
other Gram-negative bacteria that can withstand higher levels of sphingolipids. The 
minimum bactericidal concentration (MBC) for P. aeruginosa was measured at greater 
than 1.67 mM, approximately 380x higher than the MBC of the often co-infecting Gram-
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positive microbe Staphylococcus aureus [1]. Although there are many factors that 
influence antimicrobial-bacterial interactions, the extremely high sphingolipid resistance 
profile of P. aeruginosa suggests that it possesses specific mechanisms for resistance to 
or detoxification of sphingolipids. 
  Many of P. aeruginosa’s infection niches contain abundant sphingosine, 
sphingosine analogs, and sphingosine precursors, sphingomyelin and ceramide [2], [12], [13], 
[14], [15]. Therefore, it is not surprising that P. aeruginosa may possess mechanisms to 
detoxify or utilize sphingolipids. P. aeruginosa is most commonly associated with 
hospital-acquired and ventilator associated pneumonias and bacteremia [16], [17], [18], [19]. 
Incidence of infection in individuals with chronic pulmonary conditions, such as cystic 
fibrosis (CF) and chronic obstructive pulmonary disorder (COPD), is associated with 
high morbidity, rapid decline of lung function, and increased levels of immune-signaling 
molecule sphingosine-1-phosphate [20], [21], [22], [23], [24]. Within the context of pulmonary 
infections, P. aeruginosa’s ability to resist the antimicrobial affects of sphingosine is 
correlated with a significant survival advantage, likely due to the presence of sphingoid 
bases within the lung epithelium [21]. 
  During exposure to pulmonary surfactant, the lipid-rich mixture secreted by Type-
II alveolar epithelial cells located in the lower airways, a small set of sphingosine-
responsive genes is induced in P. aeruginosa, including an outer membrane β-barrel 
protein SphA, a neutral ceramidase CerN, and a predicted metabolic cassette sphBCD, 
encoding a putative cytochrome c (sphB), putative oxidoreductase enzyme (sphC), and 
putative PLP-dependent aldolase enzyme (sphD) [21], [25], [26]. Transcription of these genes 
is induced in the presence of sphingosine via the sphingosine-responsive transcriptional 
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regulator SphR, leading to increased survival of P. aeruginosa in the presence of 
sphingosine [21]. It has been determined that putative oxidase SphC, along with regulator 
SphR and β-barrel protein SphA, contributes to the ability of P. aeruginosa to resist 
killing by sphingosine but the mechanism by which SphC, in coordination with co-
expressed proteins SphB and SphD, protects against sphingosine is unknown [21]. Further 
investigation into whether the enzymes encoded by metabolic cassette sphBCD 
participate in catabolism of sphingosine is needed in order to gain a broader 
understanding of how P. aeruginosa manipulates innate immune mechanisms to establish 
and maintain successful infections. Here we describe the inducer specificity driving 
sphBCD induction, establish the role of sphBCD in sphingosine metabolism, and 
demonstrate the importance of sphBCD during P. aeruginosa growth in the presence of 
sphingosine.  
3.3 Materials and Methods  
3.3.1 Strains and Growth Conditions 
Pseudomonas aeruginosa PAO1 and mutants made from the PAO1 parent strain 
were grown on morpholinopropanesulfonic acid (MOPS) media[27] supplemented with 25 
mM pyruvate, 5 mM glucose and 20 µg/ml gentamicin, when needed for plasmid 
maintenance, for all reporter and sphingosine modification assays. Pyruvate was supplied 
at 20 mM as the sole carbon source with 20µg/ml gentamicin for P. aeruginosa growth 
assays in the presence of sphingosine. Escherichia coli strains DH5α and S17λpir, used 
for cloning and mating with P. aeruginosa, and E. coli strain T7, used for recombinant 
protein expression, were maintained in lysogeny broth (LB), Lennox formulation, 
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supplemented with 7 µg/ml gentamicin or 150 µg/ml carbenicillin as appropriate. Strains 
and plasmids can be found in Table 3.1.  
3.3.2 Sphingolipids and related analogs  
All sphingosine analogs were purchased from Avanti Polar Lipids with the 
exception of analog FTY720 and palmitate, which were purchased from MilliporeSigma.  
Stock solutions of 50 mM and 5 mM sphingosine, phytosphingosine, FTY720, and 
FTY720 O-Methyl were dissolved in 100% molecular grade ethanol. Stock solutions of 5 
mM 1-deoxysphingosine and 3-deoxysphingosine were dissolved in 3:1 chloroform: 
methanol. Palmitate was dissolved in methanol at 5mM. All sphingosine analog stocks 
were stored in glass vials at -20°C.  
3.3.3 Construction of sphBCD triple gene deletion in P. aeruginosa strains PAO1 
and PA14  
A 550 bp region upstream of the sphBCD metabolic cassette was amplified from 
PAO1 genomic DNA with primers engineered with KpnI and SmaI restriction sites 
(#2080 and #2083). A 560 bp fragment downstream of sphBCD was amplified from 
PAO1 genomic DNA using primers engineered with HindIII and SmaI restriction sites 
(#2081 and #2082). After gel purification of each fragment via Thermo Fisher’s GeneJET 
DNA Gel Extraction and Clean Up Kit (Waltham, MA), the upstream and downstream 
sphBCD flanking fragments were mixed in an equal molar ratio and spliced together by 
amplification with the outside primers (#2080 and #2082) resulting in a ~1.1 kb fragment 
flanked with KpnI and HindIII restriction enzyme sites and internal SmaI sites. The 1.1 
kb fragment was digested using enzymes KpnI and HindIII (New England Biolabs, 
Ipswitch MA) and ligated into the similarly cut suicide vector pMQ30, containing the 
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counter-selective sacB gene, to create the plasmid pMQ30:∆sphBCD to be used in 
homologous recombination with P. aeruginosa. Cloning and propagation of the plasmid 
was carried out in competent E. coli DH5α cells.  
After isolation of the plasmid from the E. coli DH5α cells via Thermo Fisher’s 
GeneJET Plasmid Extraction Kit (Waltham, MA), pMQ30:∆sphBCD was transformed 
into the chemically competent conjugative E. coli strain S17λpir. Donor S17λpir cells 
containing pMQ30:∆sphBCD were mixed with the recipient strain P. aeruginosa PAO1 
or strain PA14 and single crossover colonies that partially integrated the deletion 
construct were selected by plating on LB agar plates amended with 50 µg/ml gentamicin. 
Gentamicin resistant colonies were then grown in LB broth overnight at 37°C in order for 
the second recombination event to occur. These cultures were then plated onto LB plates 
with no salt and 5% sucrose, and LB plates containing gentamicin. Those colonies that 
were able to grow on sucrose but were no longer resistant to gentamicin were screened by 
polymerase chain reaction using primers flanking the potentially deleted region (#2080 
and #2082) to determine whether the second recombination event resulted in a reversion 
to the wild type (WT) chromosomal region or successful triple-gene deletion [28], [29]. 
Strains LAH82, a revertant to the WT PAO1 genotype (PAO1 ∆sphBCD WTR), and 
LAH83, a triple gene deletion of sphBCD (PAO1 ∆sphBCD) were grown up in LB broth 
and frozen at -80°C in 20% glycerol. Sequences of primers used to construct the 




3.3.4 Cloning of sphBCD complement constructs  
 The plasmid pMQ80 was used as the backbone for all complement constructs. 
Constructs for complementation of the whole or partial sphBCD operon were constructed 
via PCR amplification, restriction enzyme digestion, and ligation into similarly cut 
pMQ80 using the primers outlined in the sphBCD operon complement constructs section 
of Table 3.2. All plasmids were transformed via heat shock into chemically competent E. 
coli DH5α following ligation. Once propagated in and purified from E. coli, plasmids 
were introduced into the appropriated P. aeruginosa strain via electroshock 
transformation.  
3.3.5 Construction of a chromosomally integrated sphB-lacZYA transcriptional 
reporter promoter fusion in P. aeruginosa strain PA14 
A 1 kilobase (kb) region upstream of the sphBCD metabolic cassette in P. 
aeruginosa strain PAO1 was amplified from PAO1 genomic DNA using primers 
engineered with HindIII and KpnI restriction sites (#2082 and #2286). This region 
includes the promoter region of sphB for construction of the transcriptional reporter 
promoter fusion. This 1 kb fragment was digested with restriction enzymes HindIII and 
KpnI (New England Biolabs, Ipswitch MA) and ligated into the similarly cut plasmid 
pGW78, a plasmid that contains the β-galactosidase encoding operon lacZYA flanked 
with two multiple cloning sites. This resulted in a plasmid containing the lacZYA operon 
under the control of the sphB promoter region. A 500 base pair (bp) region downstream 
of the sphBCD cassette was amplified with primers engineered with NheI and SphI 
restriction sites (#2287 and #2288) and digested with enzymes NheI and SphI (New 
England Biolabs, Ipswitch MA). This fragment was ligated into similarly cut pGW78 at 
	
	 91	
the 3’ end of lacZYA to provide the second region for homologous recombination with 
the P. aeruginosa chromosome. lacZYA flanked by the sphB promoter region and the end 
of the sphBCD operon was cut from pGW78 with HindIII and SphI and ligated into 
similarly cut suicide vector pMQ30. 
After homologous recombination, carried out as described previously, the 
sphBCD metabolic cassette was replaced in P. aeruginosa strain PA14 with the lacZYA 
operon under the control of the sphB promoter, creating strain LAH118. This 
chromosomally reporter was also integrated into an sphR deletion background (∆sphR) of 
P. aeruginosa PA14 to create strain LAH122. Sequences of primers used to construct this 
chromosomally integrated reporter (sphB-lacZYA promoter fusion transcriptional 
chromosomal reporter) can be found in Table 3.2. 
3.3.6 Testing the specificity of SphR-dependent activation of the sphB-driven 
metabolic cassette via sphingosine analogs 
Transcriptional induction assays were carried out via β-galactosidase assay as 
described previously[30], [31] with the following modifications. Several sphingosine 
analogs were tested for their ability to induce transcription of the sphBCD metabolic 
cassette in an SphR-dependent manner. The chromosomally integrated sphB-lacZYA 
transcriptional reporter was used as the reporter strain for these assays to give a 
biologically relevant measure of transcriptional activity at sphBCD’s native locus. 
Transcriptional induction was measured in the presence and absence of SphR by using 
reporter strain LAH118 and reporter strain LAH122 possessing the ∆sphR background.  
The sphingosine analogs tested included sphingosine, 1-deoxysphingosine, 3-
deoxysphingosine, FTY720, FTY720 O-Methyl, phytosphingosine, and the potential 
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metabolic product of sphingosine breakdown, palmitic acid. All analogs were tested at 20 
µM in 1X MOPS media amended with 25 mM pyruvate and 5 mM glucose. Sphingosine 
analogs were added to glass tubes and solvent was evaporated under nitrogen gas before 
addition of culture and induction for 18 hours, shaking, at 37°C. Levels of growth 
(optical density at 600nm) and β-galactosidase activity (absorbance at 420 nm) were 
measured using the Synergy II plate reader (BioTek). Transcriptional activity was 
calculated via Miller’s protocol[32] reported as a percentage of the induction observed in 
the presence of the primary inducer, sphingosine.  
3.3.7 Protein expression and purification  
A maltose binding protein (MBP) N-terminal fusion of the full-length SphR 
transcriptional regulator protein was expressed and purified as previously described by 
LaBauve and Wargo, 2014. Briefly, the coding sequence of sphR was inserted 
downstream of the MBP coding sequence in vector pMALc2 and expressed in E. coli T7 
cells. Cultures were grown in LB amended with 150 µg/ml carbenicillin at 37°C for 3 
hours and protein expression induced with 1 mM isopropyl-β-D- thiogalactopyranose 
(IPTG) for 2.5 hours. Cells were then harvested by centrifugation and frozen at -20°C 
overnight. Frozen pellets were lysed the following day in 4 ml lysis buffer per 1 g cells 
(lysis buffer: 20 mM Tris HCl, pH=7.4, 1 mM EDTA, 200 mM NaCl, 1x Halt protease 
inhibitor, 3 mg/ml lysozyme) and diluted 5-fold in lysis buffer. Cell lysates were then 
clarified by centrifugation and cleared lysates were run through an amylose resin column. 
After washing the column with 10x the resin bed volume (wash buffer:  20 mM Tris-HCl, 
150 mM NaCl, 1 mM EDTA pH 7.4), MBP-tagged SphR was eluted from the column via 
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wash buffer amended with 10 mM maltose. Protein concentration was measured by 
Bradford Assay and aliquots were flash frozen in liquid nitrogen for storage at -80°C[33].  
3.3.8 Electrophoretic mobility shift assays (EMSA)  
Electrophoretic mobility shift assays testing the specificity of SphR’s 
sphingosine-mediated promoter binding ability were performed as previously described 
with some modifications [31]. As previously demonstrated, SphR binds the promoter 
region of sphA in a sphingosine-dependent manner [21]. Therefore, an sphA probe was 
amplified with 5’-biotinylation using primers #874 and #988 and purified via GeneJET 
Gel Extraction and DNA Purification Kit (ThermoFisher Scientific) for use as the probe 
for evaluation of SphR binding. 
The following modifications were made to the EMSA binding reaction 
conditions; sodium chloride was removed from the binding buffer, no magnesium 
chloride was added, and Poly(dI-dC) was substituted with 100 ngs of salmon sperm DNA 
(Invitrogen).  Sphingosine analogs were added first to each binding reaction to a final 
concentration of 5 µM and solvent was evaporated off before addition of the binding 
reaction mixture, DNA probe, and protein. 5’-biotinylated sphA probe was used at a final 
concentration of 1 femtamole per microliter (fmol/µl) and MBP-SphR protein was added 
to a final concentration of 0.5 µM. Reactions were incubated at 37°C for 40 minutes, ran 
on a prerun 5% acrylaminde gel at 100V for 1 hour and transferred to a Biodyne B Pre-
Cut Modified Nylon Membrane (ThermoFisher) then visualized as per the manufacturers 
instructions with modifications as previously described using the Pierce Lightshift 
Chemiluminescent EMSA kit (ThermoFisher Scientific)[31]. Sequences of primers used to 
amplify EMSA probes can be found in Table 3.2. 
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3.3.9 P. aeruginosa sphingosine and phytosphingosine modification assays  
P. aeruginosa PAO1 WT strain or sphBCD deletion mutant (PAO1 ∆sphBCD) 
carrying either the empty vector control, pMQ80, or complement vectors expressing one 
or more of the genes belonging to the sphBCD metabolic cassette were grown overnight 
on the roller wheel at 37°C in 1X MOPS media supplemented with 25 mM pyruvate, 5 
mM glucose, and 20 µg/ml gentamicin. Overnight cultures were collected by 
centrifugation at 13,000 rpm for 1 minute, washed with 1X MOPS buffer and adjusted to 
uniform optical density read at 600nm (OD600) and added to 1XMOPS, 25 mM 
pyruvate, 5 mM glucose, 20 µg/ml gentamicin and 20 µM sphingosine or 
phytosphingosine for a final OD600 of 0.05. Media alone +/- 20µM sphingosine or 
phytosphingosine were also incubated as controls. Cultures were incubated on the roller 
wheel for 18 hours at 37°C. After incubation the cells were collected via centrifugation 
and cell pellets were separated from supernatant. The cell pellets were then re-suspended 
in 1x MOPS media for equal volume supernatant and pellet samples.  
Lipids remaining in the culture supernatant and cell pellets were extracted by the 
following method; chloroform: methanol was added at a 1:2 (volume/volume) ratio, 
samples were then vortexed for ten seconds and one volume of water was added. After an 
additional 10 seconds of vortexing, samples were spun for 10 minutes at 14,000 rcf to 
fully separate the organic and aqueous phases. 200 microliters (µl) of the organic lipid-
containing phase was dried under nitrogen gas in glass tubes and used to induce the 
reporter strain LAH118 overnight. 200µl of the aqueous phase was also tested for 
inducing capability using reporter strain LAH118. The level of sphingosine or 
phytosphingosine remaining in each culture was determined by observation of the level 
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of SphR-dependent, sphingosine specific, induction measured via Miller’s protocol[32]. 
Levels of induction were reported as a percentage of the induction measured in 
sphingosine controls. 
3.3.10 P. aeruginosa PAO1 growth and respiration assays  
P. aeruginosa PAO1 WT and PAO1 ∆sphBCD carrying either empty vector 
pMQ80 or complement plasmids containing one or more genes belonging to the sphBCD 
cassette were adjusted from 1XMOPS, 25 mM pyruvate, 5 mM glucose, 20 µg/ml 
gentamicin overnight cultures to an OD600 of 0.5. The adjusted cells were then added to 
a 96 well culture plate to a final OD600 of 0.05 in 150 µl of 1XMOPS amended with 20 
mM pyruvate, 20 µg/ml gentamicin, 10µg/ml tetrazolium violet, and either 200 µM or 0 
µM sphingosine or phytosphingosine per well. The OD600 and absorbance at 550 nm 
was measured per well, to determine cell growth and respiration (via tetrazolium violet 
reduction), respectively, every hour for 18 hours. The growth ability of each strain was 
reported as a ratio of sphBCD mutant growth over WT growth in each condition.  
3.3.11 Thin layer chromatography for detection of sphingosine  
 Overnight culture was added to a final OD600 of 0.05 in 1 ml of 1xMOPS 
supplemented with 20mM pyruvate, 20µg/ml gentamicin, and 30µg of sphingosine and 
incubated for 18 hours on the roller wheel at 37°C. The full volume of culture was 
separated into organic and aqueous fractions via chloroform: methanol phase separation 
and the organic fractions were dried under nitrogen gas. The dried organic fractions were 
solubilized in 20µl of ethanol and 5µl of each sample was spotted at the base of a pre-run 
TLC Silica Gel 60 F254 plate (EMD Millipore Sigma). The spotted plate was then placed 
in a saturated chamber and run in a mobile phase of chloroform: methanol: water 
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(65:25:4). The dried plate was sprayed with ninhydrin solution (Sigma Aldrich) and 
placed in a heated chamber for 30 minutes or until purple coloration appeared indicating 
the presence of sphingosine via it’s amine group.  
3.3.12 Phylogenetic tree building 
 A maximum likelihood phylogenetic tree was constructed using a pipeline 
consisting of MUSCLE protein sequence multiple alignment, PhyML to determine 
phylogeny using maximum likelihood, and tree rendering by TreeDyn, provided by 
Phylogeny.fr [34], [35]. Homologs of putative oxidoreductase enzyme SphC were identified 
in other bacterial species using the National Center for Biotechnology’s BLAST tool. 
Only homologs belonging to a similar operon structure were included. A similar FAD-
linked oxidoreductase enzyme from S. cerevisiae was included as an out-group. A list of 
the accession numbers of protein sequences used in tree building are included in Table 
3.3.  
3.4 Results and Discussion  
3.4.1 Transcriptional regulator SphR interacts with sphingosine and 
phytosphingosine to bind target promoter regions and induce transcription of the 
sphingosine-responsive operon sphBCD   
Sphingosine is one of many antimicrobial sphingolipids present throughout the 
body. In order to determine whether the sphingosine-responsive metabolic operon 
sphBCD is transcribed as part of P. aeruginosa’s response to other sphingolipids and/or 
related compounds, a panel of sphingosine analogs was tested for the ability to induce a 
sphB’-lacZYA-‘sphD chromosomal reporter in P. aeruginosa strain PA14 (LAH118). 
Analogs were chosen based on biological relevance and structural factors, such as the 
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presence or absence of functional groups and the geometry of the hydrocarbon tail, to test 
the effects of these factors on ligand recognition by the sphingosine-responsive 
transcriptional regulator SphR and consecutive induction of the metabolic operon (Figure 
3.1A). Of the analogs tested, phytosphingosine was the only compound able to 
significantly induce transcription of the sphBCD operon in an SphR-dependent manner 
(****p-value<0.0001).  
Phytosphingosine is the only analog that retains sphingosine’s structure at carbons 
C1 through C3 and is the only structure to achieve SphR-dependent transcription. This 
suggests that the most important structural features needed for detection by SphR and 
subsequent gene induction are the two hydroxyl groups and one primary amine group 
present at C1 through C3. Alteration of these groups significantly decreases SphR-
dependent induction of sphBCD (Figure 3.1B). The lack of either hydroxyl group, as 
demonstrated in the 1-deoxy and 3-deoxysphingosine analogs causes a lack of sphBCD 
induction. The same ablation of sphBCD induction is observed in the presence of 
palmitate, a structurally similar fatty acid lacking an amine group. The presence of the 
hydroxyl groups and primary amine are not the only factors influencing SphR-dependent 
sphBCD induction. Drastic alternation of the hydrocarbon tail, demonstrated by FTY720, 
also reduces induction.  
While these observations support the importance of the hydroxyl and amine 
functional groups present in sphingosine’s structure for SphR-ligand recognition and 
consecutive sphBCD transcriptional induction, it does not rule out issues with transport 
across cell membranes as the limiting factor. It is known that SphR is able to bind 
sphingosine via the N-terminal domain (Figure S3.1) and binds to the promoters of 
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sphingosine-responsive genes in the presence of sphingosine [21]. In order to confirm the 
binding of SphR to promoter in the presence of analogs that induce transcription, and to 
ensure that SphR was coming into contact with the tested ligands, electrophoretic 
mobility shift assays (ESMAs) were conducted, using the promoter region of the 
sphingosine-responsive gene sphA as the target probe, in the presence of the sphingosine 
analogs. In support of our transcriptional induction observations and previously 
conducted assays [21], only compounds that induce transcription of sphingosine-
responsive genes, including sphingosine, phytosphingosine, and a C16 tail-length variant 
of sphingosine, are able to promote SphR-dependent probe shift (Figure 3.1C).   
3.4.2 The presence of a functional sphBCD operon results in the modification of 
sphingosine to a form undetectable by SphR  
 Given the predicted functions of the enzymes encoded by the sphBCD operon, 
Figure 3.2A outlines a putative sequential mechanism for sphingosine metabolism, 
involving oxidation by oxidoreducatase SphC at the C1 position followed by cleavage of 
the resulting aldol by aldolase SphD. In order to determine whether the predicted 
metabolic operon sphBCD is responsible for modification of sphingosine, sphingosine 
levels in cultures of WT and ∆sphBCD P. aeruginosa PAO1 were measured after 
incubation of 20 µM sphingosine for 18 hours with each strain. The sphingosine-
responsive transcriptional reporter strain LAH118 was used as a biological sensor to 
detect un-modified sphingosine present in the cultures, as structure-function assays 
(Figure 3.1) indicate that modification of the hydroxyl or amine groups of sphingosine 
result in a lack of SphR detection. 
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 After incubation with WT P. aeruginosa, the sphingosine signal remaining in 
culture was significantly reduced in the supernatant of cultures as compared to the 
sphingosine control sample (**p-value=0.0199). WT cell lysate contained a decreased 
level of sphingosine that approached significance when compared to the sphingosine 
control (*p-value=0.1936), suggesting that sphingosine enters the cell and accumulates in 
cytoplasm where it is subsequently modified by WT P. aeruginosa (Figure 3.2B). 
Although variability in samples caused the decrease in sphingosine signal in WT cell 
lysate cultures to be a less-than significant change (over our significance threshold of 
0.05), only 10.5% of the sphingosine-responsive transcription remained in WT cell lysate 
cultures as compared to sphingosine controls. In WT supernatant cultures there was no 
detectable sphingosine-responsive transcription remaining. This reduction in detectable 
sphingosine in total culture is not a result of increased sequestration of sphingosine into 
bacterial cells, as both the supernatant and bacterial pellets were tested for inducing 
power and found to elicit a greatly decreased level of sphingosine-responsive 
transcription. In P. aeruginosa ∆sphBCD cultures, levels of sphingosine-dependent 
induction remained comparable to sphingosine controls. Complementation of the 
∆sphBCD phenotype, via the pMQ80:sphBCD complement plasmid, recovered the ability 
of ∆sphBCD P. aeruginosa to decrease the sphingosine signal to a value that was at, or 
approaching, significance in comparison to sphingosine controls (supernatant: **p-
value=0.0193, pellet; *p-value=0.165) (Figure 3.2B). This suggests that the sphBCD 
operon is essential for modification of sphingosine into a form undetectable by SphR.    
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3.4.3 The sphBCD operon is necessary for maximal growth and respiration in the 
presence of sphingosine  
 P. aeruginosa is intrinsically resistant to high levels of sphingosine. To 
investigate whether sphingosine modification by the encoded products of the sphBCD 
operon aid P. aeruginosa growth in the presence of sphingosine, P. aeruginosa PAO1 
wild type, ∆sphBCD, and complemented strains were grown in the presence of 200 µM 
sphingosine and growth was compared. After 16 hours of growth P. aeruginosa WT and 
complement strains grew to comparable optical densities in the presence of 0 µM and 200 
µM sphingosine (Figure 3.3A). P. aeruginosa ∆sphBCD did not display a growth defect 
in the 0 µm sphingosine condition but only achieved on average 34.1% of WT growth 
when grown in the presence of 200 µM sphingosine. The WT strain grew to a 
comparable level as compared to the ∆sphBCD:sphBCD complemented strain, while the 
∆sphBCD uncomplemented strain grew to a significantly lower OD600 as compared to 
the complemented strain (*p-value= 0.0252)(Figure 3.3A). The lower cell density 
achieved after 16 hours is due to the decrease in growth rate of P. aeruginosa ∆sphBCD 
compared to WT and complement strains. There is a significant increase in the doubling 
time of the ∆sphBCD strain during log phase (between 4 and 11 hours) in the presence of 
200µM sphingosine as compared to WT and complement strains (**p-value=0.0030) 
(Figure 3.3B).  
It has been demonstrated that sphingosine accumulates within bacterial cells 
causing flocculation and/or formation of inclusion bodies of cellular contents, which may 
impact measures of OD600 [5]. To support the OD600 readings, measures of cellular 
respiration were also measured via reduction of tetrazolium violet (TV). In keeping with 
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the growth results measured by OD600, the maximum level of respiration as measured by 
TV reduction was not significant different between the 0 µM and 200 µM sphingosine 
conditions in WT and complement strains, while the ∆sphBCD 0 µM and 200 µM 
sphingosine cultures showed visible difference in respiration levels (Figure 3.3C). This 
difference in respiration can be directly correlated to the differences in cell density, as the 
respiration per cell (Abs550/OD600) is consistent between all strains in all conditions 
(Figure 3.3C).  
Total levels of respiration were expected to be lower in ∆sphBCD cultures in the 
presence of sphingosine due to the decreased amount of cells measured through OD600. 
In order to determine whether the respiration per cell varied between strains in the 
presence of sphingosine, cellular respiration, reported as the amount of TV reduction 
(Abs550 unit) per cell (OD600 unit), was measured over a time course of 18 hours. A 
significant spike in P. aeruginosa WT cellular respiration in the presence of 200 µM 
sphingosine occurs at the entry to log phase (T= 4 hours) (**p-value=0.0014). This 
transient increase in WT cellular respiration is not observed in the 0 µM sphingosine 
condition or in any other strain in the 200 µM sphingosine condition. This burst of 
respiratory activity may indicate a spike in transcription of essential sphingosine-
responsive metabolic machinery that does not occur in ∆sphBCD and constitutive 
complementation strains (Figure 3.3D).  
3.4.4 Maximum growth of P. aeruginosa in the presence of the SphR-detectable 
sphingosine analogs phytosphingosine and sphinganine is dependent on sphBCD   
 As evidenced by the transcriptional induction assays shown in Figure 3.1, 
phytosphingosine is a sphingosine analog that causes promoter binding by SphR and 
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consecutive sphingosine-responsive gene transcription, including induction of the 
sphBCD operon. Phytosphingosine is another antimicrobial sphingolipid that P. 
aeruginosa is resistant to. To determine whether sphBCD enhances the growth of P. 
aeruginosa in the presence this sphingosine analog, growth assays involving WT, 
∆sphBCD, and complement strains of PAO1 were conducted in the presence of the 
phytosphingosine. After 16 hours, the growth of P. aeruginosa WT and complement 
strains did not significantly differ in the presence of 0 µM or 200 µM phytosphingosine, 
while 200µM phytosphingosine significantly decreased the growth of the ∆sphBCD 
strain to 34.3% that of WT in the same condition (**p-value=0.0093) (Figure 3.4A). 
Another sphingosine analog with the ability to induce SphR-dependent transcription, 
sphinganine, also inhibits P. aeruginosa growth in a sphBCD-dependent manner. P. 
aeruginosa ∆sphBCD grown in the presence of 200µM sphinganine resulted in a 
significant decrease in its maximum growth as compared to P. aeruginosa WT and 
sphBCD complement strains (Figure 3.4B) (*p-value= 0.0398). The significant 
contribution of the sphBCD operon to P. aeruginosa growth in the presence of two 
biologically revelent sphingolipids, phytosphingosine and sphinganine, along with 
phytosphingosine and sphinganine’s ability to induce transcription of the sphBCD 
operon, suggests that the sphingolipid-responsive system is essential to maximal growth 
of P. aeruginosa in the presence of multiple host-derived sphingolipids.   
3.4.5 Functions of the individual members of the sphBCD operon in modification of 
sphingosine and growth in the presence of sphingosine 
 The identities and functions of each member of the sphBCD operon can be 
predicted using NCBI’s sequence alignment and conserved domain databases. The 
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putative metabolic operon includes cytochrome c SphB, oxidoreductase enzyme SphC, 
and aldolase enzyme SphD. Given the functions of these predicted products, a potential 
pathway for sequential metabolism of sphingosine, shown in Figure 3.2A, was 
developed. To investigate whether each individual member of the sphBCD operon acts on 
sphingosine and to determine the biological importance of each member, sphingosine 
modification and growth assays were conducted in strains lacking sphB, sphC, or sphD.  
 According to the predicted pathway of sphingosine metabolism, oxidation of 
sphingosine by the oxidoreductase enzyme SphC is the essential first step to create an 
aldol substrate for cleavage by aldolase SphD. To test whether action by SphC is the rate-
limiting step in sphingosine modification, singular deletions of sphingosine-responsive 
genes were tested for their effect on sphingosine modification. The putative enzymes 
encoded by the sphBCD operon, sphC and sphD, were tested for their sphingosine-
modifying abilities along with another non-enzymatic SphR-dependent sphingosine-
responsive gene, sphA. Deletion of sphC resulted in the inability of P. aeruginosa to 
modify sphingosine, while strains with deletions of the sphingosine-responsive genes 
sphA and sphD behaved similar to WT (Figure 3.5A) The ∆sphC phenotype was 
successfully complemented, showing a recovery of the P. aeruginosa WT’s ability to 
modify sphingosine, resulting in a decrease in sphingosine signal that reached or 
approached significance in both the supernatant and cell pellets of ∆sphC cultures 
complemented by plasmid-borne sphC (pMQ80:sphC) (Figure 3.5B).  
These data indicate that the first modification step achieved by SphC is 
responsible for altering sphingosine into a species undetectable by SphR (Figure 3.5B). 
This supports the hypothesis that SphC modifies one or more of the functional groups of 
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sphingosine, as sphingosine analogs with altered hydroxyl or amine groups at carbons 
C1, C2, or C3 are undetectable by SphR (Figure 3.1). 
The putative aldolase SphD is predicted to participate in the second crucial 
sphingosine cleavage step. This cleavage has the potential to improve Pseudomonas 
growth in the presence of sphingosine as it cleaves the sphingolipid into less toxic and 
metabolically useful compounds. To assess the importance of SphD to P. aeruginosa 
growth in the presence of sphingosine, ∆sphBCD complemented with sphBC but lacking 
sphD was evaluated for its growth in the presence of sphingosine. The importance of 
sphC and sphB to P. aeruginosa growth in the presence of sphingosine was also 
evaluated by complementing the ∆sphBCD strain with sphC and sphCD respectively.  
 A comparison of growth in the presence of sphingosine between strains lacking 
one or more of the members of sphBCD gave a complete picture of those members 
essential to sphingosine detoxification and/or metabolism. Surprisingly, it is not only 
SphC, but also cytochrome c SphB that is essential for maximum growth of P. 
aeruginosa in the presence of sphingosine (Figure 3.5C).  
In the presence of 200µM sphingosine, the full sphBCD operon complemented 
strain (PAO1 ∆sphBCD : sphBCD) grows to 100% of its growth in 0µM sphingosine, 
indicating that the presence of a functional sphBCD operon prevents growth attenuation 
in the presence of 200µM sphingosine. The full complement strain and WT strains do not 
show a significant difference in % growth. Complementation with sphC or sphCD alone 
did not increase growth in the presence of sphingosine, and these strains along with the 
un-complemented (EV) strain, have significantly attenuated growth as compared to the 
sphBCD complemented strain (sphC *p-value=0.0179, sphCD *p-value=0.0129, EV **p-
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value=0.0078) (Figure 3.5C). The sphBC-complemented strain grew to ~76% of its 
maximal growth, and does not show a significant decrease in growth in the presence of 
sphingosine as compared to the full sphBCD complement. This indicates that cytochrome 
c sphB is essential for oxidoreductase sphC activity and that both genes are necessary for 
maximal P. aeruginosa in the presence of 200µM sphingosine.  
The lack of sphD does not significantly impact growth of P. aeruginosa in the 
presence of sphingosine, indicating that there may be redundant cleavage mechanisms 
transcribed by P. aeruginosa. The possibility that the oxidized intermediate of 
sphingosine produced by SphC is not further metabolize but rather detoxified from 
bacterial cells by excretion is unlikely as no species possessing properties consistent with 
oxidized sphingosine are detected in P. aeruginosa WT cultures (whole culture including 
supernatant and cells) via thin layer chromatography (Figure 3.6). After incubation of 
100µM sphingosine with cultures of wild type, ∆sphC, ∆sphC:sphC, ∆sphD, and 
∆sphD:sphD, lipid fractions were collected and amine-containing species were detected 
through thin  layer chromatography using ninhydrin reagent (Figure 3.6). Amine-
containing lipids whose Rf are similar to the sphingosine control (°), including a potential 
oxidized sphingosine intermediate (*) are present in the ∆sphC culture and control only, 
indicating that SphC is necessary for further metabolism of sphingosine. No amine-
containing lipids are found to migrate at the Rf of sphingosine or a potentially oxidized 
sphingosine-like compound or sphingosine intermediate in the WT, ∆sphD, or 
complemented samples, suggesting that metabolism of sphingosine is accomplished in 
these cultures. The approximate Rf of sphingosine in a chloroform: methanol: solvent 
system is 0.28, but sample overloading may be responsible for slightly altered migration. 
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A potentially oxidized form of sphingosine is present in the sphingosine control and 
∆sphC samples, migrating at a slightly higher Rf (denoted by *) as compared to 
sphingosine (denoted by °). The presence of this species may due to spontaneous 
oxidation of the sphingosine stock. No unique amine-containing lipid was found in 
∆sphD cultures, supporting the hypothesis that deletion of sphD does not halt sphingosine 
metabolism after oxidation by SphC.  
3.5 Conclusions 
Sphingosine and other host-derived sphingolipids are an important part of innate-
immune defenses against bacterial pathogens. The ability to detect and metabolize 
antimicrobial sphingolipids plays an important role in P. aeruginosa’s interactions with 
the host [21], [38], [39], [40]. The mechanism by which P. aeruginosa resists high levels of 
sphingosine and phytosphingosine was previously unknown. The data presented in this 
manuscript describes a predicted metabolic operon, sphBCD, whose members act on 
sphingosine as substrate. Specifically, the cytochrome c SphB and oxidoreductase 
enzyme SphC are essential for sphingosine modification and maximal P. aeruginosa 
growth in the presence of sphingosine and analog phytosphingosine, while the putative 
aldolase SphD displays no essential function. The growth advantage afforded by sphBC 
may be important in biological niches where sphingosine and phytosphingosine are 
abundant, such as in the lung and on the skin. The phytosphingosine-dependent activation 
of the sphingolipid-responsive system is not surprising, as this species of sphingolipid is 
concentrated in hair follicles and comprises ~37% of hair shaft-associated lipids[8]. P. 
aeruginosa is commonly associated with hair follicle infection, termed ‘hot-tub’ 
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folliculitis [36], [37]. The ability to metabolize antimicrobial phytosphingosine at the follicle 
may contribute to P. aeruginosa’s ability to infect.  
Homologs of SphC belonging to a similar operon structure as sphBCD are found 
in a wide range of bacteria including Gram negatives and Gram positives of a pathogenic 
and nonpathogenic nature (Figure 3.7). P. aeruginosa’s SphC clusters with the rest of the 
Gram-negative homologs, most closely related to other Pseudomonas species but not far 
removed from homologs in Acinetobacter haemolyticus and Mycobacterium tuberculosis. 
The conservation of members of the sphBCD operon in several professional and 
opportunistic pathogens demonstrates the importance of the sphingosine-responsive 
operon to the survival of bacteria in the sphingosine-rich environments of the host.  
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3.6 Chapter 3 Figures  
Figure 3.1 SphR-dependent transcriptional induction of the sphBCD operon by 
sphingosine analogs. (A) Structures of sphingosine analogs tested for their ability to 
induce transcription of sphBCD. (B) Sphingosine and phytosphingosine induce 
significant transcription of sphBCD in an SphR-dependent manner (****p-
value<0.0001). (C) SphR binds the promoter region of sphingosine-responsive gene sphA 
in the presence of sphingosine, phytosphingosine, and tail-length variant C15 sphingosine 
(lanes with probe shift denoted with *). Alteration of either hydroxyl group or the 
primary amine of sphingosine impairs detection by SphR and subsequent induction of 
sphBCD. All values represent the averages of three independent experiments; error bars 
represent the standard deviation from the mean. Statistical significance was determined 
via two-way ANOVA with Sidak’s multiple comparison’s test.  
 
Figure 3.2 Modification of sphingosine into a form undetectable by SphR by the 
sphBCD operon (A) The predicted pathway of sphingosine metabolism via the enzymes 
encoded by the sphBCD operon. (B) WT P. aeruginosa modifies sphingosine into a form 
undetectable by SphR, which is shown in the significant decrease in sphingosine signal in 
the supernatant and a decrease that is approaching significance in the cell lysate (pellet) 
samples as compared to the sphingosine control (supernatant: **p-value=0.0199, pellet: 
*p-value=0.1936). This modification is dependent on the presence of sphBCD, as 
evidenced by a significant decrease in sphingosine signal remaining in the supernatant 
and a decreased level of sphingosine that is approaching significance in the cell lysate 
samples of an ∆sphBCD strain rescued by sphBCD complementation (supernatant: **p-
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value=0.0193, pellet: *p-value=0.1646). All values represent the averages of three 
independent experiments; error bars represent the standard deviation from the mean. 
Statistical significance was determined via two-way ANOVA with Sidak’s multiple 
comparison’s test.  
 
Figure 3.3 Growth of P. aeruginosa in the presence of sphingosine is dependent on 
sphBCD (A) ∆sphBCD reaches stationary phase at a significantly lower optical density in 
the presence of sphingosine as compared to the ∆sphBCD:sphBCD complemented strain 
(*p-value=0.0127) while there is no significant difference between the growth of WT P. 
aeruginosa and complemented strains. Statistical significance was determined via two-
way ANOVA and Sidak’s multiple comparison’s test. (B) The rate of ∆sphBCD growth 
is impacted by the presence of sphingosine while WT and complement strains are 
unaffected, as evidenced by the significantly longer doubling time of ∆sphBCD in the 
presence of 200µM sphingosine as compared to the same strain in 0µM sphingosine 
(**p-value=0.0030). Statistical significance was determined via two-way ANOVA and 
Sidak’s multiple comparison’s test. (C) There is a visible decrease in total respiration as 
measured by reduction of tetrazolium violet (TV) in cultures of ∆sphBCD in the presence 
of 200 µM sphingosine. The lower amount of accumulated TV precipitate is consistent 
with the lower level of cell growth at the end point of 16 hours and there is not a 
significant defect in cellular respiration (Abs550/OD600) in any of the cultures. 
Statistical significance was determined via two-way ANOVA and Sidak’s multiple 
comparison’s test. (D) A significantly higher respiration rate, defined here as the amount 
of TV reduction (Abs550 units) per cell (OD600 units) is observed in the presence of 200 
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µM sphingosine in WT cells (**p-value= 0.0014) at the 4 hour time point, the entry into 
log phase, as compared to ∆sphBCD and complement strains. The burst of WT 
respiration is not observed at 4 hours in the 0µM sphingosine condition. Statistical 
significance was determined via two-way ANOVA and Tukey’s multiple comparison’s 
test. All values represent the averages of three independent experiments; error bars 
represent the standard deviation from the mean.  
 
Figure 3.4 Growth of P. aeruginosa in the presence of biologically relevant 
sphingosine analogs is dependent on sphBCD (A) Deletion of the sphBCD operon 
results in significantly lower growth of P. aeruginosa in the presence of 
phytosphingosine (**p-value<0.00983). Phytosphingosine is another potent antimicrobial 
detectable by SphR that P. aeruginosa is intrinsically resistant to. sphBCD’s contribution 
to P. aeruginosa growth in the presence of phytosphingosine as well as sphingosine 
demonstrates the versatility of the SphR-inducible metabolic system in managing 
Pseudomonas’s response to multiple host-derived antimicrobial sphingolipids. (B) A 
similar attenuation in the growth of ∆sphBCD is seen in the presence of sphinganine, a 
naturally occurring analog of sphingosine (*p-value= 0.0398). Wild type growth in the 
presence of sphinganine is not significantly altered and complementation with sphBCD 
recovers the wild type phenotype. All values represent the averages of three independent 
experiments; error bars represent the standard deviation from the mean. Statistical 





Figure 3.5 Involvement of the members of the sphBCD operon in modification of 
and P. aeruginosa growth in the presence of sphingosine (A) Mutant strains ∆sphA 
and ∆sphD were able to modify sphingosine and decrease the sphingosine signal to the 
same level as WT, but ∆sphC retained a significantly higher sphingosine signal in culture 
as compared to WT (**p-value= 0.0094). (B) ∆sphC’s sphingosine modification defect is 
recovered with sphC complementation.  This indicates that sphC is an essential member 
of the sphBCD operon to sphingosine modification. (C) In the presence of 200µM 
sphingosine, the full sphBCD operon complemented strain (PAO1 ∆sphBCD : sphBCD) 
grows to 100% of its growth in 0 µM sphingosine, while the un-complemented, sphC, 
and sphCD complemented strains only reach approximately 20%, 26%, and 29% of their 
maximal growth respectively, which is significantly less than the growth accomplished 
by the sphBCD complemented strain (EV **p-value=0.0078, sphC *p-value=0.0179, 
sphCD *p-value=0.0129). The sphBC-complemented strain grew to ~76% of its maximal 
growth, and did not show a significant decrease in growth in the presence of sphingosine 
as compared to the full sphBCD complement. Statistical significance was determined via 
one-way ANOVA and Dunnett’s post-test. All values represent the averages of three 
independent experiments; error bars represent the standard deviation from the mean. 
 
Figure 3.6 Evidence suggesting the metabolism of sphingosine by the enzymatic 
members of the sphBCD operon Amine-containing lipids whose Rf are consistent with 
the sphingosine control (°) including a potential oxidized sphingosine intermediate (*) are 
present in the ∆sphC culture indicating that SphC is necessary for further metabolism of 
sphingosine. No amine-containing lipids are found to migrate at the Rf of sphingosine or 
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an oxidized intermediate in the WT, ∆sphD, or complemented samples, indicating that 
metabolism of sphingosine is accomplished in these cultures. The approximate Rf of 
sphingosine in a chloroform: methanol: solvent system is 0.28. Sample overloading may 
result in altered migration.  
 
Figure 3.7 Distribution of SphC homologs among bacterial species. Pathogenic 
species are highlighted in red. An oxidoreductase of S. cerevisiae was used as the out-
group for tree rooting.  
 
Figure S3.1 Binding of sphingosine by the functional domains of AraC-type 
transcriptional regulator SphR. The conserved regions of AraC-type transcriptional 
regulators include a DNA-binding C-terminal domain (CTD) and an N-terminal domain 
(NTD) that is thought to be responsible for ligand binding. The ligand (3-H3-sphingosine) 
binding ability of the CTD and NTD of the AraC-type transcriptional regulator SphR was 
tested. The CTD of SphR and an unrelated transcriptional regulator control, CdhR, 
showed significant decreases in ligand binding ability (*p-value=0.0362 and **p-
value=0.0041, respectively), indicating that the NTD of SphR is responsible for 
sphingosine binding. CPM= counts per minute. Significance calculated by ordinary one-
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Figure 3.1 SphR-dependent transcriptional induction of the sphBCD operon by 





















































































































































































































































































































































































































Figure 3.4 Growth of P. aeruginosa in the presence of biologically relevant sphingosine 







































































































































































































































































g) PAO1 WT : EV
PAO1 ∆sphBCD : sphBCvsvG
PAO1 ∆sphBCD : EV
PAO1 ∆sphBCD : sphCD
PAO1 ∆sphBCD : sphBCD





Figure 3.5 Involvement of the members of the sphBCD operon in modification of and P. 





Figure 3.6 Evidence suggesting the metabolism of sphingosine by the enzymatic 











































































CTD SphR and CdhR bind significantly less sphingosine as compared to 
the full length SphR protein 
The NTD SphR sphingosine binding capacity is not significantly different 






























Figure S3.1 Binding of sphingosine by the functional domains of AraC-type 





Table 3.1 Strains and plasmids used in this study  
Designation	 Genotype	or	Description	 Plasmid Primers	Used	in	Construction	
LAH80 E.	coli	S17λpir pMQ30:sphBCDKO 2080,	2081,	2082,	2083
LAH113 E.	coli	S17λpir pMQ30:sphB'-lacZYA-'sphD 2082,	2286,	2287,	2288
LAH82 PAO1	∆sphBCD	WTR none 2080-2083
LAH83 PAO1	∆sphBCD none 2080-2083
LAH288 PA14	∆sphBCD pMQ80	 N/A
LAH289 PA14	∆sphBCD pMQ80::sphBCD 572,	573
LAH118 PA14	∆sphBCD	sphB '-lacZYA-'sphD none 2080-2083	and	2082,	2286,	2287,	2288
LAH122 PA14	∆sphRsphBCD 	sphB '-lacZYA-'sphD none 2080-2083	and	2082,	2286,	2287,	2288
LAH30 E.	coli	T7	 pMALc2x::MBP-SphR-Full 1001-1002
LAH63 E.	coli	T7 pMALc2x::MBP-SphR-NTD 1001-1950
LAH152 E.	coli	T7 pMALc2x::MBP-SphR-CTD 1002-2342
LAH96 PAO1	∆sphBCD	 pMQ80::sphBCD 572,	573
LAH121 PAO1	∆sphBCD	 pMQ80	 N/A
LAH302 PAO1	∆sphBCD	 pMQ80::sphBCvsvG 572,	2514
LAH301 PAO1	∆sphBCD	 pMQ80::sphCD 2511,	573
LAH236 PAO1	∆sphBCD	 pMQ80::sphC 2511,	2512
Strains	and	Plasmids
 













1001 5324 F pMALEcoRI GAATTCATGCACAACAATGCCGCCGA
1002 5324 R pMALBamHI GGATCCGCGTCGCGCGGCCAGCGTG
2342 SphRCTD_F_EcoRI AAGAATTCGAGCAGGAAAGCACCCAGGTG
1950 SphR_Nterm_Rvs_KpnIXhoI accagactcgagggtaccgacCACCTGGGTGCTTTCCTGCTC 
Primer	Number	 Primer	Name	 Primer	Sequence
874 5325 prom F TTGTTGTGCATGGGCGAAATCCTG
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 CHAPTER 4: Characterization of Stenotrophomonas maltophilia K279a’s response 
to mucin  
4.1 Abstract 
 Multidrug resistance among nosocomial pathogens is a growing health concern 
worldwide. Intrinsic resistance to available therapeutics along with advantageous 
biophysical characteristics enables less virulent opportunistic pathogens, such as 
Stenotrophomonas maltophilia, to establish and maintain successful lung infections in 
individuals who are incapacitated or immunocompromised, such as individuals with 
cystic fibrosis (CF). Cystic fibrosis is a genetic lung condition that is characterized by 
aberrant ion transport and mucus overproduction. S. maltophilia, while not overtly 
virulent, possesses the ability to metabolize nutrient-rich host-derived mucins, which are 
the heavily glycosylated glycoproteins that comprise mucus. The ability to access the vast 
nutrients locked in mucins’ recalcitrant structure could provide a significant growth 
advantage to a pathogen within the lung. Here we characterize, through genetic and 
transcriptomic approaches, S. maltophilia’s interaction with mucin, observing mucin-
induced phenotypic and transcriptomic changes, and identifying genes involved in S. 
maltophilia’s response to and metabolism of mucin. This study contributes to our 
knowledge of how Gram-negative bacteria interact with host-derived compounds and 
provides a foundation for future study into how these interactions impact the 
polymicrobial infections often observed in the CF lung.  
4.2 Introduction 
Multi-drug resistant (MDR) bacteria pose a significant threat to patients in 
healthcare settings, causing an estimated 2.8 million infections annually in the United 
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States and an estimated 35,000 deaths [1], [2], [3]. Over the past decade, cases of MDR 
infections have continued to climb and several bacterial species have emerged as 
problematic opportunistic pathogens, including Stenotrophomonas maltophilia. S. 
maltophilia is a Gram-negative nosocomial pathogen whose MDR profile has garnered 
the attention of the World Health Organization, which includes S. maltophilia on its list 
of MDR bacterial pathogens that pose the highest risk to public health [4], [5]. S. 
maltophilia readily infects individuals in the hospital setting, targeting patients in 
intensive care units and those on assisted ventilation [6], [7].  
Among S. maltophilia infections, respiratory tract infections are the most common 
[7], [8], [9]. Severe and chronic S. maltophilia pulmonary infections lead to disease 
exacerbation and negative outcomes in individuals with chronic obstructive pulmonary 
disorder (COPD) and cystic fibrosis (CF), making the recent increase in S. maltophilia 
infections in these populations especially concerning [6], [10], [11]. While respiratory 
infections involving S. maltophilia have been the focus of many studies, S. maltophilia is 
also responsible for causing bacteremia, carrying a relatively high mortality rate of 
approximately 66%, as well as meningitis and soft tissue infections, which are associated 
with long hospital stays, increased antibiotic use, and in some cases death [11], [12], [13], [14], 
[15], [16].  
Primarily isolated from environmental reservoirs including water systems, soils, 
and plant roots, S. maltophilia is not a highly virulent organism, but can attribute its 
success as an opportunistic pathogen to several biophysical characteristics and its 
intrinsic MDR [11], [17]. In addition to low outer membrane permeability, S. maltophilia’s 
genome encodes for multiple antimicrobial resistance genes, including broad-spectrum β-
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lactamases, aminoglycoside aminotransferases, and multidrug efflux pumps, that together 
provide protection against the majority of the currently available antimicrobial 
therapeutics [11], [18], [19], [20]. An additional adaptive barrier to antimicrobial attack is the 
robust biofilm structure S. maltophilia forms on a variety of surfaces. The ability of the 
opportunistic pathogen to adhere to medical device materials and many of the surfaces 
that populate hospital settings, as well as its frequent presence in plumbing systems, 
provides S. maltophilia with a gateway to a susceptible host population [11], [21], [22].   
Within susceptible hosts, S. maltophilia infections are frequently polymicrobial 
[23], [24], [25], [26], [27], [28], [29]. Resistance to many of the available therapeutics has created 
niches for S. maltophilia survival that were previously occupied by more virulent 
opportunistic pathogens such as Pseudomonas aeruginosa and Burkholderia cenocepacia 
[30], [31]. The CF lung environment is a specific infective niche where polymicrobial 
infections commonly occur. Polymicrobial infections can be difficult to treat and can also 
lead to worsened outcomes due to the complex interactions between microbes. For 
example, the involvement of S. maltophilia alone in infection is associated with 
decreased forced expiratory volume (FEV), increased morbidity, and a three-fold increase 
in the likelihood of patient death or lung transplant, but co-infection with P. aeruginosa is 
observed to significantly increase S. maltophilia cell counts within the lung, ultimately 
resulting in increased patient mortality [23], [29].  
The synergy between S. maltophilia and the prevalent CF pathogen P. aeruginosa 
is one example of how opportunistic pathogens of varying virulence work together to 
increase the severity of an infection. Another phenomenon of pathogen cooperation is 
cross-feeding, or cooperative metabolism of a complex nutrient source by several 
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populations of bacteria with different metabolic capabilities. In the instance of cross-
feeding, single or multiple species of bacteria liberate simple compounds from complex 
nutrient sources, feeding other species of bacteria that would not have the ability to 
metabolize the complex substrate on their own [32], [33], [34], [35]. Polymicrobial cross-
feeding during infection has the potential to negatively impact patient outcomes, as 
priming of the infective niche by less virulent bacteria promotes the proliferation of more 
virulent pathogens with the ability to exacerbate infection [32], [33], [34], [36]. Bacterial cross-
feeding within the pulmonary environment may be an important strategy for utilization of 
complex substrates such as mucin.   
Mucins are the heavily glycosylated glycoproteins that make up a substantial 
portion of the mucus secreted at mucosal barriers throughout the body. The human 
genome has 21 known MUC genes that encode mucin-like glycoproteins [37]. These 
glycoproteins include membrane bound and secreted varieties, and O-glycosylation 
among each mucin type varies widely depending on the tissue type and the biological 
function of the mucin at the specific site [37], [38], [39]. Pulmonary mucus is comprised 
predominately of secreted mucins MUC5AC and MUC5B, and the cell-tethered mucins 
MUC1, MUC4, MUC16, and MUC20 [37]. In healthy lungs, pulmonary mucins play a 
critical role in clearing invading pathogens from the airways in combination with ciliary 
action. In the lungs of individuals with COPD or CF, mucus overproduction and/or 
aberrant ion transport transforms pulmonary mucus from a protective barrier into a static 
nutrient reservoir for bacterial proliferation. The majority of bacteria cannot efficiently 
utilize the complex structure of mucin, as the many O-linked glycans, cross-linked by 
disulfide bridges, must be metabolized before the proteinaceous backbone can be 
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accessed, but the ability to metabolize such a rich nutrient source would provide an 
invading pathogen with a significant growth advantage. In this manuscript we 
characterize the ability of the opportunistic pathogen S. maltophilia to utilize mucin and 
identify the processes involved in S. maltophilia’s response to this host-derived 
compound.   
 
4.3 Materials and Methods  
4.3.1 Strains and Growth Conditions  
Stenotrophomonas maltophilia strains K279a (ATCC BAA-2423), and two 
clinical CF isolates AU30115 (GW273) and AU32848 (GW275) were grown at 37°C 
shaking (170 rpm) in lysogeny broth (LB), Lennox formulation, M63 media[40] 
supplemented with 40 mM sodium lactate, 10 mM D-glucose, and 500 µM L-
methionine[41], or LB broth diluted 20x in M63 media (growth levels in supplemented 
M63 media and 1/20 LB/M63 media were comparable). Mucin growth screens were 
conducted in M63 salts media supplemented with 1% (w/v) mucin +/- 250 µM L-
methionine. Strains used in this study can be found in Table 4.1. 
 
4.3.2 Pig Gastric Mucin (PGM) Media Preparation  
M63 1% mucin media used PGM (Millipore-Sigma) as the mucin component. 
M63 1% mucin was prepared as follows; 40 g PGM was dissolved into 600 ml dH2O 
with mixing overnight at 4°C.  The PGM solution was transferred to dialysis tubing and 
dialyzed against dH2O for 8 hours with water changes every 2 hours. Dialyzed mucin was 
brought up to 4 L in M63 media +/- nitrogen (ammonium sulfate) amended with 10 g 
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agar per 1 L media for solid media. A clarification step, with centrifugation at 10,000 rpm 
for 20 minutes, was added when preparing media for the transposon mutant screens. 
Media for subsequent growth assays was not clarified, as there were no significant 
differences in levels of bacterial growth in clarified versus un-clarified mucin media.  
 
4.3.3 Mucin growth assays  
S. maltophilia strains K279a, AU30115, and AU32848, were grown in M63 
media supplemented with 40 mM sodium lactate, 10 mM D-glucose, and 500 µM L-
methionine overnight at 37°C. Cells were collected by centrifugation and added at a final 
OD600 of 0.05 to M63 media amended with 1% mucin or amended with 40 mM sodium 
lactate, 5 mM D-glucose, and 500 µM L-methionine and grown for 18 hours at 37°C 
shaking. S. maltophilia growth was evaluated via CFU plating with CFU output counts 
normalized to input counts. 
 
4.3.4 Mucin-induced biofilm assays 
 S. maltophilia strains K279a, AU30115, and AU32848, were grown in 1/20 
LB/M63 media overnight at 37°C shaking at 170 rpm. Cells were then adjusted to a final 
OD600 of 0.05 (approximately 7E5 CFU/ml) in either 1/20 LB/M63 or 1% mucin M63 
media, added in 150 µl volumes in technical duplicate to wells in a flexible 96 well plate, 
and placed in a humidified chamber at 37°C for an 18 hour stationary incubation. Biofilm 
formation was evaluated via the crystal violet staining protocol described by O’Toole et 
al. [23]. Levels of biofilm formation were reported as the fold biofilm formation (Abs550) 
in the 1% mucin M63 condition over the 1/20 LB/M63 minimal media condition. Fold 
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calculations were conducted within each strain, comparing each strains biofilm formation 
in mucin versus its minimal media biofilm formation, or across strains, comparing the 
clinical isolate biofilm formation in each condition to Sm K279a’s biofilm levels in the 
minimal media condition. All experiments were conducted in biological triplicate and 
technical duplicate.  
 
4.3.5 Mucin as carbon source (liquid media screen) 
Cultures were transferred from 96-well freezer stocks to M63 agar plates 
supplemented with 40 mM sodium lactate, 10 mM glucose, and 500 µM L-methonine, 
using a 48-pin device, or ‘frog’. Spot plates were grown overnight at 37°C. The next 
morning, spotted colonies were frogged from solid media plates into 120 µl of liquid 
culture in 96-well plates, containing 120 µl of either control minimal media (M63, 15 
mM lactate, 5 mM glucose, 500 µM L-methionine) or 1% mucin media (M63, 1% (w/v) 
mucin). 96-well plates were grown at 37°C stationary overnight (~18 hours). Liquid 
growth plates were then observed for growth defects by eye and potential mucin-growth 
defective transposon mutants (TnMs) were rescreened by spot plating on M63 minimal 
agar plates (solid media) and inoculating 500 µl of M63 minimal, LB, and M63 1% 
mucin liquid media, to rule out general liquid growth defects and to confirm mucin-
dependent growth defect phenotypes. CFU counting was made difficult by the increased 
clumping observed in the presence of mucin so growth defects were scored visually. All 




4.3.6 Mucin as sole carbon, nitrogen, and methionine source (solid media screen)  
To bypass any growth defects dependent on liquid growth (motility/swimming 
defects) and to put increased pressure on S. maltophilia to utilize the proteinaceous 
backbone of mucin, a second more stringent screen was conducted. This screen used M63 
minimal and M63 (no nitrogen) 1% mucin agar plates for screening of mucin as a sole 
source of carbon and nitrogen. Freezer stocks of TnMs were frogged into media 
containing 180 µl 1/20 LB/M63 media (tested and showed similar growth as M63 
minimal media used previously and supported growth out of freezer) and grown 
overnight at 37°C stationary. The next day 5 µl of liquid cultures were spot plated onto 
M63 (no nitrogen) 1% mucin agar plates and incubated overnight, stationary, at 37°C. 
TnMs with visible growth defects compared to wild type spots were considered potential 
hits and validated through further screening. To validate potential hits, the TnMs were 
grown overnight in 1/20 LB/M63 on the roller wheel at 37°C. Cultures were adjusted to 
OD600 of 1.0 in 1/20 LB/M63 and 5 µl of OD600 1.0 culture was added to 495 µl of 1/20 
LB/M63 and M63 (no nitrogen) 1% mucin. Cultures were incubated stationary at 37°C 
for 24 hrs and CFU plated on PIA plates at times 0, 6, and 24 hours. All validation 
experiments were conducted in technical duplicate and biological triplicate. Cultures 
were pipetted vigorously before plating to break up clumps.  
 
4.3.7 CTAB Genomic DNA purification  
To identify transposon insertions in S. maltophilia K279a’s genome, CTAB 
genomic DNA purifications were performed on all TnMs with aberrant mucin growth. 
Cells were grown overnight in 1.5 ml of LB, collected via centrifugation and resuspended 
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in 567 µl of Tris EDTA buffer (pH=8). 15 µl of 20% SDS was added to samples and 
samples were vortexed to mix. After addition of 3 µl of Proteinase K (20 U/µl) and 
mixing via pipette samples were incubated for 20 minutes at room temperature before 
addition of 100 µl of 5 M NaCl. Afger mixing 80 µl of CTAB was added and samples 
were incubated for 15 minutes at 42°C. After incubation a volume of chloroform/isoamyl 
alcohol (24:1) equal to the sample volume (~765 µl) was added and samples were 
centrifuged for 5 minutes at 20,000 x g to extract the aqueous layer. A second extraction 
was performed via addition of an equal volume of phenol: chloroform: isoamyl alcohol 
(25:24:1) with centrifugation at 20,000 x g  for 5 minutes. Purified DNA present in the 
aqueous layer was then precipitated using 0.6 volumes of isopropanol. The vortexed 
mixture was then incubated at -80°C for 5 minutes. After precipitation the DNA was 
collected via centrifugation and the DNA pellet was washed 2x with 70% EtOH. The 
pellet was then air dried overnight and resuspended in 100 µl of molecular grade water. 
gDNA samples were then RNase treated by adding 100 µl of 2x RNase buffer (20 mM 
Tris HCl (pH=8), 600 mM NaCl, 1 mM EDTA) and 4 µl of RNase A/T1 and incubating 
for 1 hour at 37°C. RNase treated samples were isopropanol precipitated again, washed, 
and resolubilized before quantification via nanodrop.  
  
4.3.8 Identification of Transposon Insertion Sites through Arbitrary-Primed PCR 
(AP-PCR) 
 Amplification of transposon insertion sites from TnM gDNA was conducted using 
a transposon specific primer (specific for the transposon pBT20) and arbitrary reverse 
primers. Several rounds of Arbitrary PCR were run to clarify specific bands. Primers 895 
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and 898 were used for the first round of PCR amplification and primers 900 and 901 were 
used for the second round. Amplified fragments were then excised from the gel and 
purified using Fisher’s GeneJET Gel Extraction and DNA Clean Up Kit (ThermoFisher 
Scientific, Waltham, MA). Purified DNA was sent to Vermont Genetics Network (VGN) 
core at the University of Vermont for sequencing.  
  The sequences surrounding the transposon insertion sites were run through 
NCBI’s BLAST algorithm against the S. maltophilia K279a genome to identify the 
location of gene disruptions. Primers used to amplify regions surrounding transposon 
insertion sites can be found in Table 4.2.  
  
4.3.9 Growth conditions and RNA purification for microarray analysis  
S. maltophilia strain K279a was grown O/N from freezer stocks in M63 
supplemented with 15 mM sodium lactate, 5 mM glucose, and 500 µM L-methionine, 
conditions that are consistent with previous S. maltophilia gene expression studies 
conducted by the lab [41]. Overnight cultures (4 ml) were grown shaking (170 rpm) for 20 
hrs at 37°C, then collected by centrifugation at 13,000 rpm. Collected cells were washed 
and re-suspended in 1 ml M63 media and adjusted to an OD600 of 0.3. 500 µl of OD600 
0.3 cells were collected by centrifugation and re-suspended in pre-warmed 500 µl of 
control media (M63, 4mM sodium lactate, 250µM L-methionine) or experimental 
induction media (M63, 1% mucin). Samples were loaded into a 48-well plate in technical 
duplicate and incubated for 4 h shaking at 170rpm at 37°C. After the induction period of 
4 h cells were again collected by centrifugation and immediately re-suspended in 800 µl 
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of hot RNAzol. These samples were then stored at -80°C for RNA extraction and 
purification. Samples were run in biological triplicate.   
RNA was extracted from samples frozen at -80°C in RNAzol buffer 
(SigmaAldrich) using the RNeasy Mini Extraction Kit (Qiagen) as per the manufacturers 
instructions and further purified via a DNaseI treatment and a subsequent RNeasy 
purification. 
 
4.3.10 Microarray methodology 
The UVM Advanced Genome Technology Core completed the microarray 
analysis, which consisted of hybridization of experimental S. maltophilia K279a DNA 
probes, generated by the NuGen Pico system, to a custom Affymetrix chip containing 
probes specific to the genomes of Klebsiella pneumoniae MGH 78578, 
Stenotrophomonas maltophilia K279a, Burkholderia thailandensis E264, and 
Pseudomonas aeruginosa PA14. S. maltophilia K279a RNA used for probe generation 
and hybridization was a equal-ratio pooled mixture of RNA samples collected from three 
biological experiments performed on different days. Probe intensity was determined 
using the Expression Console and Transcriptome Analysis Console software package 
version 2.0 (Affymetrix). Transcript changes were identified as those displaying a ≥2.5-
fold change in signal between the experimental and control conditions. The statistical 
significance of changes in transcripts between conditions was unable to be evaluated 
because the limited availability of chips only allowed for one pooled run using S. 
maltophilia K279a mucin-induced RNA. To support the validity of certain changed 
mucin transcripts, transcript lists were compared between the S. maltophilia K279a 
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mucin microarray and a previously conducted S. maltophilia K279a synthetic sputum 
(SCFM2) microarray, which was run in biological triplicate [41]. SCFM2 contains high 
levels of mucin and this was reflected in the high amount of shared changed transcripts 
between the mucin and SCFM2 microarrays.  
 
4.3.11 Transcript functional annotation 
Functional annotation of transcripts was completed manually. Sequences were run 
through NCBIs BLAST algorithm and functional annotation was assigned after 
consideration of BLAST results, conserved domains in the putative proteins, homologous 
genes/proteins with known functions in other bacteria, and genomic synteny. Transcripts 
with no predicted function or similarity to genes of known function were assigned to the 
Hypothetical Protein category.  
 
4.3.12 Evaluation of mucin-associated gene conservation  
Conservation of mucin-associated genes across a cohort of 44 sequenced S. 
maltophilia strains was evaluated by running the nucleotide sequences of S. maltophilia 
K279a’s mucin-associated genes through the BLAST algorithm (BLASTn megablast) 
against the non-redundant nucleotide collection of the Stenotrophomonas maltophilia 
group (taxid:40324). A strain was considered to possess an ortholog of a specific gene if 
the coverage and identity over the genomic region was greater than 85%. The 
conservation of genes across the 44 S. maltophilia strains was recorded as the percentage 
of strains possessing convincing homologs. To assess the conservation of mucin-
associated genes between CF isolates AU30115 and AU32848 and environmental/plant 
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associated isolates BurA1 and RR-10, BLASTn megablast was run using K279a gene 
sequences against the genomes of the respective isolate. The whole-genome sequence of 
CF isolates AU30115 and AU32848 were accessed via BioProjectID: 483996. The 
whole-genome sequence of environmental isolate BurA1 was accessed via BioProjectID: 
307423, and the genome of rice root isolate RR-10 via the non-redundant nucleotide 
collection of Stenotrophomonas maltophilia RR-10 taxid: 1095923. The percent of 
coverage and identity of each mucin-associated gene within the genome of each strain 
was recorded and genes with lower than 85% coverage or identity were highlighted in 
darker shades of the respective column color to indicate which K279a genes were not 
well conserved in a specific strain.  
4.4 Results  
4.4.1 S. maltophilia K279a and S. maltophilia CF isolates quickly adapt to utilization 
of mucin as a carbon and nitrogen source while strain PAO1 of co-infecting CF 
pathogen P. aeruginosa is unable to utilize mucin 
The highly glycosylated proteinaceous structure of mucin is a potentially rich 
source of carbon and nitrogen, but accessing these nutrients can be difficult without the 
proper metabolic machinery. To assess whether S. maltophilia lab strain and CF clinical 
isolates were able to efficiently metabolize mucin, S. maltophilia strain K279a, a 
bacteremia isolate and model lab strain of S. maltophilia K279a and two CF clinical 
isolates of S. maltophilia were grown with mucin supplied as the sole source of carbon, 
nitrogen, and methionine. The opportunistic pathogen Pseudomonas aeruginosa, strain 
PAO1, was also included in the mucin growth assays as a representative of the more 
virulent pathogens that commonly participate in co-infections with S. maltophilia within 
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the lung. We observed that S. maltophilia K279a is able to utilize mucin as a source of 
carbon and nitrogen to a significantly higher degree, approximately 6-fold higher, 
compared to co-infecting CF-associated microbe Pseudomonas aeruginosa (***p-
value=0.0009) (Figure 4.1A). Both clinical CF isolates of S. maltophilia, AU30115 and 
AU32848 are also able to utilize mucin to a higher degree as compared to P. aeruginosa 
strain PAO1, approximately 6-fold and 5-fold respectively (AU30115: ***p-
value=0.0007, AU32848: **p-value=0.0039) (Figure 4.1A). Metabolism of mucin by S. 
maltophilia strains may provide metabolic assistance to the poor mucin-metabolizer P. 
aeruginosa within the infection niche, allowing for the increased growth of the more 
virulent opportunistic pathogen. All experiments were conducted in technical duplicate 
and biological triplicate and statistical significance was determined via One-Way 
ANOVA with Tukey’s multiple comparisons test. Error bars represent the standard 
deviation from the mean.  
To gain a more in-depth picture into the kinetics of the switch to mucin 
metabolism in S. maltophilia, seeing as the microbe is often introduced into the host lung 
from environmental reservoirs where mucin-metabolic machinery may not be as 
important, we observed the effects of pre-growth conditions on S. maltophilia isolates 
ability to efficiently metabolize mucin. S. maltophilia isolates are able to switch to 
efficient utilization of mucin as a sole source of carbon and nitrogen after ~18 h of 
growth on mucin. After overnight growth of S. maltophilia isolates on 1% mucin M63 
media, all isolates subsequently grown on 1% mucin media surpassed their growth on 
M63 minimal media after 18 hours of incubation (Figure 4.1B). Clinical CF isolate 
AU30115 grew to a significantly higher density on mucin, as compared to its growth on 
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M63 minimal media, when pre-grown on mucin media (**p-value=0.0053). When 
isolates were pre-grown on M63 media without mucin, subsequent growth on 1% mucin 
didn’t surpass their growth on minimal media (Figure 4.1B). This suggests that S. 
maltophilia isolates previously occupying a mucin-rich niche can more rapidly dominant 
a subsequent niche where mucin is a significant nutrient source. All experiments were 
conducted in technical duplicate and biological triplicate. Statistical significance was 
determined via two-way ANOVA with Sidak’s multiple comparisons test. Error bars 
represent the standard deviation from the mean. 
4.4.2 Biofilm formation in S. maltophilia K279a is induced in the presence of mucin 
while CF isolates display lower biofilm formation regardless of presence of mucin 
Biofilm formation is a successful strategy to promote bacterial-survival within a 
host environment and the formation of a protective biofilm structure is an integral part of 
many opportunistic pathogens’ response to the host environment. After incubation with 
1% mucin, S. maltophilia strain K279a formed a more robust surface-attached biofilm as 
compared to the same strain in media lacking mucin (*p-value=0.013) (Figure 4.2A-
4.2B). Surface-attached biofilm formation in CF isolates AU30115 and AU32848 was 
unaffected by the presence of mucin (Figure 4.2A). Significantly lower surface-attached 
biofilm formation was observed in both clinical CF isolates in both the 1% mucin M63 
media condition and the M63 minimal media condition as compared to K279a in the 
corresponding conditions (Figure 4.2C). The lack of surface-attached biofilm formation 
in the S. maltophilia clinical isolates must be considered with the caveat that we did not 
evaluate other potential biofilm-formation behaviors. It is known that S. maltophilia 
K279a and clinical isolates dispay an increased clumping phenotype ] in the presence of 
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synthetic sputum media, which contains mucin. The clinical isolates may display 
increased clumping in the presence of mucin, or increased mucin-attached biofilm 
formation, which our assay was unable to detect. We also only evaluated surface-attached 
biofilm formation at one time point and in one oxygen condition, so we cannot rule out 
different time or oxygen concentration-dependent factors on biofilm formation kinetics. 
However, the increase in surface-attached biofilm formation in S. maltophilia K279a 
suggests that biofilm formation is triggered in response to mucin in an S. maltophilia 
strain that is not well adapted to the lung environment. This also suggests that surface-
attached biofilm formation may be an important initial response to the lung in order to 
establish infection, but becomes dispensable as S. maltophilia adapts to the lung 
environment. All experiments were conducted in technical duplicate and biological 
triplicate. Statistical significance was determined by two-way ANOVA with Tukey’s test 
for multiple comparisons. Error bars represent the standard deviation from the mean. 
4.4.3 Genes involved in cell growth and morphology, sugar modification, ion 
transport and gene regulation are nessecary for S. maltophilia growth on mucin  
 To identify genes potentially involved in S. maltophilia’s metabolism of mucin, a 
mucin-growth screen was conducted using a transposon mutant library of S. maltophilia 
K279a. Transposon mutants with insertions in three genes involved in the production of 
structural cell membrane component, lipopolysaccharide (LPS), showed aberrant growth, 
including lower cell density and/or increased clumping, in 1% mucin liquid media, which 
provides mucin as the sole source of carbon. These LPS-associated transposon-disrupted 
genes included smlt0702, encoding a putative glycosyltransferase family 2 protein, 
rmlD/rfbD, encoding a putative dTDP-4-dehydrorhamnose reductase, and rmlB/rfbB, 
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encoding a putative dTDP-glucose 4,6-dehydratase (Figure 4.3A). All three of these 
genes encode putative proteins that are involved in sugar modification, specifically 
modifications that are involved in the pathway essential for LPS production (Figure 
4.3B). Further study is needed to determine whether the sugar-modification functions of 
these putative proteins can also be applicable towards the utilization of abnormal sugar 
sources such as the O-glycans associated with mucin.   
It is unclear whether these sugar-associated genes are specifically nessecary for 
growth on mucin sugars or whether they are important for general growth due to their 
function in LPS formation. In order to uncover additional mucin-specific genes that may 
have gone undetected in the mucin carbon-source screen, we conducted a similar growth 
screen with more stringent growth conditions. This more stringent screen involved solid 
media that provided mucin as the sole source of carbon, nitrogen, and methionine. This 
screen revealed four more genes necessary for maximal S. maltophilia growth on mucin. 
Disruption of smlt4208/bfmK, which encodes a HAMP domain-containing histidine 
kinase response regulator, caused significantly attenuated growth of S. maltophilia K279a 
on mucin (***p-value=0.0002). Disruption of smlt4171, encoding a putative CDP-
glycerol glycerophosphotransferase family protein, resulted in a ~63% reduction in 
growth on mucin (**p-value=0.0019). Disruption of putative rod-shape determining 
protein Smlt4058 resulted in a significant lack of growth on mucin (***p-value=0.0003), 
and disruption of smlt0517, which encodes a putative metal efflux transporter resulted in 
a 92.5% decrease in growth on mucin (****p-value<0.0001) (Figure 4.3C). The 
predicted functions of the genes necessary for growth on mucin show that regulatory, 
structural, transport, and sugar modification processes are all involved in S. maltophilia 
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K279a’s utilization of mucin (Figure 4.3D). All growth assays were conducted in 
technical duplicate and biological triplicate. One-way ANOVA was used to determine 
statistical significance with Dunnett’s test for multiple comparisons. Error bars represent 
the standard deviation from the mean. 
4.4.4 The top three characterized transcript classes involved in S. maltophilia’s 
response to mucin include primary metabolism genes, phage related/DNA transfer 
genes, and protease/peptidase genes  
 Our transposon mutant screens identified multiple genes necessary for S. 
maltophilia growth on mucin, but did not identify any of the protease or peptidase genes 
predicted to be needed for degradation of the peptide backbone of mucin. We can assume 
that S. maltophilia K279 is degrading the peptide backbone of mucin because K279a is 
auxotrophic for methionine, an amino acid that was only present in the media as part of 
mucin’s peptide backbone. Because we did not identify any putative protease or 
peptidase enzymes in our growth screens, it is likely that peptidase and/or protease 
actions are functionally redundant and render a transposon mutant screen, which 
presumably only disrupts one gene at a time, an insufficient method for identification.  
To gain a broader picture of the genes involved in mucin-metabolism in S. 
maltophilia, and to potentially identify the proteases and/or peptidases involved in mucin 
degradation, we exposed S. maltophilia to 1% mucin and a control media containing no 
mucin and identified differentially expressed genes via microarray. There are 45 genes 
that are expressed greater than 2.5-fold higher in the presence of mucin over the control 
condition in S. maltophilia K279a (Table 4.3). Of these genes, the majority encode for 
hypothetical proteins with unknown function (Figure 4.4A). Among the transcripts with 
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predicted functions, the first most abundant is comprised of genes that are phage related 
or involved in DNA transfer. The second most abundant functional transcript class 
includes genes involved in primary metabolism, and the third most abundant is comprised 
of predicted protease and peptidase genes (Figure 4.4A).  
 Although it is the third most abundant functional transcript class, 4 of the 5 genes 
belonging to the protease/peptidase transcript class are among the most highly induced 
genes in response to mucin. Putative auto-transporter smlt1350 is the most highly induced 
predicted protease, followed by smlt1001, then smlt4145, then smlt4395, and lastly 
smlt3895 (Figure 4.4B). Only two genes, smlt4397 and smlt4396, surpass the putative 
protease/peptidases in expression levels in the presence of mucin. The two most highly 
induced transcripts in response to mucin include smlt4397, which transcribes a putative 
thioredoxin-fold containing SCO1/SenC family protein most likely involved in 
cytochrome c oxidase assembly and smlt4396, which transcribes an exported protein of 
unknown function and is located immediately downstream of protease smlt4395.  
4.4.5 The majority of S. maltophilia K279a’s mucin-associated genes are conserved 
across metabolizing CF isolates AU30115 and AU32848  
 All three of our tested S. maltophila isolates are able to sufficiently metabolize 
mucin. After gaining a more detailed picture of the genes necessary for and involved in 
mucin metabolism in S. maltophilia K279a, we investigated whether these genes were 
conserved among sequenced S. maltophilia isolates. The degree of conservation of all 
mucin-associated genes between different strains of S. maltophilia was assessed using 
NCBI’s BLAST algorithm against a collection of 44 sequenced S. maltophilia strains. A 
gene was considered to be conserved in a given strain if the strain possessed a homolog 
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with coverage and identity of greater than 85%. Of all 12 mucin-associated genes 
analyzed, the majority were conserved in 98-100% of the S. maltophilia strains analyzed. 
Four genes were only present in 45-86% of S. maltophilia strains, including putative 
auto-transporter and potential protease encoding gene smlt1001, putative extracellular 
serine protease encoding gene smlt4145, histidine kinase response regulator encoding 
gene smlt4028, and putative rod-shape determining and scaffolding protein encoding 
gene smlt4058 (Figure 4.5A).  
 We were specifically interested in the degree of conservation of the mucin-
associated genes in the CF clinical isolates of S. maltophilia. The clinical CF isolates 
AU30115 and AU32848 showed strong conservation of mucin-associated genes with two 
exceptions. Strain AU30115 lacks a homolog of the Co(II)/Zn(II) efflux transporter 
encoded by smlt0517 (dmeF). Strain AU32848 possesses a putative extracellular serine 
protease with homology to the putative extracellular serine protease encoded by 
smlt4145, but it has low coverage and identity, lower than the ≥85% criteria (Figure 
4.5B). As both CF isolates are equally as effective at utilizing mucin, loss of these genes 
may not be sufficient to disrupt growth on mucin, or there may be redundant mechanisms 
in the accessory genomes of these strains. We were also interested in whether more 
human-associated strains of S. maltophilia held higher conservation of mucin-associated 
genes as compared to environmental isolates. To evaluate this, we compared the 
conservation of mucin-associated genes between our clinical isolates and several 
environmental and plant-associated isolates. Our comparisons showed that the two 
environmental isolates, soil-associated strain BurA1 and rice root-associated strain RR-
	
	 151	
10, displayed lower conservation of mucin-associated genes, with only 66.67% of genes 
conserved in BurA1 and even less, 33.33% conserved in RR-10 (Figure 4.5B). 
4.5 Discussion 
4.5.1 Mucin utilization in S. maltophilia K279a as a carbon and nitrogen source is a 
complex and redundant process   
The heavily glycosylated glycoprotein structure of mucin is extremely nutrient 
rich, providing a source of carbon, nitrogen, and methionine to the methionine 
auxotrophic Gram-negative opportunistic pathogen S. maltophilia K279a. The ability to 
utilize mucin is not shared among all Gram-negatives and has the potential to provide S. 
maltophilia with a growth advantage in infective niches where mucin is present in high 
quantities, like within the CF lung. Aberrant ion transport and overproduction of mucus 
are part of the pathology of CF, leading to a high concentration of mucin within the 
airways. Although mucin is an abundant potential source of nutrients in CF sputum, not 
all bacteria are able to metabolize it due to its complex structure, consisting of O-linked 
glycans and disulfide cross-linked sugars, which shield the proteinaceous core from 
degradation.  
 Throughout this study we identified multiple genes that are necessary and/or 
involved in S. maltophilia’s response to and utilization of mucin. Our results suggest that 
metabolism of mucin by S. maltophilia involves redundant processes. For example, none 
of the genes that were highly induced in the presence of mucin, including proteases and 
peptidases, were hit in our phenotypic screens. This may indicate that these 
proteases/peptidases are redundant in function and can compensate for the loss of one or 
more of the other proteases. The two most highly induced putative proteases, smlt1350 
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and smlt1001, have high sequence similarity and may be compensatory for each other. If 
S. maltophilia K279a possess multiple proteases that can achieve the same mucin 
degradative function, disruption of a singular protease/peptidase in the phenotypic screen 
would not have significantly impacted the ability of S. maltophilia to grow on mucin. 
Another indication of the complexity of S. maltophilia’s response to mucin is the 
necessity of the histidine kinase response regulator protein smlt4208/bfmK in utilization 
of mucin. smlt4208 has been partially characterized by Zheng and colleagues, who 
confirmed its role in biofilm formation in S. maltophilia, renaming it bfmK [42]. bfmK is 
part of a two-component signaling system with bfmA (smlt4209), a signaling system that 
is predicted to be involved in multiple different cellular processes that have yet to be 
characterized.   
4.5.2 S. maltophilia K279a’s response to mucin includes expression of processes and 
putative proteins predicted to be involved in virulence  
The majority of genes involved in the degradation of mucin are strongly 
conserved between infection-causing clinical isolates of S. maltophilia, such as clinical 
CF isolates AU30115 and AU32848 which possess orthologs for 11 of the 12 identified 
S. maltophilia K279a mucin-associated genes. In comparison, two examples of S. 
maltophilia strains with low conservation of mucin-associated genes are the soil-isolate 
BurA1 and rice-root isolate RR-10. While there are other environmental isolates such as 
R551-3 and JV3 that share the majority of mucin-associated genes, BurA1 and RR-10 are 
good examples of how few mucin-associated genes are necessary for S. maltophilia 
survival in the environmental niche. BurA possesses homologs for 8 of the 12 mucin-
associated genes and the rice-root isolate RR-10 possesses only four. The decrease in the 
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strength of conservation of mucin-associated genes as S. maltophilia strains are isolated 
further from the human niche suggests that genes involved in the degradation of mucin 
are important during interactions with the host and become less necessary as S. 
maltophilia adapts to different environments such as the soil or plant roots. Many of the 
genes induced in the presence of mucin are also induced in the presence of synthetic CF 
sputum media (SCFM2), indicating that S. maltophilia’s response to mucin is a large 
component of S. maltophilia’s overall response to the CF lung environment [41]. SCFM2 
has also been observed to induce other virulence-associated phenotypes such as increased 
resistance to oxidative stress in S. maltophilia K279a, AU30115, and AU32848, and 
increased biofilm formation in K279a. Because of the parallels in gene expression and 
induced biofilm phenotype between the mucin and SCFM2 response, it is possible that S. 
maltophilia’s response to mucin may induce similar virulence-associated pathways such 
as oxidative stress resistance. 
There are several mucin-associated genes with the potential to be involved in S. 
maltophilia K279a virulence in response to host-derived mucin. The putative 
autotransporters smlt1001 and smlt1350 are highly transcribed in response to mucin and 
are predicted to be displayed on the outer membrane due to the autotransporter β-barrel 
conserved domain in their C-terminal. Smlt1001 possesses a predicted ClpP/crotonase 
domain in its N-terminal, supporting the hypothesis that it is an extracellular secreted 
protease involved in degradation of mucin peptides (Figure 4.6A) [43]. Putative 
autotransporter Smlt1350 does not possess any conserved domains in the N-terminal 
region but 3D modeling of the N-terminal alone produces a structure most similar to a 
ClpP protease subunit [44]. Despite the similar predicted fold to protease ClpP, Smlt1350 
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only retains two of the three predicted catalytic triad members present in ClpP’s 
sequence, raising the question of whether Smlt1350 is an active extracellular protease, or 
whether it is a non-catalytic paralog of Smlt1001 with a different evolved function 
(Figure 4.6B). Many autotransporter proteins act in bacterial virulence via catalytic 
protease, esterase, or lipase activity, or through non-enzymatic mechanisms including 
biofilm formation and adhesion to host cells (the many roles of autotransporter passenger 
domains are outlined by Henderson and Nataro[45]). The predicted extracellular secretion 
of Smlt1001 and Smlt1350, putative protease-like domains, and predicted protease-like 
secondary structure, suggest that these autotransporters are involved in S. maltophilia 
virulence, either through degradation of mucin components or adhesion, in the case of the 
potentially non-catalytic Smlt1350.  
Another extracellular protease with the potential to bind and degrade 
glycoproteins like mucin is the putative autotransporter serine protease Smlt4145. 
Sequence analysis of the putative protein Smlt4145 reveals a conserved S8/S53 serine 
protease domain characteristic of endo and exopeptidases, an autotransporter β-barrel 
domain, and a fibronectin-binding domain (Figure 4.6C)[46]. Fibronectin is a 
glycoprotein component present in the extracellular matrix of eukaryotic cells that 
pathogenic bacteria like Salmonella enterica bind during pathogenesis, using 
extracellular fibronectin-binding proteins like S. enterica’s ShdA [47]. The presence of a 
glycoprotein-binding domain in the extracellular protease Smlt4145 suggests that it may 
be instrumental in the binding and degradation of mucin during host infection.  
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4.5.3 Liberation of nutrients from a complex and abundant substrate like mucin by 
S. maltophilia may impact the dynamics of polymicrobial lung infection 
Overproduction of mucus causes multiple issues with host immune defense 
against bacterial pathogens. Physically, mucus overproduction and aberrant ion transport 
in cases of CF and COPD result in thick mucus that prevents productive mucociliary 
clearance. Mucus overproduction can also lead to issues with the host complement 
system by affecting the antimicrobial function of properin, or Factor P [48], [49], [50]. Apart 
from these adverse affects, mucus has the potential to provide abundant nutrients to 
infecting bacterial pathogens. Although mucin is a potential source of nutrients, it is not 
utilized effectively by many of the opportunistic pathogens you usually find in the CF 
lung, including many strains of Pseudomonas aeruginosa, which in the presence of 
healthy mucus down-regulates virulence associated genes including those involved in 
siderophore production, quorum sensing, and type three secretion  [51].  
Non-mucin metabolizing pathogens still survive in the lung environment, but 
experience significant boosts in growth when cross-fed the byproducts of mucus 
metabolism by mucin-degraders [32]. Flynn and colleagues determined that addition of 
mucin-fermenting oral anaerobes to a P. aeruginosa PA14 culture containing mucin 
enabled PA14 to grow to a significantly higher density in the presence of mucin as 
compared to when PA14 was grown alone on mucin [32]. Flynn et al. also found that the 
major byproducts of mucin fermentation, propionate and acetate, were being metabolized 
by P. aeruginosa, enabling its increased growth [32]. Other CF pathogens including 
Achromobacter xylosoxidans, Burkholderia cenocepecia, Stenotrophomonas maltophilia 
and Staphylococcus aureus were tested for their ability to grow on the byproducts of 
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mucin fermentation, and all pathogens experienced a significant increase in growth in the 
presence of mucin fermenters [32]. The increase in growth of other CF pathogens when 
cross-fed by mucin-degrading bacteria is an example of how niche priming by less 
pathogenic bacteria (oral microbes) can promote the growth of more pathogenic bacterial 
species such as S. aureus. An increase in pathogenic species fed by mucus-fermenters 
negatively impacts the host, starting a cycle of increased inflammation and epithelial 
damage, which increases the nutrient pool, fueling sustained pathogen growth.  
While S. maltophilia is a non-fermentative microbe, it is still able to degrade 
mucin and may provide metabolic products other than, or in addition to, propionate and 
acetate to co-infecting pathogens [10]. We can hypothesize that the many secreted 
proteases up-regulated in the presence of mucin help to liberate amino acids for bacterial 
utilization and that S. maltophilia imports the sugars derived from cleavage of O-linked 
glycans into the cell for reduction via aerobic respiration as the SCO1/SenC family 
cytochrome c oxidase assembly protein Smlt4397 is the highest up-regulated putative 




4.6 Chapter 4 Figures  
Figure 4.1 S. maltophilia more efficiently utilizes mucin as a sole source of nutrients 
when given time to adjust to mucin as the primary nutrient substrate. (A) S. 
maltophilia K279a and S. maltophilia CF isolates AU30115 and AU32848 grow 
approximately 5.5 fold higher than the maximum growth of CF pathogen P. aeruginosa 
on M63 supplemented with 1% mucin as the sole carbon and nitrogen source. All S. 
maltophilia isolates grow significantly higher on 1% mucin compared to P. aeruginosa, 
suggesting the presence of mucin-specific metabolic machinery in S. maltophilia isolates 
(K279a ***p-value=0.0009, AU30115 ***p-value=0.0007, AU32848 **p-
value=0.0039).  (B) The ability of S. maltophilia isolates to efficiently utilize 1% mucin 
as a sole carbon and nitrogen source is influenced by pre-growth conditions. Overnight 
growth of strains on 1% mucin media causes higher subsequent growth of S. maltophilia 
isolates on fresh 1% mucin media (between 3 fold and 5 fold) after adjustment to a 
uniform OD600. While all isolates showed higher subsequent growth on 1% mucin media 
after overnight growth in the presence of mucin, clinical CF isolate AU30115 achieves a 
significantly higher fold growth as compared to its growth on M63 minimal media (**p-
value=0.0053). Overnight growth of S. maltophilia isolates on M63 minimal media does 
not induce the processes necessary for efficient mucin utilization, as M63 minimal media 
pre-grown cultures do not show significantly higher growth when subsequently grown on 





Figure 4.2 Stenotrophomonas maltophilia isolates displaying varying degrees of 
biofilm formation under different conditions (A) Mucin induced significantly higher 
biofilm formation (~2 fold increase) in S. maltophilia K279a as compared to its biofilm 
formation in 1/20 LB/M63 media (*p-value=0.013). Clinical CF isolates AU30115 and 
AU32848 showed no significant changes in biofilm formation in the presence of mucin. 
(B) Crystal violet staining demonstrates the robust mucin-dependent biofilm formation in 
S. maltophilia K279a. (C) After incubation in either 1/20 LB/M63 media or M63 1% 
mucin media S. maltophilia strain K279a displays significantly higher biofilm formation 
as compared to clinical CF isolates AU30115 and AU32848. Respective p-values: 1/20 
LB/M63 AU30115 **p-value=0.0027, 1/20 LB/M63 AU32848 **p-value=0.0017, 1% 
mucin M63 AU30115 ***p-value=0.0005, 1% mucin M63 ***p-value=0.0004.  
 
Figure 4.3 Liquid and solid media screens of a S. maltophilia K279a transposon 
mutant (TnM) library identified several genes involved in wild type S. maltophilia 
growth on mucin as a sole source of carbon and nitrogen. (A) TnMs displaying 
aberrant growth in liquid 1% mucin media, including increased clumping and decreased 
cell density, had disruptions in genes involved in the synthesis of cell structural 
component lipopolysaccharide (LPS). (B) A gene-association map predicted using the 
STRING database, which takes factors such as experimental evidence, genomic 
proximity, co-expression, and co-occurrence of certain genes into account, shows the 
likely involvement of all liquid screen hits in the process of LPS production, including O-
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antigen synthesis. (C) Four TnMs with aberrant mucin growth were identified in the solid 
media screen (smlt4208: ***p-value=0.0002, smlt0517: ***p-value=0.0003, smlt4171: 
**p-value=0.0019, smlt4058: ****p-value<0.0001). (D) Disruptions in genes involved in 
cell growth and morphology, sugar modification, ion transport, and gene regulation 
resulted in some degree of aberrant mucin growth in S. maltophilia K279a.   
 
Figure 4.4 Microarray analysis identified transcripts of genes with more than a 2.5-
fold increase in expression in S. maltophilia K279a in the presence of 1% mucin. (A) 
Analysis of the predicted functions of the up-regulated genes showed that the largest 
transcript class consisted of genes of unknown function. Of the up-regulated genes with 
predicted functions, genes involved in primary metabolism, phage/DNA transfer, and 
protease/peptidase production were among the top three most abundant transcript classes. 
(B) Protease and peptidase genes were among the most highly up-regulated genes, with 
predicted autotransproters smlt1001 and smlt1350 displaying over 10-fold increases in 
expression in mucin over the control condition.  
 
Figure 4.5 Mucin-associated genes are highly conserved among S. maltophilia strains 
with a few exceptions. (A) Conservation of mucin-associated genes among 44 sequenced 
strains of S. maltophilia shows that 66.67% are highly conserved (defined as 85% or 
higher coverage and identity). Genes with lower conservation across the 44 strains are 
highlighted in purple and include the sensor-histidine kinase response regulator smlt4208 
(bfmK), predicted rod-shape determining protein smlt4058 (mreC), putative 
autotransporter smlt1001, and putative autotransporter-containing peptidase smlt4145. 
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(B) Among the strains studied, including bacteremia isolate K279a and CF isolates 
AU30115 and AU32848, the majority of mucin-associated genes are conserved, with 
gene coverage and identity between 98-100%. Clinical isolate AU30115 lacks a homolog 
for smlt0517, the predicted CDF family Co(II)/Zn(II) efflux transporter. Clinical isolate 
AU32848 possesses a potential homolog for predicted peptidase smlt4145 but with low 
coverage and identity. The conservation of mucin-associated genes is weaker in two 
environmental isolates, BurA1 and RR-10. Genes with coverage lower than 85% are 
highlighted in a darker shade of the column color. 66.67% of mucin-associated genes 
were highly conserved in BurA1 while only 33.33% were conserved in the rice-root 
isolate RR-10. A 16S rRNA control gene that is highly conserved among S. maltophilia 
strains and is not associated with the response to mucin, rsmD, was also analyzed for 
conservation across strains and was highly conserved in all four.  
 
Figure 4.6 Several highly expressed autotransporters have characteristics that may 
contribute to S. maltophilia virulence (A) Smlt1001 possesses a ClpP/crotonase-like 
domain in the N-terminus predicted to be involved in protein degradation. (B) Although 
lacking a conserved proteolytic domain, the predicted secondary structure of Smlt1350 
most closely resembles a ClpP protease subunit, but the absence of the third member of 
ClpP’s catalytic triad (boxed in red) may indicate a lack of catalytic activity. (C) 
Smlt4145 has the most probable protease domain, belonging to the S8/S53 superfamily of 
serine proteases, with several catalytic residues present. The fibronectin- binding domain 
between the protease and autotransporter domains suggests that Smlt4145 binds 
glycoproteins for subsequent cleavage via the serine protease domain.  
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4.7 Chapter 4 Tables	 
Table 4.1 Strains used in this study 
Table 4.2 Primers used in the study  
Table 4.3 Transcript changes in S. maltophilia K279a in response to mucin  










































Figure 4.1 S. maltophilia more efficiently utilizes mucin as a sole source of nutrients 
















































































































Figure 4.2 Stenotrophomonas maltophilia isolates displaying varying degrees of biofilm 





































































* by One Way ANOVA
















smlt4058 mreC;	rod	shape-determining	protein solid	(Fig	3B)  
 
Figure 4.3 Liquid and solid media screens of a S. maltophilia K279a transposon mutant 
(TnM) library identified several genes involved in wild type S. maltophilia growth on 







































Smlt3861 putative	proline	dipeptidase 3.92  
 
Figure 4.4 Microarray analysis identified transcripts of genes with more than a 2.5-fold 

























Gene	ID Coverage	 Identity Coverage Identity Coverage Identity Coverage Identity
smlt0702 100% 100% 100% 99.17% 100% 89.64% 100% 91.90%
smlt0650 100% 100% 98% 85.28% 98% 88.88% 0% 0%
smlt0647 100% 100% 100% 96.02% 100% 95.65% 0% 0%
smlt4208 100% 100% 100% 98.92% 0% 0% 98% 85.15%
smlt0517	 0% 0% 99% 97.94% 100% 94.15% 99% 95.71%
smlt4171 100% 100% 100% 98.96% 99% 92.04% 3% 81.08%
smlt4058 100% 100% 100% 98.81% 100% 92.15% 6% 93.55%
smlt1350 100% 100% 100% 98.99% 57% 86% 0% 0%
smlt1001 100% 100% 98% 99.55% 22% 81.63% 0% 0%
smlt4145 100% 100% 69% 77.96% 74% 86.54% 73% 86.80%
smlt4395 100% 100% 100% 99.66% 100% 96.43% 100% 85%
smlt3861 100% 100% 100% 99.10% 100% 96.47% 4% 89.09%




Figure 4.5 Mucin-associated genes are highly conserved among S. maltophilia strains 












Figure 4.6 Several highly expressed autotransporters have characteristics that may 













































Table 4.3 Transcript changes in S. maltophilia K279a in response to mucin  













































putative	two-component	regulatory	system	family,	response	regulator	protein Smlt2645 2.51  
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CHAPTER 5: Dissertation Summary  
 
Opportunistic pathogens such as Pseudomonas aeruginosa and Stenotrophomonas 
maltophilia pose a large threat to human health and the growing incidence of multi-drug 
resistant infections caused by these nosocomial pathogens is a public health concern[1], [2], 
[3], [4]. Even related bacteria that are generally considered nonpathogenic, such as 
Pseudomonas putida, are able to exploit host-derived nutrients and, on rare occasions, 
cause infection in immunocompromised individuals[5]. The ability of these pathogens to 
transition from the environment to a human host is in large part predicted to be due to 
transcription of specific regulators that detect host-derived compounds and initiate the 
transcription of genes involved in the exploitation of these compounds, promoting 
pathogen growth and virulence[6].  
The rapid increase in multidrug resistance among Gram-negative bacteria and the 
emergence of new opportunistic pathogens highlight the necessity for the development of 
new strategies for treatment of opportunistic infections. The goal of the research outlined 
in this dissertation is to gain a better understanding of how Gram-negative bacteria of 
varying degrees of virulence detect, respond to, and exploit host-derived nutrients, and 
how these responses impact the host-pathogen interaction.  
5.1 Chapter 2 Summary  
In Chapter 2 of this dissertation, a creatine-responsive system regulating creatine 
metabolism was identified in the environmental Gram-negative bacteria P. putida. 
Creatine is a physiologically important and bioactive polyamine compound, playing vital 
roles in the cycling and transport of high-energy molecules throughout the blood and 
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tissues of the body[7]. Given the phylogenetic distribution of homologs of P. putida’s 
creatine-responsive genes primary in non-pathogenic bacteria, it appears that this creatine 
metabolic system evolved as a mechanism for exploitation of a nitrogen-rich compound 
encountered in soils during mammalian tissue degradation and waste excretion. The 
appearance of orthologs of P. putida’s creatine-responsive transcriptional regulator 
PP_3665 and the creatinase PP_3667 in several pathogenic species including 
Acinetobacter and Burkholderia species, calls into question whether metabolism of 
creatine aids infection by allowing for exploitation of a nutrient-rich compound that is 
abundant in mammalian tissues and serum.  
In addition to furthering our understanding of the potential role of creatine in 
bacterial pathogenesis, characterization of the creatine-responsive transcriptional 
regulator can also aid in our understanding of regulators belonging to the same family. 
PP_3665 is a class-I glutamine amidotransferase domain-containing AraC-family 
transcriptional regulator (GATR), a type of transcriptional regulator that has been 
associated with the detection of multiple N-methylated amine and polyamine compounds 
that are important to bacterial metabolism and stress resistance. Identifying the cognate 
ligand for GATR PP_3665 establishes the function of a previously uncharacterized 




5.2 Remaining Questions regarding the role of creatine metabolism 
5.2.1 Does creatine metabolism contribute to bacterial virulence and does horizontal 
gene transfer of creatine metabolic genes to pathogenic bacteria increase survival 
within certain infection niches? 
As discussed in Chapter 2, P. putida rarely causes infections in humans. The 
likely use for the creatine responsive and metabolic genes transcribed by P. putida is for 
degradation of animal excretions or decaying tissues present in the soil, P. putida’s 
primary niche. The appearance of creatinase PP_3667 orthologs on plasmids carried by 
more pathogenic bacteria such as Acinetobacter species (Figure 2.6) raises the question 
as to whether P. putida’s creatine-degrading genes have the potential to support tissue 
damage in the context of a tissue-invasive bacterial infection. Certain isolates of 
Pseudomonas aeruginosa associated with the presentation of Shanghai fever, which is an 
enteric illness with symptoms including necrotizing enteritis, sepsis, and echythema 
gangrenosum, possess orthologs of the creatine-responsive creatinase in P. putida[8].  It is 
possible that the presence of creatine-metabolism genes promotes P. aeruginosa growth 
in the context of a necrotizing tissue-damaging infection like Shanghai fever.  
 The ability of pathogens possessing creatinase PP_3667 and transcriptional 
regulator PP_3665 homologs to grow on creatine, including P. aeruginosa Shanghai 
fever and Acinetobacter isolates, could be tested via creatine growth assays like those 
conducted in Chapter 2. The role of the creatinase-responsive system in growth on 
creatine in these isolates could be evaluated through targeted gene deletions and 
assessment of the mutants’ abilities to grow on creatine. Measuring levels of tissue 
damage caused by and/or levels of serum survival of strains possessing or lacking the 
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creatine metabolic genes would allow us to determine if creatine metabolism contributes 
to virulence.  
If we observed any increase in virulence of strains possessing homologs to P. 
putida’s creatine metabolism genes, it would also be interesting to evaluate whether P. 
putida’s creatine-responsive and metabolic genes can directly transfer the ability to 
degrade creatine to other Gram-negative bacteria. The cross-species activity of P. 
putida’s creatine metabolic system could be evaluated by expressing the creatine 
metabolic genes of P. putida along with the creatine-responsive transcriptional regulator 
PP_3665 on a plasmid and/or via chromosomal integration in a species of interest, such 
as Pseudomonas aeruginosa, that does not efficiently metabolize creatine. Seeing as 
transposons containing creatinase orthologs are retained on plasmids in pathogenic 
Acinetobacter, it is reasonable to hypothesize that creatine metabolism genes are 
susceptible to gene transfer and that they may be useful during infection (Figure 2.6).  
5.3 Chapter 3 Summary 
In Chapter 3 of this dissertation, a sphingosine-responsive metabolic operon of the 
Gram-negative opportunistic pathogen P. aeruginosa was characterized. This metabolic 
operon, containing a putative mono-heme cytochrome c SphB, putative oxidoreductase 
enzyme SphC, and putative aldolase enzyme SphD, was evaluated for its ability to 
modify sphingosine and its biological relevance in the context of P. aeruginosa growth in 
the presence of sphingosine. Sphingosine is an amphipathic host-derived lipid that is 
primary generated by metabolism of the host membrane components sphingomyelin and 
ceramide. Sphingosine is an effective antimicrobial against many Gram-positive and 
Gram-negative bacteria and acts as a first line of innate-immune defense on the skin and 
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at mucosal barriers throughout the body [9], [10]. Gram-positive bacteria generally succumb 
to lower concentrations of sphingosine, while certain Gram negatives like P. aeruginosa 
can withstand extremely high sphingosine concentrations [11].  
Chapter 3 of this dissertation validated the role of sphBCD in aiding P. 
aeruingosa growth in the presence of high concentrations of sphingosine. The necessity 
of sphB and sphC for metabolism of sphingosine by P. aeruginosa was also observed. 
The sphBCD operon was transcribed in response to multiple biologically-relevant 
sphingosine analogs, and was necessary for the maximal growth of P. aeruginosa in the 
presence of several antimicrobial sphingosine analogs. This research begins the 
characterization of a bacterial system used to neutralize the negative effects of a host-
derived antimicrobial on bacterial growth. It also validates the existence and activity of 
genes involved in metabolism of a host-derived compound that in its bioactive form, 
sphingosine-1-phosphate (S1P), plays a critical role in immune cell signaling (S-1-P 
immune signaling review[12]). As a whole, this research adds to the fields of host-
pathogen interactions and bacterial sphingolipid metabolism and providing a foundation 
for future studies into how P. aeruingosa sphingosine metabolism effects the progression 
of opportunistic infections.  
5.4 Research In Progress: P. aeruginosa sphingosine metabolism  
5.4.1 Identification of sphingosine metabolic products produced by Pseudomonas 
aeruginosa 
Chapter 3 of this dissertation provided evidence of the role of metabolic operon 
sphBCD in sphingosine modification by P. aeruginosa. The hypothesized metabolic 
pathway beginning with reduction by putative oxidoreductase SphC, followed by 
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cleavage by putative aldoase SphD, was also validated in Chapter 3, as loss of SphC 
alone is enough to prevent modification of sphingosine into a form that is no longer 
detectable by SphR (Figure 3.5A). Although we have experimental evidence suggesting 
that sphBCD acts on sphingosine, we have yet to confirm the identities of the metabolic 
products of sphingosine metabolism. In order to achieve this goal, constructs expressing 
tagged versions of enzymes SphC and SphD have been built. A vsvG-tagged version of 
SphC has been tested for its ability to complement wild type P. aeruginosa growth in the 
presence of sphingosine and its ability to modify sphingosine when expressed in a PAO1 
∆sphC background (Figure 5.1A, 5.1B). Currently no phenotypic defect has been 
observed in PAO1 ∆sphD mutants potentially due to redundant aldolase enzymes in P. 
aeruginosa, so the activity of a tagged-SphD enzyme will be tested in an in-vitro 
enzymatic assay, which is under development. The necessity of sphB for maximal sphC 
activity is also noted in Chapter 3, therefore all three sphBCD products will be expressed 
and purified for the sphingosine metabolism assays. The products of SphBCD 
metabolism of sphingosine will be determined via mass spectrometry.  
5.5 Remaining questions regarding the biological role of sphBCD  
5.5.1 At what stage of P. aeruginosa lung infection is sphBCD most important? 
Lacking functional sphR, which is the transcriptional regulator necessary for 
transcription of the sphBCD operon, significantly decreases the survival of P. aeruginosa 
within the murine lung, though curiously, lacking sphC does not significantly impact P. 
aeruginosa survival within the murine lung [13]. Despite the lack of an in vivo survival 
defect when genes in the sphBCD operon are deleted, all operon members are highly 
induced in response to lung surfactant, suggesting that sphBCD plays a role in P.. 
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aeruginosa’s interaction with the lung [13]. The two potential hypotheses given this 
information is that P. aeruginosa uses sphingosine as a nutrient source or that sphBCD is 
needed to detoxify antimicrobial sphingosine from the extracellular environment. Given 
that sphingosine isn’t efficiently used by P. aeruginosa as a source of nutrients, the more 
likely hypothesis is that of detoxification. If the function of sphBCD is detoxification, a 
survival defect would be expected in the ∆sphC strain, but curiously there is none 
observed using a short-term (24 h) murine lung infection model. This discrepancy, taken 
with the in vitro observation that lack of sphC causes a significant P. aeruginosa growth 
defect in the presence of high levels of sphingosine, raises the question of when sphBCD 
is most important during the course of infection. P. aeruginosa is endogenously very 
resistant to sphingosine, therefore only high levels of sphingosine will result in a decrease 
in P. aeruginosa growth due to sphingosine’s antimicrobial effects. It is possible that 
sphBCD becomes important in vivo only after there has been sufficient cerN-dependent 
sphingosine generation. It is also possible that the necessity of sphBCD would only be 
seen during infection of the lungs of CFTR deficient mice, which accumulate high levels 
of ceramide in their lungs prior to infection [14], [15]. An increase in ceramide and other 
sphingolipid species due to alterations in de novo sphingolipid synthesis and recycling 
pathways has also been observed in human epithelial cells from individuals with low 
functional CFTR expression or the ∆F508CFTR mutation [16]. The increased levels of 
ceramide in CFTR deficient lungs would cause higher localized concentrations of 
sphingosine after cerN-mediated ceramide hydrolysis, making sphBCD necessary for 
detoxification. The impact of sphBCD operon members on P. aeruingosa survival during 
CF lung infection could be evaluated in vitro by measuring survival of P. aeruginosa 
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wild type and sphBCD operon mutants in the presence of synthetic sputum media 
(SCFM), which has a high ceramide concentration, and in vivo using an infection model 
of gut-corrected CFTR-deficient mice [15], [17]. 
There is also evidence that sphingosine-responsive SphR-dependent genes 
become less essential as an infection transitions into a chronic one. Lars Jelsbak’s group 
at the Technical University of Demark discovered multiple intergenic regions in P. 
aeruginosa’s genome that are prone to mutation during chronic lung infection [18]. One of 
the mutated regions is the promoter region of the sphingosine-responsive cerN gene. 
Three unique mutations in SphR’s binding site are present in the P. aeruginosa chronic 
infection clinical isolates studied by Jelbak and colleagues (Figure 5.2A). The mutated 
promoter regions of cerN were tested for their ability to be recognized by SphR and 
induce sphingosine-responsive gene transcription. Two of the three mutated promoter 
regions were no longer recognized by SphR, resulting in a lack of cerN transcription in 
the presence of sphingosine (Figure 5.2A, 5.2B). This evolved loss of cerN production 
calls into question the necessity of sphBCD during chronic infection. If cerN is not 
contributing to the extracellular sphingosine pool, sphBCD may become obsolete as P. 
aeruingosa infection progresses and strains with mutation in both cerN and sphBCD 
promoter regions may be selected for. A mutation resulting in lack of sphBCD 
transcription could help to reduce inflammation by lowering the accumulation of 
hexadecenal, a putative metabolic product of sphingosine metabolism that causes 
apoptosis in several mammalian cell types [19]. Alternatively the promoter region of 
sphBCD may be unaffected and expressed during chronic infection to metabolize 
extracellular sphingosine generated by host-derived ceramidases. It would be interesting 
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to determine whether the promoter region of sphBCD is also mutated in the P. 
aeruginosa chronic infection isolates that have mutated cerN promoter regions and to test 
any mutated sphBCD promoters for SphR-dependent transcriptional activity. If sphBCD’s 
promoter region is maintained in its sphingosine-responsive state during strain evolution 
in chronic infection, it would support the hypothesis that sphBCD is still essential for 
detoxification of host-generated sphingosine even in the absence of cerN sphingosine 
generation, and/or suggest that sphingosine metabolism has other biological roles during 
chronic infection, such as modulating the host-immune response via metabolism of 
bioactive sphingolipids. The biological role of SphR-dependent genes cerN and sphBCD 
in chronic lung infections could be tested via the use of murine lung infection models that 
mimic chronic infection [20].  
5.5.2 What is the biological function of the sphBCD operon in other infection niches? 
There are several body sites abundant in sphingosine, sphingosine analogs, and 
sphingosine precursors, where P. aeruginosa infects or colonizes. Two body sites of 
particular interest are the skin, where conditions including psoriasis and atopic dermatitis 
render individuals prone to bacterial infection, and the gallbladder, from which P. 
aeruginosa is one of several bacteria isolated in cases of gallstone disease [21], [22], [23], [24], 
[25].  
5.5.3 Is sphBCD important in P. aeruginosa’s interaction with dermal sphingolipids? 
The skin produces various ceramide and sphingosine species, including all of the 
sphingosine analogs tested for induction of SphR-dependent genes in Chapter 3 of this 
dissertation. The functions of these sphingolipids are to maintain proper skin barrier 
function, primary through signaling, antibacterial activity, and prevention of trans-
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epidermal water loss [22]. Certain sphingolipids, such as phytoceramide (phytoCer), which 
is a type of ceramide consisting of a fatty acid and phytosphingosine, comprise ~32% of 
epidermal sphingolipids and are the most essential for effective barrier function. A 
reduction in phytoCer is correlated with most skin diseases, including psoriasis; a skin 
disease characterized by hyper-proliferation of keratinocytes and increased inflammation 
effecting 1-3% of the population, and atopic dermatitis, an inflammatory skin disorder 
[22]. Considering the high induction of sphBCD in response to phytosphingosine, the 
sphingolipid component of phytoCer, it can be hypothesized that sphBCD plays a role in 
P. aeruginosa survival on the skin (Figure 5.3). It is also reasonable to hypothesize that 
infection involving P. aeruginosa on the skin of individuals prone to psoriasis or atopic 
dermatitis may exacerbate the condition, as P. aeruginosa possesses the metabolic 
machinery to fully degrade phytoCer and other barrier-maintaining sphingolipids.  
There is evidence of the involvement of P. aeruginosa in psoriatic lesion 
infection, as P. aeruginosa was one of 18 genera of bacteria that have been cultured from 
psoriatic lesional skin [22]. P. aeruginosa has also been cultured from individuals with 
eczema, specifically from the leg and trunk regions. It is interesting to note that 
Staphylococcus aureus is the most commonly dominating bacteria on psoriatic skin, most 
likely due to the low levels of sphingolipids, which are highly antimicrobial to S. aureus 
[11], [22]. It is likely that sphBCD aids in the survival of P. aeruginosa on the skin, as the 
operon is highly induced in the presence of sphingolipids found on the skin. The role of 
sphBCD in P. aeruginosa skin infection is an important area requiring study, as P. 
aeruginosa has the potential to exacerbate skin conditions characterized by insufficient 
sphingolipid composition such as psoriasis and atopic dermatitis, and/or to create a 
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sphingolipid-deficient environment on otherwise healthy skin allowing for the 
proliferation of other pathogenic sphingosine-sensitive bacteria such as S. aureus. 
sphBCD’s role in modification of hair-sheath barrier lipids like phytosphingosine and 
how degradation of sphingolipids at hair follicles impacts the pathogenesis of P. 
aeruginosa folliculitis would also be an interesting topic to investigate.   
5.5.4 Do P. aeruginosa’s sphingosine-responsive genes play a role in gallstone 
disease? 
 The biliary tract contains high levels of lipids, predominantly cholesterol and 
phosphatidylcholine (PC) [25]. Microbes have been isolated from the biliary tract, 
specifically the gallbladder, in cases of symptomatic gallstone disease, where bile 
components within the gallbladder crystalize forming stones [25]. The second most 
common microbe isolated from the gallbladders of individuals with gallstone disease is 
P. aeruginosa [24]. The presence of P. aeruginosa in the gallbladders of individuals with 
gallstones is interesting, as a study by Lee et al found that mice with higher levels of 
ceramide in their bile due to dietary regiments had a higher incidence of gallstone 
formation [25]. It would be interesting to investigate whether P. aeruginosa’s ability to 
metabolize sphingomyelin, which is found in abundance in the outer leaflet of cells, into 
ceramide contributes to the formation of gallstones. The role of sphBCD in the 
gallbladder and whether the further metabolism of ceramide to inflammatory sphingosine 
contributes to the pathology of gallstone disease is also a topic of interest. It is reasonable 
to hypothesize that sphBCD is important in P. aeruingosa’s ability to metabolize host 
sphingolipids within the gallbladder due to the high levels of precursors sphingomyelin 
and ceramide present in the biliary tract, but it would be interesting to evaluate the extent 
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to which P. aeruginosa’s sphingolipid-responsive system contributes to gallstone disease 
pathology via mouse gallstone disease models infected with PAO1 wild type and 
∆sphBCD strains [26], [27].  
5.6 Chapter 4 Summary  
S. maltophilia is an opportunistic pathogen that infects the lungs of 
immunocompromised individuals such as those with CF or COPD. Chapter 4 of this 
dissertation evaluates S. maltophilia’s capacity to metabolize mucin as a sole source of 
carbon, nitrogen, and methionine, and identifies genes involved in S. maltophilia’s 
response to and metabolism of mucin. Mucins are the heavily glycosylated glycoproteins 
that comprise mucus, which is found in abundance in CF sputum and is a nutrient rich 
substrate for the bacteria that are able to metabolize it. Although mucin fermentation, 
which is carried out by many oral anaerobic bacteria, has been characterized, the 
processes involved in aerobic mucin metabolism by the non-fermenter S. maltophilia 
have not been elucidated. The mucin-associated genes identified in Chapter 4 include 
those involved in sugar modification, cell growth and morphology, transcriptional 
regulation, and peptide degradation. This research adds to our knowledge of how 
opportunistic pathogens utilize recalcitrant host-derived nutrients and provides the 
foundation for future research regarding the potential for nutritional synergy between 
opportunistic pathogens during infection.  
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5.7 Research in Progress: S. maltophilia mucin metabolism   
5.7.1 Potential protease redundancy and phenotypic defects due to selective pressure 
Chapter 4 of this dissertation identified genes that are necessary for the metabolism 
of, or involved in the response to mucin as a carbon and nitrogen source for the 
opportunistic pathogen Stenotrophomonas maltophilia. The genes identified must be 
validated through deletion and complementation of the genes from the genome of S. 
maltophilia, and subsequent testing of deletion and complement strains for aberrant 
growth on mucin. S. maltophilia K279a deletion strains have been created for the top four 
highly-induced putative proteases, including single deletions of auto-transporter 
smlt1001, extracellular protease smlt4145, and serine protease smlt4395, and a double 
deletion of both auto-transporters smlt1001 and smlt1350. Growth assays using M63 1% 
mucin media as the sole carbon, nitrogen, and methionine source showed no significant 
defects in growth between wild type K279a and deletion strains (Figure 5.4). This 
supports the hypothesis that the mucin-responsive proteases are redundant in their 
capacity to metabolize mucin and that singular deletions of proteases involved in mucin 
degradation may not be sufficient to produce defective mucin growth.  
While testing mutants in auto-transporters smlt1001 and smlt1350 for mucin-related 
phenotypes, a significant surface-attached biofilm defect was observed compared to wild 
type (Figure 5.5A, 5.5B). It was not surprising to observe a biofilm formation defect in 
K279a after deletion of mucin-associated genes, as part of S. maltophilia’s phenotypic 
response to mucin involves robust biofilm formation (Figure 4.2).  
The lack of characterized homologs in other species and the absence of predicted 
conserved domains, aside from the auto-transporter beta-barrel domains in Smlt1350 and 
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Smlt1001, and crotonase-like domain in Smlt1001, make it hard to predict the exact 
function of these auto-transporters. While Smlt1001 has a putative catalytic domain, 
Smlt1350 does not, therefore the function of these outer membrane proteins may be in 
adhesion rather than protein degradation. Unfortunately, biofilm assays conducted with 
wild type revertants of K279a ∆smlt1001 and ∆smlt1001smlt1350 strains also displayed 
varying degrees of aberrant biofilm formation, indicating that the reduced ability to form 
a biofilm in the presence of mucin was an artifact of the selection pressures applied 
during the allelic exchange protocol.   
Wild type revertant colonies are colonies that have passed through the selective 
pressure applied during the allelic exchange protocol but recombined to lose the deletion 
construct, and regenerate the wild type locus. These revertants are expected to phenocopy 
the wild type strain as, hypothetically, there are no genetic differences between wild type 
revertants and the original wild type strain. The aberrant biofilm defects observed in a 
handful of wild type revertant colonie,s as well the mutant strains, indicated that off-
target mutations were most likely accumulating during allelic exchange. It is important to 
note that both smlt1001 and smlt1350 have a tRNA present in their direct upstream or 
downstream genomic regions. tRNAs frequently recombine as they are very similar in 
sequence and there may be stress-induced chromosomal rearrangement of larger genomic 
areas around smlt1001 and smlt1350 during the process of allelic exchange, which could 
be responsible for more systemic and varied phenotypes in ‘wild type revertants’ that 
have scrambled off-site regions of the genome due to random tRNA recombination. 
Many Gram-negative bacteria are known to invert large areas of their genome in response 
to stress, creating small colony variants with phenotypes very similar to our allelic 
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exchange mutants and wild type reverts (Figure 5.3C) [28], [29], [30], [31], [32], [33]. By placing 
intense selection pressure on S. maltophilia during the allelic exchange protocol we may 
have triggered large-scale genomic inversions or rearrangements. We are currently 
purifying genomic DNA from and sequencing a selection of K279a colonies with varying 
degrees of phenotypic defects in order to determine the regions of S. maltophilia’s 
genome that are most conducive to rearrangement under antibiotic stress. This could 
provide some insight into which regions of the genome are involved in the transition to 
small colony variants during chronic infection where pathogens are continuously exposed 
to antibiotic stress.  
5.7.2 Validation of the necessity of mucin-associated genes in S. maltophilia growth 
on mucin 
Given the nonspecific phenotypic defects discovered in mutants and wild type 
revertants alike, a different protocol of mutant generation must be developed before the 
genes identified in the phenotypic screens and microarray can be evaluated for their role 
in growth on mucin. Strategies involving the CRISPR Cas9 system and single step 
recombination using chromosomally integrated antibiotic resistance cassettes are in the 
process of development and optimization. The tendency towards large-scale genomic 
rearrangement may also be strain specific; therefore we will use the previously created 
mucin-associated gene deletion constructs and attempt allelic exchange in the genetically 
tractable clinical isolates AU30115 and AU32848.  
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5.8 Remaining questions regarding mucin metabolism in S. maltophilia and 
potential roles in virulence  
5.8.1 Are there extracellular sialidases and glycosylases involved in S. maltophilia’s 
response to mucin? 
There are many different types of mucin glycoproteins expressed throughout the 
human body. The studies conducted in Chapter 4 of this dissertation used pig gastric 
mucin (PGM) as a substrate from S. maltophilia growth. There are many similarities 
between PGM and human derived mucins, such as the presence of O-linked glycans, 
terminal carboxyl and sulfate groups, and cysteine, serine and threonine rich regions, but 
the specific structures and biophysical properties of different mucin polymers are 
heterogeneous [34], [35], [36]. Although PGM was used for the microarray experiments 
conducted in Chapter 4 of this dissertation, microarrays conducted using purified bovine 
submaxillary mucins, which are very similar to human-derived mucins, garnered very 
similar results, with the majority of the mucin-associated genes that were up-regulated in 
the PGM microarray also being highly expressed in the bovine submaxillary mucin-
containing microarray [37]. The similarity in genes expressed after exposure to two 
different types of mucin suggests that S. maltophilia’s response to mucin is not specific to 
a certain mucin type.  
Although S. maltophilia’s transcriptional responses to PGM and bovine submaxillary 
mucins were similar, there are certain enzymes whose expression was expected that were 
not up regulated in the mucin microarrays. The absence of highly transcribed 
extracellular glycosylases and sialidases in the mucin microarray could be due to the time 
point at which the microarray samples were taken. The fact that proteases/peptidases 
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were the most highly transcribed genes indicates that S. maltophilia was degrading the 
proteinaceous backbone of mucin at the time of RNA isolation, and in order to access this 
backbone mucin must be stripped of its O-linked glycans. In order to identify the 
glycosylases and sialidases potentially involved in lysing the disulfide crosslinks between 
mucin glycans and hydrolyzing the O-linkages between the mucin peptide backbone and 
its attached glycans, RNA must be collected at earlier time points then the 4 hour time 
point already analyzed.  
Although no putative extracellular glycosylases were highly transcribed in response 
to mucin in K279a, several genes involved in sugar modification were hit in the 
phenotypic screens. Although the majority of these sugar-modifying enzymes have 
connections to LPS production, there is a possibility that these enzymes can moonlight as 
sugar metabolism enzymes when certain sugars are present in excess. In addition to 
testing the sugar-metabolism capacity of the LPS-associated enzymes, through 
construction of gene deletions and completion of growth assays to compare mutant 
growth on different glycans, it would be interesting to investigate whether S. maltophilia 
can incorporate irregular sugars into its LPS when supplied predominantly with a certain 
type of glycan. Glycan content could be evaluated using glycan-identifying microarray 
strategies or SDS PAGE electrophoresis with glycan-specific antibodies [38], [39]. If the 
composition of respiratory mucins shifts the composition of S. maltophilia surface and 
LPS-incorporated sugars in favor of specific mucin-associated glycans, the composition 
of S. maltophilia LPS could be used as an indicator of adaptation to the lung.  
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5.8.2 What role do the mucin-associated genes bfmK/smlt4208 and smlt4145 play in 
S. maltophilia virulence?  
There are two genes whose role in S. maltophilia’s response to mucin is of 
particular interest. The first is the histidine kinase response regulator bfmK (smlt4208). 
Although bfmK has been partially characterized, and its role in biofilm formation and cell 
motility has been confirmed, construction of a clean gene deletion for use in determining 
which genes are part of bfmK’s regulatory network during exposure to mucin (via RNA 
seq), would provide important information regarding the extent of bfmK’s role in S. 
maltophilia virulence [40]. As mucin is a signal triggering the transcription of virulence-
associated genes in other bacteria such as Acinetobacter, it is important to determine 
whether bfmK contributes to S. maltophilia virulence in a similar way, by triggering a 
multi-gene response to mucin [41], [42]. The second gene that may play a role in S. 
maltophilia mucin-mediated virulence is the putative extracellular protease smlt4145. 
Protein sequence analysis of Smlt4145 shows that in addition to a serine protease and 
autotransporter domain, Smlt4145 possesses a region between the protease and 
autotransporter domains with a predicted fibronectin-binding domain (Figure 4.6C). The 
fibronectin-binding domain identified in Smlt4145 is modeled off of the host colonization 
protein ShdA of Salmonella enterica [43], [44]. Although ShdA and Smlt4145 share low 
sequence similarity, Salmonella sp. 3DZ2-4SM possesses a putative autotransporter 
serine protease containing a fibronectin-binding domain with 76.69% identity over the 
133 amino acid region. The similarity between the two whole protein sequences was 
slightly lower at 54.92%. Fibronectin is a glycoprotein that is bound by many pathogenic 
bacteria to assist with colonization. The presence of a putative glycoprotein-binding 
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domain and protease domain makes Smlt4145 a good candidate protein for involvement 
in mucin binding and degradation. Although the already constructed K279a ∆smlt4145 
strain does not show aberrant growth on mucin (Figure 5.4), a new deletion mutant must 
be made using a system that does not result in non-specific biofilm defects so that the 
contribution of smlt4145 to mucin binding by S. maltophilia can be reliably evaluated. It 
is also possible that any of the other mucin-responsive putative proteases may be able to 
compensate for a lack of smlt4145, resulting in no measurable mucin growth defect in the 
single ∆smlt4145 mutant strain.  
5.8.3 What is the role of S. maltophilia mucin metabolism during polymicrobial 
infection?  
Mucin is not easily metabolized by many opportunistic pathogens associated with 
the CF lung. The contribution of mucin-fermentative oral anaerobes to the growth of CF 
pathogens via cross-feeding with mucin fermentation products has been studied [45]. S. 
maltophilia is non-fermentative and most likely does not metabolize mucin in the same 
way as oral anaerobes, therefore the effects of S. maltophilia mucin metabolism on the 
growth of non-mucin metabolizing organisms during polymicrobial lung infection has yet 
to be evaluated. The first step in evaluating S. maltophilia’s ability to cross-feed co-
infecting lung pathogens like P. aeruginosa would be to conduct trans-well experiments 
where P. aeruginosa is supplied with the byproducts of S. maltophilia mucin metabolism 
as the primary nutrient source. If P. aeruginosa, a microbe that is unable to utilize mucin 
efficiently, grows well in the presence of the products of S. maltophilia mucin 
metabolism, it can be hypothesized that the presence of S. maltophilia within a mucin-
rich environment like the CF lung will improve the growth of P. aeruginosa during poly-
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microbial infection. Further characterization of any nutritional synergy between P. 
aeruginosa and S. maltophilia could be achieved by identification of the specific products 
of S. maltophilia mucin metabolism via mass spectrometry and subsequent evaluation of 
P. aeruginosa growth on the identified mucin metabolic products.  
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5.9 Material and Methods  
5.9.1 Strains and Growth Conditions  
 Pseudomonas aeruginosa PAO1 wild type and ∆sphR strains carrying cerN 
transcriptional reporter plasmids (Table 5.1) were grown in 1xMOPS media 
supplemented with 25 mM pyruvate, 5 mM glucose, and 20 µg/ml gentamicin +/- 20 µM 
sphingosine for transcriptional induction assays. Stenotrophomonas maltophilia K279a 
knockout strains were grown in 1/20 LB/M63 media or M63 1% mucin media to test 
mutants’ ability to utilize mucin as a sole source of carbon, nitrogen, and methionine.  
5.9.2 P. aeruginosa cerN promoter mutant transcriptional induction assays 
 P. aeruginosa PAO1 wild type and ∆sphR strains carrying cerN promoter mutant 
reporter plasmids (Table 5.1) were grown overnight in 1xMOPS media supplemented 
with 25 mM pyruvate, 5 mM glucose, and 20 µg/ml gentamicin at 37°C shaking at 170 
rpm. Strains were washed with 1xMOPs and added to a final OD600 of 0.05 to glass tubes 
containing 1xMOPS supplemented with 25 mM pyruvate, 5 mM glucose, 20 µg/ml 
gentamicin and +/- 20 µM sphingosine. Sphingosine was added to 20 µM from a 5 mM 
stock solution in ethanol. Ethanol was evaporated off before addition of media and cells. 
The cultures were incubated for 4 hours, shaking, at 37°C. Levels of growth (optical 
density at 600 nm) and β-galactosidase activity (absorbance at 420 nm) were measured 
using the Synergy II plate reader (BioTek). Transcriptional activity was calculated via 
Miller’s protocol[46] and reported as a percentage of the wild type cerN promoter 
transcriptional activity.  
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5.9.3 P. aeruginosa sphBCvsvG sphingosine growth assays and assessment of SphC-
vsvG’s sphingosine modification ability via thin layer chromatography 
 P. aeruginosa sphingosine growth assays were conducted as previously described 
in Chapter 3 of this dissertation. The sphBCvsvG complement construct was tested for the 
ability of a tagged version of SphC to recover wild type growth in the presence of 
sphingosine. vsvG-tagged SphC’s ability to modify sphingosine was also evaluated via 
sphingosine modification assays run with P. aeruginosa ∆sphC complemented with 
tagged and untagged sphC. Breifly, P. aeruingosa ∆sphC:sphC complement strains were 
incubated for 18 hours at 37°C with 50 µM sphingosine, followed by the separation of 
the cultures into the organic and aqueous phases. Visualization of sphingosine remaining 
in the organic phase of each culture was achieved via separation by thin layer 
chromatography and staining with ninhydrin spray. The sphingosine modification assay 
protocol is described in detail in Chapter 3 of this dissertation.  
5.9.4 Deletion of mucin-associated genes in S. maltophilia K279a via homologous 
recombination  
 Deletion constructs for mucin-associated genes smlt4145, smlt4395, smlt1350, 
and smlt1001, were built using sequence-specific primers as outlined in Table 5.2. 
Deletion constructs were created via amplification, restriction digestion, and sequential 
ligation of gene-of-interest flanking regions into the similarly cut S. maltophilia-
compatible suicide plasmid pGW67, which possesses the gentamicin and tetracycline 
antibiotic resistance cassettes, for selection of single cross-over mutants, and the sacB 
gene for counter-selection of double-crossover mutants. Homologous recombination was 
preformed as follows: E. coli S17λpir strains carrying the deletion constructs were mated 
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with S. maltophilia K279a at 1:1 and 1:10 concentrations and plated on LB agar plates 
supplemented with 40 µg/ml tetracycline, 20 µg/ml gentamicin, and 100 µg/ml 
kanamycin (LB +Abx), for the first round of selection. Single-crossover mutants were re-
streaked on LB + Abx plates once more to ensure that there is no carry over of antibiotic 
sensitive colonies. Confirmed single-crossover mutants were grown for 4 hours in LB to 
allow for the second crossover to occur. 1:100 and 1:1000 dilutions were plated on LB no 
salt agar plates amended with 10% sucrose to select for deletion mutants or wild type 
revertants. Strains were screened for gene deletion or wild type reversion using the 
screening (scrn) primers outlined in Table 5.2.  
5.9.5 S. maltophilia K279a mucin growth assays  
 Mucin growth assays were carried out as previously described in Chapter 4 of this 
dissertation using S. maltophilia K279a ∆smlt4145, ∆smlt4395, ∆smlt1001, and 
∆smlt1001smlt1350 deletion strains. ∆smlt4145, ∆smlt4395, and ∆smlt1001 are deletion 
mutants of single putative proteases, while ∆smlt1001smlt1350 is a double deletion of 
potential paralogs smlt1001 and smlt1350.  
5.9.6 S. maltophilia K279a mucin biofilm assays  
 Biofilm assays +/- 1% mucin were conducted as previously described in Chapter 
4 of this dissertation. Coverslip-attached biofilm assays were also conducted by 
incubating coverslips vertically in S. maltophilia cultures grown on M63 media 1% 
mucin or 1/20 LB/M63 media, followed by washing of the coverslip and crystal violet 
staining to visualize bacterial clumping and the surface attached biofilm structure using a 
light microscope.   
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5.9 Chapter 5 Figures  
Figure 5.1 Modification of sphingosine is dependent on the presence of SphC (A) 
vsvG-tagged SphC complements wild type (WT) growth in the presence of 200µM 
sphingosine. There is no statistical difference between WT : EV and ∆sphBCD : 
sphBCvsvG strain growth but the un-complemented strain, ∆sphBCD : EV grows to a 
significantly lower OD600 (*p-value=0.0399). Statistical significance was determined via 
2wayANOVA and Tukey’s test for multiple comparisons. (B) vsvG-tagged SphC 
complements untagged SphC’s ability to metabolize sphingosine, presented as the 
disappearance of the ninhydrin stained sphingosine spot separated via thin layer 
chromatography (TLC) after sphingosine was incubated with complemented or un-
complemented PAO1 ∆sphC strains of P. aeruginosa. The organic phase of each sample 
was isolated and run on the TLC plate along with a sphingosine control sample. The 
retention factor (Rf) of sphingosine is approximately 0.83 in the solvent system used 
(chloroform: methanol: water (65:25:4)).  
Figure 5.2 P. aeruginosa isolates from chronic CF lung infections acquire mutations 
in the cerN promoter region (A) A multiple sequence alignment of cerN wild type and 
mutant promoters shows mutations in or around SphR’s binding half site (highlighted in 
yellow). (B) Only mutations within the SphR half site sequence cause ablation of SphR-
dependent induction of cerN (****p-value<0.0001). All transcriptional induction 
experiments were conducted in biological triplicate and technical duplicate. Statistical 
significance was determined via One Way ANOVA using Dunnett’s multiple 
comparisons test.  
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Figure 5.3 Phytosphingosine, the sphingolipid component of phytoceramide, causes 
high SphR-dependent induction of the sphBCD operon (****p-value<0.0001). All 
transcriptional induction experiments were run in biological triplicate and technical 
duplicate. Statistical significance was determined using 2way ANOVA and Sidak’s 
multiple comparisons test.  
Figure 5.4 Single deletions of mucin-induced proteases in S. maltophilia K279a don’t 
impact growth on mucin. S. maltophilia K279a gene deletions of mucin-associated 
putative proteases show no significant deficiencies in growth on 1% mucin as a sole 
source of carbon, nitrogen, and methionine as compared to wild type S. maltophilia 
K279a. 
Figure 5.5 Deletion of smlt1350 via allelic exchange resulted S. maltophilia K279a 
clones with phenotypic defects (A) S. maltophilia K279a ∆smlt1350 has a biofilm 
defect when compared to wild type in the presence of 1% mucin (*p-value=0.0261) but 
there was no statistically significant difference between wild type and ∆smlt1350 surface-
attached biofilm formation in minimal media or diluted LB media. (B) Although the 
difference in biofilm formation between S. maltophilia K279a wild type and ∆smlt1350 
in diluted LB media is not statistically significant, there is a visible decrease in 
∆smlt1350’s biofilm formation in 1% mucin and diluted LB media’s. (C) There is also a 
visible difference in cell size and clumping in the presence of 1% mucin, with smaller 
cells and less clumping in ∆smlt1350 as compared to wild type. Biofilm assays were 




5.10 Chapter 5 Tables  
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Figure 5.4 Single deletions of mucin-induced proteases in S. maltophilia K279a don’t 
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Figure 5.5 Deletion of smlt1350 via allelic exchange resulted S. maltophilia K279a 






Table 5.1 Strains and plasmids used in this study.  
 
Designation Genotype	or	Description Plasmid Primers	Used	in	Construction	
LAH135 PAO1	WT pMW5:cerN	promoter	mutant	206.3 574,	1807
LAH136 PAO1	∆sphR pMW5:cerN	promoter	mutant	206.3 574,	1807
LAH137 PAO1	WT pMW5:cerN	promoter	mutant	222.2 574,	1807
LAH138 PAO1	∆sphR pMW5:cerN	promoter	mutant	222.2 574,	1807
LAH141 PAO1	WT pMW5:cerN	promoter	mutant	243.5 574,	1807
LAH142 PAO1	∆sphR pMW5:cerN	promoter	mutant	243.5 574,	1807
LAH147 PAO1	WT pMW5:cerN	WT	promoter 574,	1807
Designation Genotype	or	Description Plasmid Primers	Used	in	Construction	
LAH158 E.	coli	S17λpir pGW67:smlt4145KO	 2448,	2449,	2450,	2451
LAH199 K279a	∆smlt4145 none N/A
LAH178 E.	coli	S17λpir pGW67:smlt4395KO 2476,	2477,	2478,	2479
LAH196 K279a	∆smlt4395 none N/A
LAH169 E.	coli	S17λpir pGW67:smlt1350KO 2444,	2445,	2446,	2447
LAH193 K279a	∆smlt1350 none N/A
LAH179 E.	coli	S17λpir pGW67:smlt1001KO 2615,	2616,	2617,	2618
LAH213 K279a	∆smlt1001smlt1350 none N/A
LAH192 K279a	∆smlt1001	 none N/A
Designation Genotype	or	Description Plasmid Primers	Used	in	Construction	
LAH206 PAO1	∆sphC	 pMQ80:sphCvsvG 2511,	2514
LAH212 PAO1	∆sphC	 pMQ80 N/A
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